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Abstract
In eukaryotic cells, octamers of histone proteins intricately organize DNA, forming a macromolecule
known as nucleosomes. A nucleosome is comprised of two copies of histone H2A, H2B, H4, and H3.
Histone H3.3 (H3.3), a histone variant, is often found at actively transcribed loci. H3.3 plays a role in
cellular inheritance as ablation of H3.3 expression leads to loss of active gene states and dysfunction of
heterochromatin telomeric structures. H3F3A and H3F3B, the two genes are known to encode H3.3, are
expressed in all human cells with higher expression in the gonads and brain. A recent publication detailed
H3.3 as the causative gene in a neurodevelopmental disorder with craniofacial abnormalities. The
underlying cause of the disease is unknown; however, H3.3 is involved in a wide range of central nervous
system functions. This dissertation highlights work that aimed to profile the effects of these germline
mutations. We performed a comprehensive screen on pathogenic H3.3 variants utilizing a combination of
techniques and methodology, including tissue culture, bottom-up proteomics, and neurodevelopmental
assays in Xenopus laevis. We found global alterations to histone post-translational modifications with
significant alterations to histone acetylation on histone H2a, H3, and H4 peptides. In addition, performing
quantitative proteomics in the 293T cells led us to determine that these mutations affect several cellular
processes, such as RNA splicing, cell motility, neurofilament maintenance, folic acid metabolism, and
post-synaptic density, all processes known to be dysregulated in other neurological syndromes. Utilizing
the model organism Xenopus, we introduced two of the pathogenic variants into embryos. We observed
reduced craniofacial cartilage, abnormal head shape, and impaired motility due to kinked tails in the
mutant tadpoles. We performed quantitative proteomics on these tadpoles and found pathways related to
carbon metabolism and amino acid degradation upregulated. Lastly, our transcriptomic analyses
corroborated some of these finds and an upregulation of the TGF-beta signaling pathway in one of the
mutants. This work provides the first mechanistic study of these germline H3.3 mutations, introduces
pathways dysregulated that can be further studied. Understanding the basic biology of these mutations
will shed light on the molecular mechanisms of H3.3 in neurodevelopment.
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ABSTRACT

ELUCIDATING THE PATHOLOGICAL MECHANISM OF HISTONE H3.3 MUTATIONS
IN NEURODEVELOPMENT
Khadija D. Wilson
Benjamin A. Garcia

In eukaryotic cells, octamers of histone proteins intricately organize DNA, forming
a macromolecule known as nucleosomes. A nucleosome is comprised of two copies of
histone H2A, H2B, H4, and H3. Histone H3.3 (H3.3), a histone variant, is often found at
actively transcribed loci. H3.3 plays a role in cellular inheritance as ablation of H3.3
expression leads to loss of active gene states and dysfunction of heterochromatin telomeric
structures. H3F3A and H3F3B, the two genes are known to encode H3.3, are expressed in
all human cells with higher expression in the gonads and brain. A recent publication
detailed H3.3 as the causative gene in a neurodevelopmental disorder with craniofacial
abnormalities. The underlying cause of the disease is unknown; however, H3.3 is involved
in a wide range of central nervous system functions. This dissertation highlights work that
aimed to profile the effects of these germline mutations.
We performed a comprehensive screen on pathogenic H3.3 variants utilizing a
combination of techniques and methodology, including tissue culture, bottom-up
proteomics, and neurodevelopmental assays in Xenopus laevis. We found global
alterations to histone post-translational modifications with significant alterations to
histone acetylation on histone H2a, H3, and H4 peptides. In addition, performing
quantitative proteomics in the 293T cells led us to determine that these mutations affect
several cellular processes, such as RNA splicing, cell motility, neurofilament maintenance,
v

folic acid metabolism, and post-synaptic density, all processes known to be dysregulated
in other neurological syndromes.
Utilizing the model organism Xenopus, we introduced two of the pathogenic
variants into embryos. We observed reduced craniofacial cartilage, abnormal head shape,
and impaired motility due to kinked tails in the mutant tadpoles. We performed
quantitative proteomics on these tadpoles and found pathways related to carbon
metabolism and amino acid degradation upregulated. Lastly, our transcriptomic analyses
corroborated some of these finds and an upregulation of the TGF-beta signaling pathway
in one of the mutants. This work provides the first mechanistic study of these germline
H3.3 mutations, introduces pathways dysregulated that can be further studied.
Understanding the basic biology of these mutations will shed light on the molecular
mechanisms of H3.3 in neurodevelopment.
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Chapter 1: Introduction
1.1
1.1.1

Epigenetics
Epigenetic regulation of gene expression
The term epigenetics can be broken down into two parts: first, the Greek word

“epi” can be translated to “above” coupled with genetics, which describes the study of how
the genome is regulated without direct alterations to the genetic sequence. Termed
initially “epigenotype” in 1942 by C. H. Waddington, he recognized a complex biological
process during development that was responsible for the transition from genotype to
phenotype (Waddington, 2012). This mechanism was discovered to exist outside of the
central dogma (Figure 1.1) (González-Pardo and Pérez-Álvarez, 2013).
Eukaryotic cells have evolved
to package DNA utilizing proteins to
form

chromatin.

Chromatin

is

comprised of nucleosomes, each of
which consists of 147 base pairs of
DNA wrapped around an octamer of
proteins known as histones; histone
H2A, H2B, H3, and H4 (Kornberg,
Figure 1-1: Schematic representation of
the "central dogma of molecular biology"
Figure adapted from Crick 1958 including
currently known epigenetic mechanisms.

1974; Luger et al., 1997; Kouzarides,
2007).

These

nucleosomes

are

connected by linker DNA, short DNA

segments, and specific interactions,
Figure 1-2: Schematic representation of
forming a 30 nm chromatin fiber (Tremethick, 2007). Condensation of these fibers results
the "central
molecular
biology"
Figure
adapteddogma
from of
Crick
1958 including
currently known epigenetic mechanisms.

1

Figure 1-3: Schematic representation of
Figure adapted from Crick 1958 including

in chromatin compaction, forming the large-scale tertiary structures that shape
chromosomes (Tremethick, 2007). Over the past few decades, epigenetic mechanisms
have been defined as 1) modifications to chromatin structure through enzymatic
modifications to either DNA or histone proteins, 2) chromatin remodeling, 3) and noncoding RNA regulation (Figure 1.1) (Aristizabal et al., 2020). These epigenetic
mechanisms modulate genomic activity in response to cellular stimuli, internal and
external, and mediate cell-specific gene expression, which plays a role in tissue-specific
gene expression and function. Epigenetic mechanisms dictate fundamental cellular
processes, including transcription, RNA modifications, translation, DNA replication and
repair, and maintenance of genomic stability (Qureshi and Mehler, 2018). Furthermore,
these molecular mechanisms dictate developmental processes such as X-chromosome
inactivation and heritability through genomic imprinting (Almouzni and Cedar, 2016).
DNA is modified with the covalent addition of a methyl group (consisting of one
carbon atom and three hydrogens -CH3) to DNA (Dunn and Smith, 1958). This
modification predominantly occurs on a cytosine nucleotide, on carbon 5, generation 5methylcytosine (5mC), and is catalyzed by DNA methyltransferases (Ehrlich and Wang,
1981). It is highly specific, and insertion of a methyl group changes the appearance and
structure of DNA, altering its interaction with the transcriptional machinery. This
methylation has been proposed to be highly specific and regulates transcription and
maintenance of chromosome structure and DNA repair (Ehrlich and Wang, 1981).
Additionally, DNA methylation has been shown to confer long-term gene silencing,
playing a critical role in imprinting and X-inactivation (Reik, 2007). 5mC is converted to
5-hydroxyl-methyl-cytosine (5hmC), which, unlike 5mC, is enriched at transcriptionally
active regions (Tahiliani et al., 2009; Mellén et al., 2012). DNA methylation and

2

hydroxymethylation

are

primary

forms of epigenetic gene regulation,
whereas

another

form

involves

histone proteins.
Histone proteins are rich in
essential amino acids, lysine (Lys)
and arginine (Arg), resulting in an
overall positively charged protein
that promotes and strengthens the
Figure 1-2. Complex landscape of epigenetic interaction with negatively charged
mechanisms.
Figure taken from Aristizabal et. al 2020.
et al., 2020.

DNA. Due to this vital interaction,
the nucleosome can sterically block
transcriptional

machinery,

RNA

polymerase II, from binding to DNA, thereby altering gene accessibility and expression
(Li, Carey, and Workman, 2007). The role of histones extends beyond DNA compaction,
Figure taken from Aristizabal et. al 2020.
as post-translational modifications (PTMs) to histone proteins can result in either open
et al., 2020.
chromatin (euchromatin) or closed chromatin (heterochromatin) (Figure 1.1A). Histones
are covalently modified by multiple chemical motifs, including acetylation, methylation,
Figure taken from Aristizabal et. al 2020.
phosphorylation, and ubiquitination (Zhao and Garcia, 2015). Due to recent technological
et al., 2020.
advances, more histone modifications have been discovered, including various forms of
acylation, lactylation, serotonylation, and dopaminylation; however, they are currently
Figure taken from Aristizabal et. al 2020.
understudied, and their role in biological processes are still being explored (Zhao and
et al., 2020.
Garcia, 2015; Chan and Maze, 2020). These modifications primarily occur on the flexible
N-termini of histones, also known as histone tails, which project from the nucleosome.
Figure taken from Aristizabal et. al 2020.
However, there are also modifications found within the globular domain and C-termini
et al., 2020.
3
Figure taken from Aristizabal et. al 2020.
et al., 2020.

tails of histones as well. Histone PTMs are regulated by epigenetic machinery, often in the
form of protein complexes, that are responsible for the deposition (writers), removal
(erasers), and recognition (readers) of the histone code (Strahl and Allis, 2000).
Histone “writers” deposit PTMs at specific genomic loci, and this deposition results
in either the promotion or inhibition of transcription by influencing chromatin
accessibility. Histone acetylation defines active transcription, whereas histone
methylation is more complex as it can depict activation or repression. “Eraser” proteins
remove histone PTMs, allowing for tight regulation of gene expression as PTM removal
often results in the opposite chromatin state. “Reader” domains are usually found on or in
conjunction with writer proteins and chromatin remodelers, who move nucleosomes in an
ATP-dependent manner. These proteins are highly regulated, resulting in a cell-typespecific steady state of histone PTMs, which is malleable and allows for rapid response to
cellular signals. Therefore, our understanding of the fine-tuned mechanisms that regulate
the epigenetic machinery under normal conditions is critical to elucidate the mechanisms
of pathogenic variants in disease. Advances in techniques such as tandem mass
spectrometry (MS) and chromatin-immunoprecipitation followed by sequencing (ChIPseq) has shed light on histone PTM patterns, their differential abundance in a variety of in
vitro and in vivo models, their genomic localization, and modifications that coexist
(Vermeulen et al. 2010). For example, bivalent domains, which contain co-occurring
marks like H3K4me3 (activating mark) and H3K27me3 (repressive mark) at
developmental genes, have been shown to “poise” loci for rapid transcriptional activation
(Voigt, Tee, and Reinberg 2013). Bivalency is necessary for the proper differentiation of
neuronal and neural crest stem cells (Burney et al., 2013). Collectively, extensive studies
have displayed the importance of establishing and maintaining histone PTMs during
development and disease progression.
4

1.1.2

Histone Acetylation
Lysine acetylation, a ubiquitous modification found on histone proteins, is a

crucial modulator of chromatin structure and gene expression (Kornberg, 1974). All
histones, including variants and linker histones, can undergo acetylation. The negative
charge of the acetyl group neutralizes the positive charge of the lysine residue, reducing
the interaction of the modified histone with negatively charged DNA. This impedes the
generation of higher order chromatin structure, ultimately resulting in an open chromatin
state (Figure 1.2). Histone acetylation, commonly found in active promoters and
enhancers, plays a critical role in gene activation and is regulated by histone
acetyltransferases (HATs) and histone deacetylases (HDACs) (Imhof and Wolffe, 1998;
Wang et al., 2008; Lawrence, Daujat and Schneider, 2016; Gong and Miller, 2013).
Human HATs are classified into two groups based on their subcellular localization: type A
and type B. Type A HATs reside in the nucleus and contain bromodomains that recognize
acetylated lysines, and often interact with other chromatin remodeling complexes and
transcription factors (Dhalluin et al., 1999; Sanchez and Zhou, 2009; Marmorstein and
Zhou, 2014). On the other hand, type B HATs, which often lack bromodomains, are located
in the cytoplasm and regulate the acetylation of newly synthesized histones (Richman et
al., 1988; Bannister and Kouzarides, 2011).
Type A HATs are further subdivided into five homology superfamilies: the Gcn5related acetyltransferase (GNAT), p300/CBP, MYST, general transcription factor HATs
family and the nuclear-hormone receptor HATs (Mizzen et al., 1996; Chen et al., 1997;
Spencer et al., 1997; Steunou, Rossetto and Côté, 2013). The substrate specificity of most
HATs depends on the other protein complex members. The GNAT family of HATs
including GCN5/KAT2A (MIM: 602301) and PCAF/KAT2B (MIM: 602303) is known to
acetylate H3K14. In specific protein complexes it has the ability to acetylate free and
5

nucleosomal histones at H3K9/K36 and H4K8/K16 (Marmorstein, 2001; Roth, Denu and
Allis, 2001). The cyclin AMP response element-binding protein (CREB) binding protein,
CBP (also known as CREBBP or KAT3A) (MIM: 600140) and p300 (EP300 or KAT3B)
(MIM: 602700) are two members of the p300/CBP subfamily of HATs. The p300/CBP
complex primarily regulates gene expression through its HAT activity in acetylating H2B
at residue K85, H3 on residues K9, K14, K27, K36, K56, and H4 on residues K12, K20 and
K44 (Bannister and Kouzarides, 1996; Das et al., 2009; Carré et al., 2018). Additionally,
CBP/p300 regulates gene expression through recruitment of transcription factors or basal
transcription machinery. Notably, CBP and p300 are implicated in cell differentiation,
proliferation, and apoptosis. CBP or p300-deficient embryos exhibit heart and neural tube
defects, often resulting in gestational death (Yao et al., 1998; Tanaka et al., 2000).
Therefore, both CBP and p300 are required for proper brain development, and mutations
in either of these HATs can result in a neurological disorders (Yao et al., 1998; Viosca et
al., 2009; Tsui et al., 2013). The MYST subfamily is comprised of five human HATs that
all share a highly conserved MYST domain: KAT5 (MIM: 601409), KAT6A (MIM:

Figure 1-3. Reaction schemes of histone acetylation and deacetylation.
Figure taken from (Steunou, Rossetto and Côté, 2014)
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Figure 1-5 Reaction schemes of histone acetylation and deacetylation of a histone
lysine residue.Figure taken from (Steunou, Rossetto and Côté, 2014)

601408), KAT6B (MIM: 605880), KAT7 (MIM: 60988) and KAT8 (MIM: 609912). KAT5
can acetylate all core histones, KAT6A/B can acetylate H3 at residues K14, K18 and K23,
and KAT8 specifically acetylates H4K16. These HATs are involved in many cellular
processes such as proliferation and differentiation, therefore it is not surprising that
dysfunction of KAT5, KAT6A/B and KAT8 have been linked to neurological diseases.
HDACs are erasers of histone acetylation. In humans there are 18 identified
HDACs, classified into two categories, “zinc-dependent” and “nicotinamide-adeneinedinucleotide (NAD)-dependent”, based on whether they require zinc or NAD for catalysis.
There are four classes of HDACs within the zinc-dependent class: class I (HDACs 1, 2, 3,
8), class IIa (HDACs 4, 5, 7, 9), class IIb (HDACs 6, 10) and class IV (HDAC 11). Class I
HDACs are primarily found in the nucleus, while class II HDACs shuttle between the
cytoplasm and the nucleus. NAD-dependent deacetylases, also known as Sirtuins, are
expressed throughout the body, with high expression in the brain, and are highly regulated
in a spatiotemporal pattern, which has been speculated to play a role in aging (Deardorff
et al., 2012).
1.1.3

Histone Methylation
Histone methylation occurs on both arginine and lysine residues and plays a

critical role in transcriptional regulation (Allfrey and Mirsky, 1964; Allfrey, Faulkner and
Mirsky, 1964). Unlike acetylation which is a binary system (acetylation or no acetylation),
methylation is more complicated. Histone lysine methylation is a quaternary system as
lysine residues can be mono-, di-, and tri-methylated, while arginine residues can be
mono- and di- methylated. Importantly, none of these modifications alter the lysine's
positive charge. Histone methylation is ambiguous as it is associated with both activation
and repression of gene expression depending on the residue modified and the number of
methyl groups added (Zhang, 2001; Black, Van Rechem and Whetstine, 2012). To date
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methylation on H3K4, H3K36, and H3K79 have been shown to mark active regions,
whereas H3K9, H3K27, and H4K20 methylations are associated with repressed chromatin
(Black, Van Rechem and Whetstine, 2012). In humans there are approximately 30 lysine
methyltransferases (KMT) that have been classified. There are two classes of KMTs in
humans, and this classification depends on the presence or absence of the catalytic
Su(var)3-9, E(z) (enhancer of zeste), and trithorax (SET) domain (Dillon et al., 2005;
Jenuwein, 2006; Nguyen and Zhang, 2011). Despite having distinct catalytic domains, all
KMTs utilize S-adenosyl-L-methionine (SAM) as the methyl group donor, and have high
specificity to specific residues as well as the degree of methylation (Dillon et al., 2005;
Nguyen and Zhang, 2011). Like acetylation, methylation is removed by a group of enzymes;
these are known as lysine demethylases (KDMs) (Shi et al., 2003). For decades, lysine
methylation was presumed static and irreversible due to the slow turnover of methylated
histones, and the fact that no demethylases had been identified. In 2004, the first bona
fide lysine demethylase was discovered, revealing that methylation was a dynamic mark
that can be altered to mediate gene expression (Shi et al., 2004). To date, approximately
20 KDMs have been identified and divided into two classes based on the catalytic domain,
either flavin adenine nucleotide (FAD)-dependent oxidase domain or Jumonji C (JmjC)
domain (Shi et al., 2004; Shi and Whetstine, 2007). Like KMTs, KDMs have a high degree
of specificity for their target substrates.
1.2
1.2.1

Histone H3 Variant, H3.3
Histone H3.3
Another form of epigenetic regulation involves histone variant exchange. Histone

variants are nonallelic counterparts to canonical core histones. To date, variants have been
defined for each canonical histone. For example, H2A variants play distinct cellular roles:
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H2A. X has been shown to module DNA damage repair, H2A.Z plays a role in gene
regulation

and

neuronal

activity,

macroH2A/H2A.Y

is

involved

in

heterochromatinization, and there are testis-specific H2A variants (Martire and
Banaszynski, 2020). Histone H2B has four variants H2B, H2BE, TSH2B, and H2B.W;
however, these involve few amino acid substitutions and have not been explored. For many
years no variants of histone H4 were found. However, recently a histone H4 variant, H4G,
was discovered in breast cancer lines and was demonstrated to specifically affect
recombinant DNA expression (Long et al., 2019). There are two canonical H3 histones
(H3.1 and H3.2), and they differ by one amino acid at position 96. Additionally, there are
three replication-independent variants: histone H3.3, CENP-A, and testis-specific histone
H3.4 and H3.5. CENP-A is the centromeric H3 variant; it is enriched at centromeres and
is required for centromere identity and genome stability (Gambogi and Black, 2019).
Histone H3.3 (H3.3) is encoded by two distinct genes, H3F3A and H3F3B,
resulting in an identical 136 amino acids protein product (Szenker, Ray-Gallet, and
Almouzni, 2011). This is distinct from canonical H3, which is encoded by ten genes
organized in a cluster. Furthermore, the canonical histone H3 products are not polyadenylated, but H3.3 mRNA is poly-adenylated. H3.3 is distinct from H3.2 by four amino
acids (Ser31, Ala-87, Ala-88, and Gly-90) and from H3.1 by one additional amino acid
(Ser96). These residues have been shown to play a role in chaperone specificity,
contributing to H3.3’s distinct biological function. Ser31 (S31) is positioned between
H3K27 and K36 and has been demonstrated to be phosphorylated (H3.3S31ph). This
phosphorylated S31 was shown to promote trimethylation of H3.3 at lysine-36
(H3.3K26me3), which is subsequently recognized by zinc-finger MYND-type containing
11 (ZMYND11) (Wen et al., 2014, p. 1). Secondly, H3.3S31ph has been determined to
promote acetylation of H3.3K27, which is essential for gastrulation in Xenopus laevis
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(Sitbon et al., 2020, p. 31). The other three amino acids (residues 87, 88, and 90) reside
in the α-helix 2 in the core of the protein. The canonical histone H3 87-90 motif consists
of Ser-Ala-Val-Met, whereas H3.3 contains Ala-Ala-Ile-Gly, the chaperone-recognition
motif (Grover, Asa and Campos, 2018). This chaperone distinction is crucial in H3.3
localization throughout the genome (Elsaesser and Allis, 2010).
Not surprisingly, H3.3 deposition confers unique properties onto the genome.
H3.3 deposition has been shown to significantly impair the formation of higher-order
chromatin structure, which promotes gene activation (Chen et al., 2013). H3.3 deposition
is usually associated with dynamic chromatin, as H3.3 has decreased nucleosome stability
and higher turnover rates on a genome-wide level, especially at enhancers and superenhancers (Jin and Felsenfeld, 2007; Deaton et al., 2016). Additionally, H3.3 is selectively
enriched at transcriptional start sites of active genes and is characteristic of euchromatin.
Accordingly, it has been coined the “active” variant (Jin et al., 2009). H3.3 is also shown
to be predominantly enriched with activating PTMs (Goldberg et al., 2010). The
replication-independent nature of this histone variant allows for its accumulation in postmitotic cells and cells in cellular quiescence (Contrepois et al., 2017; Tvardovskiy et al.,
2017). Previous studies have shown that H3.3 accumulates from 10-15% of H3 genomic
content at birth to approximately 90% in adulthood in cerebral cortical neurons (Piña and
Suau, 1987). In addition, H3.3 has been determined to be a key regulator of embryonic
neural stem cell differentiation, wherein knockdown of H3.3 promotes premature
terminal differentiation in immature neurons (Xia and Jiao, 2017). Not only has H3.3 been
shown to be essential for neuronal differentiation, but it has also been found to play a
critical role in neuronal function. Upon neuronal stimulation, there is increased mRNA
expression of both H3F3 genes, and H3.3 is dynamically deposited in an activitydependent fashion (Maze et al., 2015; McNally et al., 2016). H3.3 is loaded into distinct
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genomic loci upon neuronal depolarization, regulating immediate early genes BDNF and
c-Fos, crucial for neuronal activity (Michod et al., 2012; Maze et al., 2015). Knockdown of
H3.3 in neurons results in defective synapses with a significant reduction in the density of
dendritic spines (Maze et al., 2015; Xia and Jiao, 2017). Overall, these studies show that
H3.3 plays a critical role in mediating synaptic connectivity and plays a role in learning
and memory.
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Figure 1-4. Human histone H3.3 compared with H3.1 and H3.2.
Figure taken from Szenker et al., 2011.

Figure taken from Szenker et al., 2011.
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tadpole

phenotype.Figure 1-5 Surface interactions

deposit H3.3 at imprinted regions and endogenous retroviral elements (Elsässer et al.,
2015). Like UBN1, DAXX binds explicitly and recognizes the G90 residue of H3.3, but it is
a de novo chaperone, meaning it can bind and fold H3.3-H4 dimers. In addition, DAXX
contains a histone binding domain (HBD) that recognizes and forms a tower-like structure
around the α2-helix of H3.3 (DeNizio, Elsässer, and Black, 2014). This tower interface is
lined with polar, charged residues and a solvent-filled cavity surrounding G90, forming
hydrogen bonding, electrostatic and hydrophobic interactions (DeNizio, Elsässer, and
Black, 2014; Daniel Ricketts et al., 2015). Between DAXX and H3.3, ten water molecules
are coordinated within this cavity-forming 26 hydrogen bond interactions (Drane et al.,
2010). Interestingly, DAXX can discriminate loss of water molecules, as mutations of Gly
to Met decrease the interaction by 50%. Only four water molecules can reside in the cavity
in these mutants, resulting in only eight hydrogen bonds within Vitro tower binding also
diminished in these mutants (DeNizio, Elsässer, and Black, 2014, p. 4). Understanding
these deposition processes is still being explored, but these chaperones suggest a critical
role in genome regulation due to histone variant H3.3.
1.3

Chromatin Dysregulation in neurological Diseases
Neurodevelopmental

disorders

(NDD),

ranging

from

attention-deficit

hyperactivity disorder (ADHD), Fragile X syndrome, autism spectrum disorder (ASD) to
intellectual disability (ID) disorders, occur when the central nervous system (CNS)
develops abnormally. ID, which involves defects in general cognition and adaptive
behavior, has a prevalence of 3% worldwide, affecting 1 in 6 children in the US (Bhasin et
al. 2006). NDD patients often exhibit ID and other comorbidities such as ASD,
developmental delay (DD), epilepsy, and psychomotor impairments. The etiology of ID is
heterogeneous; it has been linked to environmental factors during pregnancy, infections,
chromosome deletions, and recently de novo point mutations. Next-generation
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sequencing (NGS) has propelled the study of these disorders by identifying 750 genes; all
proposed to be causative of ID (Kochinke et al. 2016). Importantly, many of these are
considered monogenic disorders; however, the pathological mechanism driving ID
disorders is largely unknown. Interestingly, epigenetic determinants account for 8% of ID
disorders and are starting to be recognized as significant players in neurological disorders
(Tjitske Kleefstra et al. 2014). Some of these proteins directly affect histone PTMs that
have been demonstrated to play a large role in neurodevelopment. For example, bivalency
is necessary for proper differentiation of both neuronal and neural crest stem cells (Burney
et al. 2013). Interestingly, dynamic H3K27me3 changes on transcription factor promoters
mediates neocortex development, highlighting the importance of histone PTMs in the
developing brain (Albert et al. 2017).
Furthermore, profiling of histone marks in neural progenitor cells reinforces this
notion as PTMs influence cellular identity (Mikkelsen et al. 2007). In mature neurons,
histone acetylation and methylation drive activity-dependent modulation of neuronal
networks (Bonnaud, Suberbielle, and Malnou 2016). Mice with heterozygous mutations in
histone modifying enzymes exhibit altered synaptic plasticity resulting in decreased
learning, short and long-term memory, and behavioral anomalies (Levenson and Sweatt
2005). Moreover, chromatin factors are ubiquitously expressed in key brain regions for
learning, memory, and movement (Figure 1.7). Intriguingly, individuals carrying germline
mutations in epigenetic machinery often demonstrate severe neurological dysfunction
manifesting as developmental and psychomotor delay. This suggests that the
consequences of improper epigenetic regulation result in neuronal dyshomeostasis and
ultimately severe impairment to the CNS. Although these germline mutations are
ubiquitously expressed, it is interesting that the brain is the most affected organ in these
individuals. Thus, there is sufficient evidence depicting the importance of epigenetic
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machinery in neurodevelopment and neuronal function. However, it is imperative to
illustrate how alterations to the epigenetic landscape and gene expression profiles result
in observed phenotypes in these individual disorders. The following paragraphs focus on
mutations in chromatin modifying enzymes that drive ID disorders. Specifically, writers
and erasers of histone acetylation and methylation, and even mutations in histones
themselves.

Figure 1-6 Chromatin Spatial expression of epigenetic factors dysregulated
in NDD.
(left) Graphical representation of brain regions in which most genes are highly
expressed and their respective functions. (right) Expression in these three regions
according to Consensus normalized expression (NX) levels on Protein atlas. This
dataset was created by combining two transcriptomic datasets (GTEx and FANTOM5).
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1.3.1

HATs: p300/CBP Family
CBP mutations are the primary cause of 55-60% Rubinstein-Taybi syndrome

(RSTS) 1 (MIM: 180849) cases, while EP300 mutations are causative in 8% of RSTS2
(MIM: 613684) cases (RUBINSTEIN and TAYBI, 1963; Roelfsema et al., 2005; Roelfsema
and Peters, 2007). RSTS1 is a rare congenital disorder characterized by mild to severe ID,
microencephaly, growth retardation and distinct facial features. RSTS2, although similar
to RSTS1, results in less severe facial dysmorphism and overall better cognitive function;
however, RSTS2 individuals tend to have more severe microencephaly and specific
malformation of jaw bone structures (Bartsch et al., 2010). In the vast majority of RSTS2
cases other comorbidities exist such as psychomotor deficits, language and
gastrointestinal problems (Pérez‐Grijalba et al., 2019). The pathogenic variants of both
CBP and p300 in RSTS1/2 result from frameshift, nonsense, or splice-site mutations and
are predicted to have a loss-of-function mechanism causing haploinsufficiency. Cbp
haploinsufficiency leads to a decrease in the number of neurons generated and is seen to
regulate neurogenesis and cortical precursor differentiation in mice (Wang et al., 2010;
Valor et al., 2011). Mice with loss-of-function Cbp had defects in hippocampal memory
which was rescued by two different HDAC inhibitions (Korzus, Rosenfeld and Mayford,
2004). Moreover, an in vitro neuronal model of RSTS1 and RSTS2 was developed using
patient-derived induced pluripotent stem cells (IPSCs). In this study, they observed
morphological changes and decreased neuronal excitability (Alari et al., 2018).
Furthermore, these patient-derived neurons had increased number of branches; however,
the length of the branches was reduced (Alari et al., 2018). Interestingly, heterozygous
mutations in exons 30-31 of CBP or p300 have recently been discovered to have a
substantially distinct phenotype from RSTS. Patients harboring these mutations display
DD, autistic behavior, short stature, microcephaly, and distinct facial anomalies (Menke
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et al., 2016, 2018; Banka et al., 2019). Depending on the causative gene, it is known as
Menke-Hennekam syndrome (MKHK) 1 for CBP mutations and MKHK2 for p300
mutations. It is hypothesized that CBP mutations confer a gain-of-function mechanism
and p300 mutations are explicitly affecting the conformation of the zinc finger domains.
It is important to note that despite similarity in causative genes and overall symptoms,
RSTS and MKHK are phenotypically distinct. Ultimately, mutations in either CBP or p300
lead to aberrant neurodevelopment through either dysregulation of its HAT activity or
improper recruitment of transcription factors.
1.3.2

HATs: MYST family
KAT5 (also known as Tip60/PLIP) is the catalytic subunit of the NuA4 HAT

complex and mediates acetylation of H2A and H4 (Frank et al., 2003; Doyon et al., 2004).
Recently, Humbert et. al reported a multisystem disorder named neurodevelopmental
disorder with dysmorphic facies, sleep disturbance, and brain abnormalities (NEDFASB)
(Humbert et al., 2020). NEDFASB is caused by de novo heterozygous mutations in the
KAT5 gene. Individuals with NEDFASB exhibited severe ID, sleep disturbances,
behavioral deficits, and epilepsy (MIM:619103) (Humbert et al., 2020). Functional
assessment of these mutations revealed decreased HAT activity, which suggested
haploinsufficiency (Humbert et al., 2020). Furthermore, transcriptomic analysis
demonstrated dysregulation of critical developmental genes which was proposed to be the
cause of the syndrome. However, further research including other neuronal and
developmental models can potentially highlight pathways in which these dysregulated
genes are involved. KAT6A (also known as MYST3/MOZ) or its paralog KAT6B (or
MYST4/MORF) form a stable complex with ING5, EAF6 and BRPF proteins (Ullah et al.,
2009). In recent years, heterozygous KAT6A mutations were identified in Arboleda-Tham
syndrome (ARTHS) (MIM: 616268), formerly known as autosomal dominant mental
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retardation 32 (Arboleda et al., 2015; Tham et al., 2015). ARTHS patients share standard
features such as impaired intellectual development, dysmorphic facial features, speech
delay, congenital heart disease, and microencephaly (Kennedy et al., 2018). KAT6A and
KAT6B both acetylate H3K9 and K18, while KAT6B also acetylates H3K23 (Lv et al., 2017;
Yan et al., 2020). Kat6a-deficient mouse embryos lead to H3K9 hypoacetylation, which is
linked to reduced transcription of Hox genes and abnormal craniofacial development
(Voss et al., 2009; Kong et al., 2014). Functional studies in ARTHS patient-derived
fibroblasts revealed substantial reduction in H3K9 acetylation with increased K18
acetylation as well as dysregulation in signaling pathways of p53, which is a non-histone
KAT6A substrate (Arboleda et al., 2015). Kat6a-deficient mice exhibited mild craniofacial
abnormalities and cardiac defects (Voss et al., 2009, 2012). Despite the failure to
phenocopy the human syndrome in these mice, animal models such as these can prove
useful in uncovering KAT6A function in development.
Interestingly, KAT6B, the paralog of KAT6A, is known to be mutated in multiple
neurodevelopmental disorders; however, it is the causative gene in Say-Barber-BieseckerYoung-Simpson variant of Ohdo syndrome (SBBYSS) (MIM:603736) and Genitopatellar
syndrome (GTPTS) (MIM: 606170) (Clayton-Smith et al., 2011; Simpson et al., 2012).
SBBYSS

is

clinically

characterized

by

craniofacial

abnormalities

involving

blepharophimosis (underdeveloped eyelids) and cleft palates, severe ID, hypotonia, and
cardiac defects (Clayton-Smith et al., 2011). These de novo truncating KAT6B mutations
mainly affect exons 16-18 of the gene and are predicted to cause haploinsufficiency
(Clayton-Smith et al., 2011; Marangi et al., 2018). KAT6B is critical for mammalian CNS
development as homozygous mutations of Kat6b in mice resulted in a smaller cerebral
cortex and cortical plate when compared to wildtype animals (You, Yan, et al., 2015).
Furthermore, these mice exhibited craniofacial abnormalities similar to the SBBYSS
19

patients (You, Yan, et al., 2015). Although the causative gene in GTPTS is also KAT6B,
these patients do not exhibit distinct craniofacial abnormalities (Cormier-Daire et al.,
2000; Simpson et al., 2012). However, they do display severe ID, thin corpus callosum,
psychomotor retardation, cardiac defects, and genital anomalies. As with SBBYSS, GTPTS
is delineated by truncation mutations that occur at the proximal end of exon 18; this
creates KAT6B variants lacking methionine-rich domains which is known to bind to the
transcription factors runt-regulated transcription factor (RUNX)1 and RUNX2. The role
of RUNX genes in mammalian CNS involves formation of neural circuits, specifically
mediating somatosensory sensation, olfaction, and motor control. Notably, the molecular
mechanisms for both disorders are still being speculated. However, SBBYSS is currently
thought to be a result of haploinsufficiency whereas mutations GTPTS results in loss-offunction due to alterations in critical KAT6B binding sites.
It is important to note that the border between SBBYSS and GTPTS syndromes is
almost non-existent as they both have significant overlap with regards location of
mutations. With this in mind, four distinct groups of KAT6B mutations have been recently
suggested (M et al., 2015; Radvanszky et al., 2017). Group 1 mutations are proximal
mutations, predominantly in the MYST domain and have been mainly associated with
SBBYSS. Group 2 mutations, mainly seen in GTPTS, affect the acidic patch and
transcription activation domain. Group 3 mutations are associated with SBBYSS and
GTPTS and they lack transcription activation domain with either a truncated or intact
acidic patch. Lastly, group 4 mutations, exclusive to SBBYSS, contain truncations in the
transcription activator domain. The majority of mutations (groups 2-4) reside after the
MYST domain, suggesting that these truncated mutants retain HAT activity (M et al.,
2015). However, without the remaining regulatory portions of the protein, these
truncations may cause loss/gain-of-functions, altering cellular processes through
20

dysregulation of histone acetylation or transcriptional activation. KAT8 (previously
known as MOF) resides in both the male-specific and nonspecific lethal complex, MSL and
NSL, respectively and catalyzes the acetylation of H4K16 (Akhtar and Becker, 2000; Cai
et al., 2010). Heterozygous mutation in the KAT8 gene resulted in Li-Ghorbani-WeiszHubshman syndrome (LIGOWS) (MIM: 618974). LIGOWS is defined by global DD,
speech impairments, and mild dysmorphic features. All pathogenic variants altered
H4K16 acetylation (Li et al., 2020). Deletion of Kat8 resulted in decreased proliferation
of neural stem and progenitor cells and affected neurogenesis in E13.5 mice (Li et al.,
2020). Notably, MOF has been shown to play a critical role in mediating neurogenesis
through hyperacetylation of H4K16 in the presence of histone H3 variant, H3.3K36
trimethylation (Xia and Jiao, 2017). Further studies are necessary to determine the
molecular mechanisms in which KAT8 regulates cortical neuron and by extension,
cerebral development. KAT8 plays a critical role in the regulation of chromatin, through
distinct mechanisms which involves the interplay with histone H3 variant, H3.3. This
poses an intriguing question regarding the relationship between HATs and histone variant
exchange in the context of regulating corticogenesis. In addition to the HATs that are
dysregulated co-factors and subunits of the MYST family HATs have also been link to
neurological disorders.
Bromodomain and PHD finger containing protein 1 (BRPF1) (MIM: 602410)
serves as a scaffold, mediating the interaction between KAT6A, KAT6B, ING5 and EAF6.
BRPF1 is critical for HAT activity and transcriptional activation. BRPF1 consists of
multiple domains which are responsible for many of its protein-protein interactions, and
it also contains a PWWP domain which recognizes H3K36me3 (Yan et al., 2016, p. 1). In
2017, a cohort of 10 patients containing heterozygous BRPF1 mutations was identified, all
exhibiting mild to severe ID, dysmorphic facial features, ptosis, hypotonia, brain and
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behavioral anomalies (Yan et al., 2016). These mutations result in a truncated form of
BRPF1, resulting in impaired H3K23 acetylation. Concurrently in 2017, another group
identified 6 individuals who had what they referred to as an Intellectual Developmental
Disorder with Dysmorphic Facies and Ptosis (IDDDFP) (Mattioli et al., 2017). Similar to
the previous group, these patients all exhibited mild to moderate ID, growth retardation,
ptosis and microencephaly (Mattioli et al., 2017). BRPF1, in this second cohort, retained
the ability to bind KAT6A/B; however, these mutations prevented the formation of
tetrameric complexes and had reduced HAT activity (Mattioli et al., 2017). Interestingly,
aside from disrupting complex formation, a few of the pathogenic variants bearing
mutations predominantly in the PWWP domain, maintain normal HAT activity.
Therefore, a potential mechanism for this epigenetic dysregulation could be due to
mislocalization of this HAT complex.
Functional studies of BRPF1 and its pathogenic variants elaborate on its role in
brain development and function. BRPF1 is critical for forebrain development, as
conditional knock-out in the forebrain results in small litter size with all mice exhibiting
neurological and behavioral defects (You, Zou, et al., 2015, p. 1). Additionally, forebrainspecific inactivation of mouse Brpf1 lead to abnormal cerebral and hippocampal
development (Yan et al., 2016). These developmental anomalies were the result of BRPF1
loss in which caused the downregulation of neuronal migration, cell cycle progression and
transcriptional control through the compromised status of neural stem and progenitor
cells (You, Yan, et al., 2015). Moreover, despite no intrinsic HAT activity of BRPF1, there
is sufficient evidence demonstrating its interaction with KAT6A and KAT6B is critical for
regulating histone acetylation both in vitro and in vivo (Yan et al., 2016). Heterozygous
Brpf1 mice displayed a decrease in H3K23 acetylation, similar to the reduction seen in
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patient-derived fibroblasts (Yan et al., 2016). These findings illustrate the importance of
co-writers, and accessory proteins in HAT complexes.
KAT8 regulatory NSL complex subunit 1 (KANSL1) (MIM: 612452) is a part of the
non-specific lethal (NSL) complex, which includes previously mentioned KAT8 as well as
KANSL2 and WDR5. The NSL complex influences gene activation through acetylation of
H4K16 and the transcription factor, p53 (Dou et al., 2005; Mendjan et al., 2006; Li et al.,
2009). The stability and activity of the NSL complex is dependent on KANSL1 (Raja et al.,
2010). In 2012, two unrelated patients exhibiting characteristic symptoms of chromosome
17q21.31 deletion syndrome were discovered to have the first de novo mutations in
KANSL1 (Zollino et al., 2012). Concurrently, another group performed Sanger sequencing
on 16 unrelated patients, identifying de novo heterozygous truncating mutations in
KANSL1 in two unrelated patients (Koolen et al., 2012). The patients from both studies
were all diagnosed with Koolen-de Vries syndrome (KDVS) (MIM: 610443) which is
characterized by moderate to severe ID, hypotonia, and dysmorphic facial features
(Koolen et al., 2012, 2016; Zollino et al., 2012). The KANSL1 haploinsufficiency seen in
KDVS is sufficient to generate a full manifestation of the chromosome 17q21.31 deletion
syndrome and there were no clinically meaningful differences between the two syndromes
(Zollino et al., 2012; Koolen et al., 2016).
Whole transcriptomic sequencing on Epstein-Barr virus (EBV)-transformed
patient cells bearing either a KANSL1 point mutation or deletion showed that there was a
high correlation between the differential expression genes between both syndromes
(Koolen et al., 2012). Moreover, gene ontology (GO) analysis revealed enrichment in genes
associated with neuronal and synaptic processes (Koolen et al., 2012). These results were
supported using chromatin immunoprecipitation as the KANSL1 Drosophila homolog,
wah, was bound to the promoter of many genes enriched for the same GO terms (Raja et
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al., 2010). Global knockdown of wah lead to altered synapse morphology at the
neuromuscular junction and endosomal maturation, which is crucial for synaptic
trafficking (Lone et al., 2010). Additionally, conditional knockdown of wah in mushroom
bodies, the learning and memory center of the Drosophila brain, resulted in a 25%
reduction in learning ability (Koolen et al., 2012). Functional analysis of the KANSL1
Drosophila homolog revealed the importance of this protein in complex brain functions
such as learning and memory. To date there are no causative NDD mutations in sirtuins;
however, mutations in three HDACs (HDAC4, HDAC6 and HDAC8) (4,6,8) have been
determined as causative in neurodevelopmental disorders.
1.3.3

HDACs
HDAC4 (MIM: 605314), a class IIa HDAC, is highly expressed in the postnatal

brain and regulates neuronal cell death; however, the substrates of HDAC4, and therefore
the mechanism of action, remain elusive (Bolger and Yao, 2005). Homozygous deletion of
Hdac4 in mice exhibit impaired learning, memory and long-term synaptic plasticity (Kim
et al., 2012). Haploinsufficiency due to mutations or deletions of HDAC4 were determined
to cause brachydactyly mental retardation (BDMR) syndrome (MIM: 600430)
characterized by DD, ID, behavioral

abnormalities and dysmorphic features

(Villavicencio-Lorini et al., 2013; Williams et al., no date). Currently, there is some debate
on whether or not HDAC4 is the driver for BDMR or if mutations in the TWIST2 or
FLJ43879 genes are driving the phenotype (Wheeler, Huang and Dai, 2014). HDAC4 has
been shown to regulate myocyte enhancer factor-2 (MEF2) proteins during development,
therefore altered HDAC4 activity potentially results in BDMR through dysregulation of
MEF2 (Bolger and Yao, 2005). However, this remains speculative.
HDAC6 (MIM: 300272), a class IIb HDAC, is also highly expressed in the
brain and it primarily resides in the cytoplasm; however, HDAC6 can translocate to the
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nucleus resulting in transcriptional repression due to cellular stress. (Nagase et al., 1998;
d’Ydewalle, Bogaert and Van Den Bosch, 2012; LoPresti, 2020). HDAC6 is a key regulation
of synaptic function during acute stress in the prefrontal cortex, a region responsible for
higher-order cognition (Lee et al., 2012). X-linked dominant Chondrodysplasia with
platyspondyly, distinctive brachydactyly, hydrocephaly, and microphthalmia (CPDBHM)
(MIM: 300863) is caused by heterozygous mutations in HDAC6 (Chassaing et al., 2005;
Simon et al., 2010). CPDBHM is characterized by macrocephaly, growth retardation,
skeletal and craniofacial abnormalities and mild intellectual disabilities, these phenotypes
are more pronounced in males (Chassaing et al., 2005; Simon et al., 2010). In pathological
conditions, HDAC6 translocate to the nucleus, dysregulating synaptic function due to
decreased expression of brain-derived neurotrophic factor (BDNF) (Lee et al., 2012).
Furthermore, HDAC6 has been implicated in many neurological conditions such as
Alzheimer’s’ disease, Charcot-Marie-Tooth disease, and mood disorders. However,
whether this regulation is mediated through deacetylation of its known substrates (βcatenin, α-tubulin) or another target of HDAC6 remains unclear.
HDAC8 (MIM: 300269) is known to deacetylate H3 and H4 in vitro, and
structural maintenance of chromosomes 3 (SMC3) in the cohesin complex (Deardorff et
al., 2012; Bjornsson, 2015). Loss of HDAC8 activity results in increased SMC3 localization
to chromatin, leading to amplified cohesin localization which results in altered
transcriptional activity (Deardorff et al., 2012). Mutations in HDAC8 are responsible for
Cornelia De Lange Syndrome (CdLS) 5 (MIM: 300882) (Boyle et al., 2014; Kaiser et al.,
2014; Mordaunt and McLauchlan, 2015). CdLS5 is deﬁned by ID, facial dysmorphism, preand post-natal delay, microcephaly, heart defects, upper limb abnormalities, and
genitourinary anomalies (Yuan et al., 2015). A characteristic feature of CdLS5 is abnormal
skull formation. Interestingly, HDAC8 represses homeobox transcription factors, Otx2
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and Lhx1, in cranial neural crest cells; thus, HDAC8 mediates patterning of the skull and
deletion in mice leads to perinatal lethality due to skull instability (Haberland et al.,
2009). To this date, no in vivo studies have elucidated the role of HDAC8 in cognition or
behavior despite the accumulating number of mutations in HDAC8 related to ID
syndromes. In the past year, two histone acetyl readers, PHF6 and BRWD3, have been
discovered as causative genes for intellectual disability disorders.
1.3.4

KMTs
Lysine methyltransferase 2A (KMT2A) (MIM: 159555), also known as mixed

lineage leukemia 1 (MLL1), catalyzes the trimethylation of histone H3K4 (Schneider et al.,
2005; Dou et al., 2006). KMT2A, like other SET domain-containing KMTs, is often found
in a complex with four other subunits: ASH2L (absent, small, or homeotic-2 like), WDR5
(WD repeat domain 5), DPY30 (protein Dpy-30 homolog), and RbBP5 (retinoblastoma
binding protein 5). KMT2A also interacts with Menin and HCF1, forming COMPASS-like
complex (Shilatifard, 2012). Importantly, H3K4 mono-, di- and trimethylation mark
distinct active genomic regions with K4me1 enriched at enhancers, K4me2 at 5' end of
actively transcribed genes, and K4me3 at actively transcribed promoters (Santos-Rosa et
al., 2002, p. ; Heintzman et al., 2007; Kim and Buratowski, 2009). In 1989, three groups
reported clinical findings from unrelated patients, all detailing hypertrichosis cubiti
(abnormal amount of body hair), short stature, craniofacial abnormalities, and DDs
(Flannery et al., 1989; Hans-Rudolf Wiedemann et al., 1989; MacDermot et al., 1989).
From 1989 to 2010, seven other groups reported approximately 40 patients all exhibiting
distinct facial features, DDs, and short stature (Edwards et al., 1994; Steiner and Marques,
2000; Polizzi et al., 2005; Koç et al., 2007; Koenig et al., 2010; Jones et al., 2012). This
disorder was named Weidemann-Steiner (WDSTS) (MIM 605130) and Jones et al.
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identified heterozygous de novo truncating mutations in the KMT2A gene in four of these
WDSTS patients (Jones et al., 2012).
By employing whole-exome sequencing (WES) and confirmatory Sanger
sequencing, a variety of mutations were observed: missense, nonsense, and frameshift
truncating mutations. These mutations result in a loss-of-function or haploinsufficient
KMT2A in patients presenting clinically similar phenotypes (Koenig et al., 2010; Miyake
et al., 2016; Stellacci et al., 2016; Sun et al., 2017; Li et al., 2018; Jinxiu et al., 2020;
Nardello et al., 2020). Based on these findings, KMT2A was concluded to be the causative
gene in WDSTS. Experimental studies revealed the critical role of KMT2A in neurogenesis
in the mouse postnatal-brain, specifically with neuronal differentiation (Lim et al., 2009).
Kmt2a-deficient murine brains showed severe impairment in neuronal differentiation
with reduced size and number of neurons, potentially due to the decrease in bivalent
promoters in neural precursor cells (Lim et al., 2009). It also has been demonstrated that
KMT2A-mediated H3K4 trimethylation is critical in prefrontal neurons as it regulates a
subset of genes involved in cognition and behavior (Jakovcevski et al., 2015). Lastly, mice
with reduced KMT2A expression had reduced dendritic spines and increased aggression
(Vallianatos et al., 2020). These studies, taken together, reveal the role of KMT2A in
neurogenesis and CNS function, and it is suspected that these functions are impaired in
WDSTS patients (Jones et al., 2012). The phenotype of this syndrome continues to
expand; however, the molecular mechanism remains poorly understood. To further
understand this disorder, more functional assessments in model organisms must be
conducted to elucidate the role of KMT2A in cognition.
Lysine methyltransferase 2B (KMT2B) (MIM: 606834), also known as MLL4, is a
paralog of KMT2A and is responsible for the trimethylation of H3K4 (FitzGerald and Diaz,
1999, p. 2). KMT2B has been linked with gene-specific activation and functions in
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preimplantation development as well as embryonic genome activation (Shao et al., 2014).
In 2016, an autosomal dominant neurological disorder was discovered where patients
exhibited microencephaly, mild ID, and DD; this disorder was classified as childhoodonset dystonia-28 (DYT28) (Zech et al., 2016). Several groups provided evidence that de
novo mutations in KMT2B result in haploinsufficiency, causing DYT28 (MIM 617284)
(Zech et al., 2016, 2017; Kawarai et al., 2018). Mutations have been observed in over 75
patients to date. They encompass frameshift, missense, nonsense, and splice-site
mutations, and all affect KMT2B protein function (Zech, Lam and Winkelmann, 2019).
KMT2B is highly expressed in human tissue and ubiquitously expressed in the brain, with
the highest expression in the cerebellum (Meyer et al., 2017). This expression is reduced
in DTY28 patients; however, the levels on H3K4 methylation were not significantly
altered, suggesting a potential role of KMT2B beyond K4 methylation (Meyer et al., 2017).
In vitro, KMT2B knockdown results in decreased neuronal differentiation from embryonic
stem cells (Lubitz et al., 2007). Moreover, KMT2B is critical in neuronal programming as
ablation impairs transdifferentiation of fibroblasts to induced neuronal cells (iNs)
conversion (Barbagiovanni et al., 2018). The loss of KMT2B leads to redistribution of
H3K4me3 rather than reduction, explaining why previous studies found similar levels of
methylation between patients and controls (Meyer et al., 2017; Barbagiovanni et al., 2018).
The mechanism driving the dystonia caused by KMT2B remains elusive. However, looking
at the role of this KMT outside of K4 methylation might provide promising non-histone
targets that can potentially aid in the understanding of DYT28 pathogenicity
Lysine methyltransferase 2C (KMT2C) (MIM: 606833), also known as MLL3,
mediates H3K4 mono- and dimethylation (Ruault et al., 2002; Sedkov et al., 2003; Herz
et al., 2012). KMT2C is functionally active in the COMPASS complex and is often recruited
to enhancers and active gene promoters (Hu et al., 2013). Additionally, KMT2C is a central
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component of the activating signal cointegrator-2 (ASC-2) complex, which acts as a coactivator for hormone receptors (Goo et al., 2003; Lee et al., 2009). Knockdown of the
Drosophila KMT2C homolog, thrithorax related (Trr), in the brain impaired short-term
memory, highlighting its role in synaptic plasticity and cognition (Koemans et al., 2017).
Kleefstra et al. performed WES on five individuals with the same clinical phenotype,
including psychomotor delay, severe ID, dysmorphic facial features, and behavioral
problems (Kleefstra et al., 2012). They discovered a heterozygous de novo nonsense
mutation in the KMT2C gene in a female patient, resulting in truncation of KMT2C
(Kleefstra et al., 2012). This truncation is predicted to reduce methyltransferase activity
as it lacks the enzymatic SET domain. Another group identified five unrelated patients
with de novo mutations in the KMT2C gene, all which are predicted to cause loss-offunction variants (Koemans et al., 2017). These patients, previously diagnosed with an
undefined developmental disorder, were classified as all suffering from Kleefstra
Syndrome-2 (KLEFS2) (MIM: 617768)(Koemans et al., 2017). It is evident that
dysregulation of KMT2C function potentially underlies the broad spectrum of
neurodevelopmental abnormalities observed. Unfortunately, specific gene targets of
KMT2C remain unknown, but future research potentially utilizing ChIP-seq will likely
reveal molecular targets. Intriguingly, it has been recently shown that when KMT2C is
promoter-bound, this represses gene transcription through recruitment of specific factors
(Cheng et al., 2014). Based on these studies, KMT2C can potentially both activate and
repress genes and understanding its role in chromatin regulation will clarify its effect on
transcriptional regulation during brain development.
Lysine methyltransferase 2D (KMT2D) (MIM: 602113), also known as MLL2, is a
paralog of KMT2C and, as such, mediates mono- and dimethylation of H3K4 in
mammalian cells as well (Hu et al., 2013; Lee et al., 2013). WES uncovered KMT2D
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variants as the causative gene in Kabuki syndrome 1 (KS1) (MIM 147920) (Ng et al., 2010).
KS1 is an autosomal-dominant disorder phenotypically similar to aforementioned
neurodevelopmental disorders; it is characterized by infantile hypotonia, craniofacial
abnormalities, mild-moderate ID, and DD (Ng et al., 2010, p. 2). There are dozens of
clinical reports detailing over 100 unique de novo mutations of KMT2D identified in
individuals with KS1 (Ilyina et al., 1995; Kobayashi and Sakuragawa, 1996; Lerone et al.,
1997; Tsukahara et al., 1997; Ewart-Toland et al., 1998; Kawame et al., 1999; McGaughran,
Donnai and Clayton-Smith, 2000; Hannibal et al., 2011; Micale et al., 2011; Paulussen et
al., 2011; Banka et al., 2012, 2013). These mutations all result in loss-of-function variants
by disrupting its reader domains (PHD fingers), loss of its catalytic SET domain, or
disruption of the 3D structure (Dhar et al., 2012; Banka et al., 2013, p. 2; Bögershausen
and Wollnik, 2013). In vitro studies determined that KMT2D mediates neural
differentiation by activating neuronal differentiation genes, HOXA1-3 and NESTIN, via
H3K4me3 deposition (Dhar et al., 2012). These studies suggest that the loss-of-function
mutations affecting the tandem PHD domains or SET domain will likely lead to loss of
H3K4me3, which is necessary for neuronal differentiation gene expression. Van
Laarhoven et al. performed morpholino-mediated knockdown of kmt2d in zebrafish and
observed significant craniofacial and cardiac defects (Van Laarhoven et al., 2015).
Additionally, this knockdown resulted in the reduction of mature neurons and brain size
despite the accumulation of neural precursor cells, suggesting the defects were due to
cellular dysfunction rather than perturbed development. Further functional studies on
this writer will prove beneficial for understanding its role in neuronal maturation and
function.
Lysine methyltransferase 2E (KMT2E) (MIM: 608444), also known as MLL5,
diverges from the KMT2 family of methyltransferases since it lacks histone
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methyltransferase activity (Sebastian et al., 2009). Nonetheless, it has been reported to
play critical roles in cell cycle progression, genomic stability maintenance, and
differentiation (Sebastian et al., 2009, p. 5). Despite the lack of KMT activity, the KMT2E
homolog in Drosophila, UpSET, regulates promoter-associated histone acetylation and
H3K4 di- and trimethylation when in complex with Rpd/Sin3-repressor proteins (RinconArano et al., 2012). O'Donnell-Luria-Rodan syndrome (ODLURO) (MIM: 618512) is a
neurodevelopmental disorder characterized by DD, intellectual disabilities, and subtle
craniofacial abnormalities with heterozygous mutations in KMT2E being the causative
gene (O’Donnell-Luria et al., 2019). Individuals with ODLURO either have proteintruncating variants or missense mutations in the KMT2E gene, with the latter resulting in
increased severity (O’Donnell-Luria et al., 2019). Moreover, the individuals with missense
mutation often develop drug-resistant infantile epileptic encephalopathy(O’Donnell-Luria
et al., 2019). To this date, no functional analyses have been conducted; however, it has
been hypothesized that haploinsufficiency is potentially the pathogenic mechanism for the
truncation and missense mutations. Collectively, these mutations are hypothesized to
produce loss-of-function variants.
SET domain-containing protein 1A (SETD1A) (MIM: 611052), also known as
KMT2F, mediates the trimethylation of H3K4 at promoters of active genes (Lee and
Skalnik, 2008, p. 1). SETD1A associates with the canonical COMPASS complex, in
addition to CpG-binding protein (CXXC1) and WD repeat domain 82 (WDR82) (Lee and
Skalnik, 2005, 2008, p. 82; Deng et al., 2013). Loss-of-function variants in SETD1A have
been implicated as causative in two neurodevelopmental disorders and schizophrenia
(Swedish Schizophrenia Study et al., 2016). In 2019, de novo heterozygous mutations in
SETD1A were discovered in individuals with early-onset epilepsy with or without DD
(EPEDD) (MIM: 618832) (Yu et al., 2019). Mutant SETD1A expression decreased the
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number of excitatory synapses on mouse cortical primary neurons (Yu et al., 2019).
Significantly, these mutations did not affect general neuronal morphology which suggests
a role of SETD1A in synapse formation (Yu et al., 2019). Kummeling et al. discovered de
novo heterozygous mutations in the SETD1A gene in 15 unrelated patients with a
neurodevelopmental disorder with speech impairment and dysmorphic facies (NEDSID)
(MIM: 619056) (Kummeling et al., 2020). These were missense, nonsense, frameshift, and
splice-site mutations, all expected to disrupt the catalytic SET domain. Patient-derived
fibroblasts displayed increased activation of DNA damage response, and increased DNA
degradation under stress (Kummeling et al., 2020). Additionally, when SETD1A was
knocked down in Drosophila mushroom bodies to assess neural programming, results
determined that SETD1A is required for proper neuronal function during the formation of
memory. Given that both disorders are clinically distinct despite both deriving from
pathogenic SETD1A, it will be essential to elucidate this protein's role in neural
development and neuronal function.
SET domain-containing protein 1B (SETD1B) (MIM: 611055), also known as
KMT2G, is a paralog of SETD1A and, as such, also mediates the trimethylation of H3K4
(Lee et al., 2007). Despite their homology, SETD1A and SETD1B localize to a
nonoverlapping set of target genes suggesting that these methyltransferases have
nonredundant contributions to the epigenetic control of gene expression (Lee et al., 2007).
Recent studies provided evidence that intellectual developmental disorder with seizures
and language delay (IDDSELD) (MIM: 619000) is caused by de novo heterozygous
mutations in SETD1B (Roston et al., 2020). As its name suggests, IDDSELD is
characterized by global DD with speech and language impairment, and the onset of
myoclonic seizures early in life (Palumbo et al., 2015; Hiraide et al., 2018, 2019; Den et al.,
2019; Roston et al., 2020). Additionally, individuals often exhibit behavioral
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abnormalities such as ASD and facial dysmorphism. Interestingly, the mutations
discovered have been predicted to confer loss-of-function or gain-of-function effect on
SETD1B. Additional functional studies on these pathogenic variants and patient cells are
required to determine the pathological mechanism. Krzyzewska et al. identified a shift in
the DNA methylation landscape in IDDSELD patient cells (Krzyzewska et al., 2019).
Notably, SETD1B variants imposed a hypomethylated epigenetic signature which lead the
authors to speculate SETD1B is enduring a loss-of-function effect (Krzyzewska et al.,
2019).
Euchromatic histone methyltransferase (EHMT1) (MIM: 607001), or G9a-like
protein (GLP), catalyzes mono- and dimethylation of H3K9 and is known to recruit
Polycomb Repressive Complex-2 (PRC2) (Mozzetta et al., 2014). EHMT1 predominantly
deposits H3K9me2 in the genome, which promotes transcriptional repression (Peters et
al., 2003; Rice et al., 2003). Heterozygous mutations on EHMT1 cause chromosome
9q34.3 deletion syndrome, better known as Kleefstra syndrome-1 (KLEFS1) (MIM:
610253) (Harada et al., 2004; Iwakoshi et al., 2004, p. 34; Stewart et al., 2004; Neas et
al., 2005; Kleefstra et al., 2006, p. ). Standard features in patients with KLEFS1 are severe
ID, distinct facial gestalt, hypotonia, microencephaly, seizures, and cardiac defects
(Kleefstra et al., 2006, 2012). Individuals contain missense, nonsense, frameshift, and
splice-site mutations (Kleefstra et al., 2006, 2009, 2012). Biochemical characterization of
missense mutations of EHMT1 reveals these mutations decrease its methyltransferase
activity, potentially reducing H3K9me2 at specific loci, causing KLEFS1 (Yamada,
Shimura and Shinkai, 2018). Heterozygous Ehmt1+/- mice have reduced dendritic
branching and a reduced number of mature spines in hippocampal neurons resulting in
learning and memory deficits, specifically during stress (Balemans et al., 2013).
Additionally, Ehmt1+/- mice exhibited overexcitability due to deficiencies in inhibitory
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neuron maturation and excitatory impairments (Negwer et al., 2020). To ascertain
whether these effects are observed in human cells, excitatory cortical neurons were
generated from IPSCs derived from KLEFS1 patients (Frega et al., 2019). Frega et al.
observed similar overexcitability in patient-derived neurons. They demonstrated that
these changes were due to upregulation of the NMDA receptor (NMDA-R) subunit, which
correlated with reduced H3K9me2 at its promoter (Frega et al., 2019). Davis et al.
suggested that EHMT1 haploinsufficiency results in disrupted NMDA-R expression
promoting abnormal forebrain development, ultimately resulting in information
processing deficits (Davis et al., 2020). Understanding the cognitive deficits and the
pathways involved would provide a basis for targeted therapeutics, since Frega et al. were
able to rescue KLEFS1 patient-derived neuronal phenotypes through pharmacological
inhibition of NMDA-Rs (Frega et al., 2019).
Enhancer of zeste 2 (EZH2) (MIM: 601573) in complex with suppressor of zest 12
(SUZ12) and embryonic ectoderm development (EED) acts as the catalytic subunit of
Polycomb repressive complex-2 (PRC2), which functions to repress gene expression
through trimethylation of H3K27 (H3K27me3) (O’Carroll et al., 2001; Cao et al., 2002).
PRC2 is essential for development as reducing a single subunit results in embryonic
lethality and severe developmental defects (O’Carroll et al., 2001, p. 2; Pasini et al., 2004).
H3K27me3 deposition and removal are critical in epigenetic inheritance of repressed
transcriptional landscapes and neurogenesis (Burgold et al., 2008; Fragola et al., 2013;
Park et al., 2014; Coleman and Struhl, 2017). Mainly, EZH2 knockdown results in
abnormal migration of cortical neurons due to overexpression of Reelin, a glycoprotein
that regulates neuronal migration (Zhao et al., 2015). Furthermore, chicken embryos
lacking Ezh2 exhibit impaired neural tube organization due to dysregulated neural
progenitor cell renewal and impaired Rho signaling (Akizu and Martínez-Balbás, 2016).
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Weaver syndrome (WVS) (MIM: 277590), an overgrowth syndrome characterized by ID,
macrocephaly, DD, and characteristic facial features, is caused by heterozygous mutation
EZH2 (Weaver et al., 1974; Gibson et al., 2011). Cohen et al. determined that WVS-causing
EZH2 mutations reduce PRC2 activity in vitro, suggesting that WVS is caused by altered
PRC2 function (Cohen et al., 2016). Interestingly, despite the decreased activity, PRC2
harboring WVS-causing EZH2 mutations displayed increased association with chromatin,
suggesting dysregulated disengagement between the complex and chromatin (Lee et al.,
2018). Mice bearing Ezh2 mutations result in perinatal lethality when homozygous, and
overgrowth when heterozygous (Lui et al., 2018). Loss of PRC2 during differentiation
severely compromised neural gene induction due to marked loss of bivalent enhancers
(Cruz-Molina et al., 2017). Collectively, this evidence suggests EZH2 plays a critical role in
neurodevelopment; however, understanding how these mutations impart their effects on
human neurogenesis remains unclear.
ASH1-like histone lysine methyltransferase (ASH1L) (MIM: 607999), also known
as KMT2H, catalyzes mono- and dimethylation of H3K36, promoting gene expression by
counteracting Polycomb silencing (Miyazaki et al., 2013). Moreover, ASH1L plays a critical
role in development by activating homeobox (HOX) genes and is highly expressed in both
embryonic and adult brains (Miller et al., 2014; Okamoto et al., 2017). Various groups
reported ASH1L as the causative gene in Autosomal dominant mental retardation-52
(MRD52) (MIM: 617796) (de Ligt et al., 2013; Krumm et al., 2015; Wang et al., 2016;
Okamoto et al., 2017; Stessman et al., 2017). Individuals with MRD52 have mild-severe
ID, ASD, speech delay, facial dysmorphisms, and overall DD (de Ligt et al., 2013; Wang et
al., 2016; Okamoto et al., 2017; Stessman et al., 2017). No functional analyses have been
conducted on patient cells; however, knockdown of Zebrafish homolog, ash1a, resulted in
a reduction in the number of neurons in the pineal gland (Cau and Wilson, Stephen W.,
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2003). Furthermore, mice expressing catalytically inactive ASH1L had a wide range of
skeletal anomalies and impaired fertility (Miyazaki et al., 2013; Brinkmeier et al., 2015).
Interestingly, ASH1L is enriched at the promoter of neurexin1α, a presynaptic adhesion
molecule essential for synapse formation, upon neuronal stimulation (Zhu et al., 2016). It
will be critical to determine how the ASH1L pathogenic variants affect the synaptic
formation, synaptic plasticity, and ultimately learning and memory.
Nuclear receptor SET domain-containing 1 (NSD1; also known as KMT3B) (MIM:
606681) catalyzes mono and dimethylation of H3K36 and trimethylation of H4K20 (Wang
et al., 2007; Berdasco et al., 2009; Lucio-Eterovic et al., 2010; Qiao et al., 2011).
Haploinsufficiency of NSD1 is the primary cause of Sotos syndrome-1 (SOTOS1) (MIM:
117550), accounting for over 75% of reported cases (Sotos et al., 1964; Hook and Reynolds,
1967; Bejar et al., 1970; Kurotaki et al., 2002; Douglas et al., 2003; Türkmen et al., 2003,
p. 1; Baujat and Cormier-Daire, 2007; Fryssira et al., 2010). SOTOS1 is characterized by
overgrowth, distinctive facial features, mild-severe ID, macrocephaly, and seizures (Sotos
et al., 1964; Kurotaki et al., 2002). Different de novo mutations have been reported in
individuals with SOTOS1, including missense, nonsense, frameshift, or deletion mutations
(Kurotaki et al., 2002; Douglas et al., 2003; Türkmen et al., 2003, p. 1; van Haelst et al.,
2005; Visser et al., 2005; Kaminsky et al., 2011). Although widely distributed across the
NSD1 protein, these mutations affect the PHD domain, SET domain, and cofactor binding
regions resulting in haploinsufficiency (Niikawa, 2004; Pasillas, Shah and Kamps, 2011).
Loss of NSD1 results in reduced H3K36 methylation and gene expression in vitro (LucioEterovic et al., 2010). This methylation recruits DNMT3A, a DNA methyltransferase, to
intergenic regions. Furthermore, blood samples from individuals with SOTOS1 exhibit
hypomethylation of intergenic DNA (Weinberg et al., 2019). A mouse model for SOTOS1
with a heterozygous Nsd1 mutation has been generated, which could be used in future
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work to elucidate the molecular mechanisms of these pathogenic variants(Oishi et al.,
2020).
Nuclear receptor SET domain-containing 2 (NSD2) (MIM: 602952) also known as
Wolf-Hirschhorn syndrome candidate 1 (WHSC1) or multiple myeloma SET domain
(MMSET), is similar to NSD1, by depositing mono- and di-methylation at H3K36 (Wagner
and Carpenter, 2012). Interestingly, NSD1 and NSD2 loss-of-function results in distinctly
different phenotypes despite deposition of the same histone modification. Nsd1
knockdown mice have impaired gastrulation, whereas Nsd2 knockout mice showed
growth retardation and developmental defects (Rayasam et al., 2003; Nimura et al.,
2009). As previously discussed, NSD1 result in Sotos syndrome. Haploinsufficiency of
NSD2, on the other hand results in the majority of Wolf-Hirschhorn syndrome (WHSC)
(MIM: 194190) characterized by growth abnormalities, microcephaly, ID, seizures, and
severe craniofacial abnormalities (Stec et al., 1998; Paradowska-Stolarz, 2014). NSD2
mutations attributed to WHSC result in de novo loss-of-function variants (Lozier et al.,
2018; Barrie et al., 2019; Derar et al., 2019; Jiang et al., 2019). Studies reported reduced
cellular proliferation and cell viability in WHSC patient-derived fibroblasts suggesting that
the haploinsufficiency either reduces proliferation or increases apoptosis (Nevado et al.,
2020). Severe craniofacial abnormalities are characteristic phenotypes of WHSC. To
explore this, NSD2 expression was decreased in Xenopus laevis which correlated with
downregulation of several NSD2-associated genes and significantly affected craniofacial
patterning, specifically cartilage formation and neural crest motility (Mills et al., 2019).
Additionally, NSD2 has been demonstrated to regulate gene expression through Runx2,
and p300 (Lee et al., 2014). Researchers observed that NSD2 regulates the expression of
bone-related genes through modulation of H3K36 dimethylation (Lee et al., 2014). Lastly,
knockdown of zebrafish NSD2 homolog, DrWhsc1, affected endbrain enlargement,
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abnormal cartilage, bone reduction, and incomplete motor neuron formation (YamadaOkabe et al., 2010, p. ). Despite all these functional studies, there are currently no
therapeutics developed for WHSC, suggesting that the pathomechanism remains elusive.
Currently, only symptomatic treatments are available.
SET domain-containing protein 2 (SETD2) (MIM: 612778) is the primary
methyltransferase for trimethylation of H3K36 (H3K36me3) (Sun et al., 2005; Hu et al.,
2010). SETD2 mediates genomic imprinting and embryonic development, as Setd2-/embryos result in embryonic lethality (Xu et al., 2019). SETD2 ablation causes LuscanLumish syndrome (LLS) (MIM: 616831), previously known as Sotos-like syndrome. LLS,
is categorized by macrocephaly, facial dysmorphism, ID, speech and language DD, and
behavioral problems, including ASD (Luscan et al., 2014; Lumish et al., 2015). Thus far,
de novo SETD2 mutations are proposed to be loss-of-function either due to truncation or
missense mutations (Marzin et al., 2019). Setd2 conditional knockout mice mimicked
phenotypes seen in patients, such as defective social interaction, reduced motor learning,
and spatial memory (Xu et al., 2021). Xu et al. concluded that SETD2 is required for
cortical arealization, the process of subdividing neocortex, and for the formation of cortical
circuits (Xu et al., 2021). Functional studies utilizing patient samples are needed to
determine the pathogenicity of the SETD2 mutations in neurodevelopment.
SET

domain-containing

protein

5

(SETD5)

(MIM:

615743)

mediates

trimethylation of H3K36 (Xiao, Wilson and Gamblin, 2003; Dillon et al., 2005; Sessa et
al., 2019). SETD5 mutations have been associated with neurodevelopmental disorders,
including Cornelia de Lange and ASD (Parenti et al., 2017; Fernandes et al., 2018; Pizzo et
al., 2019). Furthermore, heterozygous loss-of-function mutations in SETD5 cause
autosomal dominant mental retardation-23 (MRD23) (MIM: 615761) characterized by
psychomotor delay, speech impairments, dysmorphic facial features, ID, and behavioral
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abnormalities (Rauch et al., 2012; Grozeva et al., 2014; Kuechler et al., 2015; Green et al.,
2017; Stur, Soares and Louro, 2017; Fang et al., 2019; Crippa et al., 2020). Deliu et al.
demonstrated that Setd5-haploinsufficient mice have impairments in cognitive tasks due
to dysregulated transcription via interaction with HDAC3 and PAF1 (Deliu et al., 2018).
Haploinsufficiency of SETD5 in both mice and zebrafish resulted in global alterations to
H3K36me3, impaired proliferation of neural progenitor cells, and defective synapse
formation, ultimately resulting in learning and behavioral abnormalities (Sessa et al.,
2019). Finally, Nakagawa et al. showed that SETD5 mediates ribosomal DNA expression
through recruitment of HDAC3, and this regulation is critical for neural cell proliferation
(Nakagawa et al., 2020). Sufficient evidence proves that SETD5 haploinsufficiency drives
abnormal neurodevelopment. Future studies are needed to continue elucidating the
pathology of MRD23 and other SETD5-related syndromes. Additionally, this work can be
used to aid in the understanding of histone H3K36-related disorders.
1.3.5

KDMs
Lysine-specific demethylase 1A (KDM1A or LSD1) (MIM: 609132), the first

demethylase discovered, catalyzes FAD-dependent oxidative demethylation of mono and
dimethylated H3K4, which results in gene repression (Shao et al. 2014). Heterozygous
mutations in KDM1A are causative for a syndrome of cleft palate, psychomotor
retardation, and distinctive facial features (CPRF) (MIM: 616728) (Chong et al. 2016;
Tunovic et al. 2014). Individuals with pathogenic KDM1A variants present global DD, ID,
and craniofacial abnormalities (Chong et al. 2016; Tunovic et al. 2014). One such
pathogenic variant contains a replacement of an evolutionarily conserved tyrosine (Y385),
potentially conferring a gain-of-function mutant giving rise to decreased H3K4
methylation (Tunovic et al. 2014). Notably, KDM1A is a crucial subunit of CoREST
(corepressor to the REST (RE1 silencing transcription factor/neural restrictive silencing
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factor) complex), which mediates repression of neuronal genes (Ballas et al. 2001; Andrés
et al. 1999). Knockdown of Kdm1a in mouse cortical neurons led to decreased dendritic
arborizations and neurite width, suggesting it plays a critical role in neurite
morphogenesis (Zibetti et al. 2010). Taken together, KDM1A regulates neuronal function
and programming; however, further studies are needed to determine the factors that
recruit KDM1A in specific regulatory regions in neurons and the influence of these
pathogenic mutations on its function.
KDM4B (MIM: 609765) also known as JMJD2B is a member of the KDM4 family
of demethylases and removes di- and trimethylation from H3K9, with increased
demethylation of H3K9me3 (Yang et al. 2010). KDM4B plays a critical role in opening
heterochromatic structures and is regulated by several stimuli including DNA damage,
cellular stress and steroid hormones (Wilson and Krieg 2019). Duncan et. al identified
heterozygous mutations in KDM4B in 9 unrelated patients, these mutations were
predicted to result in loss-of-function variants (Duncan et al. 2020). All individuals
presented with DD, with increased severity of ID and motor skills. Utilizing an animal
model, this group determined that heterozygous loss of Kdm4b resulted in decreased brain
volume with partial agenesis of the corpus callosum (Duncan et al. 2020). They
hypothesized that reduction of KDM4B resulted in aberrant repression of genes that
regulate corticogenesis (Duncan et al. 2020). This was the first report of KDM4B
mutations and future studies determining transcriptional targets will aid in determining
the pathology and the role of KDM4B demethylation in neurodevelopment.
KDM5B (other aliases include: JARID1B, SUV420H1) (MIM: 605393) is a member
of the KDM5 family of JmjC domain containing demethylases and demethylates di- and
trimethylated H3K4 (Xiang et al. 2007). KDM5B-mediated demethylation regulates RNA
polymerase II initiation and elongation as well as alternative splicing in embryonic stem
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cells (He and Kidder 2017). Notably, both homozygous and heterozygous germline
mutations of KDM5B have been discovered as causative in mental retardation, autosomal
recessive 65 (MRT65) (MIM: 618109) (Faundes et al. 2018; Martin et al. 2018).
Individuals with MRT65 display moderate-severe DD, inconsistent dysmorphic facial
features, and behavioral abnormalities (Faundes et al. 2018; Martin et al. 2018). KDM5B/- embryos exhibit several neural defects due to derepression of developmental regulators
in early embryogenesis (Albert et al. 2013). Moreover, a loss-of-function model mimicking
MRT65 showed similar phenotypes as patients, including increased behavioral
abnormalities, decreased learning, and skeletal abnormalities (Martin et al. 2018, 20).
Zhou et al. demonstrated that KDM5B negatively regulates neurogenesis in adult
subventricular zone through regulation of Reelin expression suggesting a role of KDM5B
in neuronal migration and cortical circuit organization (Zhou et al. 2016). Extensive
studies have found KDM5B as a major regulator of neuronal differentiation, however the
specific genes involved in this disorder and how they affect neurogenesis remains elusive.
KDM5C (also known as JARID1C, SMCX) (MIM: 314690) catalyzes the
demethylation of di- and trimethylated H3K4, recognizes H3K9me3 and negatively
regulates transcription through the REST complex (Lan et al. 2007; Tahiliani et al. 2007).
KDM5B is highly expressed in brain and skeletal muscle, and pathogenic KDM5C variants
account for approximately 3% of Claes-Jensen type of X-linked syndromic mental
retardation (MRXSCJ) (MIM: 300534) (Jensen et al. 2005; Peng et al. 2015). Individuals
present with ID, microcephaly, epilepsy and abnormal facial features (Jensen et al. 2005).
To date, at least 30 mutations have been identified encompassing nonsense, missense, and
frameshift mutations in individuals with MRXSCJ. Functional studies of these mutations
reveal decreases in KDM5C activity, suggesting a loss-of-function pathological mechanism
(Tahiliani et al. 2007; Iwase et al. 2007). Patient-derived fibroblasts revealed altered
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genomic localization of KDM5C, altered DNA methylation and loci specific alterations in
histone methylation (Jensen et al. 2005; Brookes et al. 2015; Grafodatskaya et al. 2013;
Schenkel et al. 2018). Additionally, KDM5C is critical for neuronal development and
maturation (Iwase et al. 2007; Scandaglia et al. 2017). Iwase et. al recapitulated MRXSCJ
abnormalities with a condition knockout of Kdm5c in mouse brains, including behavioral
anomalies and memory deficits (Iwase et al. 2016). Investigating patient mutations in
Neuro2a cells revealed dysregulation of genes involved in neuronal development due to
methylation changes at their promoters; the differential expression resulted in
morphological changes including abnormal neurite length (Wei et al. 2016). Another
promising study demonstrated that reduced functionality of KDM5C causes a lack of
repression in neurodevelopmental transcripts, and a decreased KDM5C dosage resulting
in neuronal defects (Poeta et al. 2019). Moreover, they demonstrated that KDM5C is a
Vorinostat-sensitive gene, treatment with this HDAC inhibitor ameliorates previously
compromised neuronal differentiation (Poeta et al. 2019). The role of KDM5C has been
extensively studied and characterized in neuronal differentiation, and its pathogenic
variants have been corrected in vitro and in vivo using Vorinostat, making it a promising
therapeutic for MRXSCJ.
Lysine demethylase 6A (KDM6A or UTX) (MIM: 300128) contains a catalytic JmjC
domain and preferentially demethylates di- or trimethylated H3K27. Also, it is a member
of the KMT2C/D COMPASS-like complex (Hong et al. 2007; Lan et al. 2007; C. Wang et
al. 2012; Cho et al. 2007; M. G. Lee et al. 2007). As a member of the COMPASS-like
complex, KDM6A regulates enhancer activation, independent of its demethylase activity
(S.-P. Wang et al. 2017). Individuals presented with KS1 characteristics, described earlier,
were screened for mutations in KMT2D but instead carried de novo heterozygous
mutations in KDM6A (Noriko Miyake et al. 2013; Lederer et al. 2012). Like KS1, Kabuki
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syndrome 2 (KS2) clinically presents with DD, ID, and craniofacial abnormalities (Lederer
et al. 2012). Some features of KS1 were less common in KS2 individuals; however, all KS2
patients exhibited postnatal growth retardation and short stature (Noriko Miyake et al.
2013). Conditional knockout of Kdm6a in neural stem cells led to increased anxiety-like
behavior and impaired learning and memory in mice (Tang et al. 2017). Moreover,
hippocampal neurons in these mice displayed impaired synaptic formation and plasticity,
revealing a role of KDM6A in regulating cognition (Tang et al. 2017). Another model
demonstrated that KDM6A loss increases neural stem cell proliferation and decreases
terminal mitosis, resulting in aberrant neuronal differentiation (Lei and Jiao 2018).
Interestingly both KS1 and KS2 stem from altered KMT2C/D COMPASS-like complex
functions. Although extensive studies have been conducted in the context of cancer,
specific pathways involved in neurogenesis remains ambiguous.
PHD finger protein 8 (PHF8 also known as KDM7B) (MIM: 300560) is the first
monomethyl H4K20 demethylase identified. Interestingly, it can also demethylate monoand dimethylated H3K9 (Qi et al. 2010). PHF8 binds H3K4me3, and through this
interaction, positively regulates gene expression (Feng et al. 2010; Horton et al. 2010).
Reduction of phf8 in zebrafish embryos caused cell death in the developing brain and
neural tube and significant defects in craniofacial development (Qi et al. 2010). PHF8
directly controls the expression of homeodomain transcription factor MSX1/MSXB,
mediating signaling and developmental pathways (Qi et al. 2010). Given its role in
neurodevelopment, it is not surprising that mutations in PHF8 results in a NDD, Sideriustype X-linked syndromic mental retardation (MRXSSD) (MIM: 300263) (Siderius et al.
1999; Laumonnier et al. 2005). MRXSSD primarily affect males and patients often have
ID, mild dysmorphic features, and bilateral/unilateral cleft lip or palate (Koivisto et al.
2007). In vitro analysis of MRXSSD patient mutations abolished demethylase activity and
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transcriptional activation (Feng et al. 2010). PHF8 potentially mediates serotonin
signaling and downregulation of PHF8 results in stress-induced anxiety, depression and
cognitive impairment (Walsh et al. 2017). Moreover, Phf8 knockout mice displayed
reduction cognition and memory due to impaired long-term potentiation. Chen et al.
demonstrated PHF8 plays a role homeostasis of mTOR signaling, and suppression of
mTOR recovers the cognitive deficits observed in PHF8 knockout mice (X. Chen et al.
2018, 8). These studies provide potential targetable pathways to treat MRXSSD.
1.3.6

Histone modification readers
PHD finger protein 6 (PHF6) (MIM: 300414), a transcriptional repressor,

functions as a reader of H2BK12 acetylation, and it also has E3 ligase activity specifically
modifying H2BK120 ubiquitination (Oh et al., 2020, p. 120). PHF6 was discovered as the
causative gene in Börjeson–Forssman–Lehmann syndrome (BFLS) (MIM:301900)
(Lower et al., 2002). Mutations in PHF6 resulted in moderate to severe ID, epilepsy and
hypogonadism in individuals (Lower et al., 2002). Voss et. al performed the initial
functional assessment of PHF6, and found that murine Phf6 is highly expressed in the
developing brain and facial structures and remains moderately expressed in the specific
neuronal subtypes including cortical neurons (Voss et al., 2007). Further studies revealed
a critical role of PHF6 in neuronal migration as loss of PHF6 severely impairs
corticogenesis, leading to abnormal white matter and neuronal activity (Zhang et al.,
2013). Mice expressing pathogenic variants of PHF6 had increased neurogenic gene
expression and decreased expression synaptic genes in the cortex (Cheng et al., 2018).
Additionally, mice expressing pathogenic PHF6 protein displayed cognitive and social
impairments that mimics that of BFLS patients. To date, there have been many functional
analyses exploring molecular mechanisms of PHF6 pathogenicity and further studies
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understanding the specific pathways dysregulated and potential therapeutics are still
needed.
Bromodomain and WD repeat-containing protein 3 (BRWD3) is a histone
acetylation reader and was been demonstrated to associate with transcriptionally-active
genes (D’Costa et al., 2006). Mutations in BRWD3 were found to cause X-linked mental
retardation (XLMR) characterized by macrocephaly, obesity, behavioral problems and,
mild to moderate ID (Field et al., 2007; Ostrowski et al., 2019). Mutations in the
Drosophila ortholog, dBRWD3, were discovered to negatively regulate H3.3 deposition by
its chaperone, histone cell cycle regulator (HIRA) thereby altering gene expression,
resulting in developmental abnormalities (Chen et al., 2015). Intriguingly, the inactivation
HIRA-H3.3 deposition pathway, rescues the effects of mutant dBRWD3 (Chen et al.,
2015). This interplay of epigenetic regulators, like HIRA and BRWD, highlights the
importance of understanding their function in development as determining the specific
alterations in the pathways can result in potential therapeutic targets.
Bromodomain PHD finger transcription factor (BPTF) (MIM: 601819) is the
largest subunit of the NURF complex and mediates binding to H3K4me3 (M. H. Jones,
Hamana, and Shimane 2000). BPTF has been shown to promote expression of WNT8A
which is crucial for neural posteriorization, through recruitment of NURF complex (Ma et
al. 2015). Eight heterozygous mutations in the BPTF gene were discovered in unrelated
individuals with neurodevelopmental disorder with dysmorphic facies and distal limb
anomalies (NEDDFL) (MIM: 617755) (Stankiewicz et al. 2017). NEDDFL is characterized
by delayed psychomotor development, ID, speech impairments, microencephaly and
dysmorphic features (Glinton et al. 2021). Although functional studies of patient cells have
yet to be conducted, Stankiewicz et al. suggests that haploinsufficiency is the pathogenic
mechanism of this disorder (Stankiewicz et al. 2017). CRISPR/Cas9-mediated knockdown
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of bptf gene in zebrafish resulted in increased cell death which recapitulated
microencephaly and craniofacial abnormalities seen in patients (Stankiewicz et al. 2017).
Due to the novelty of this disorder, there is currently no potential pathological mechanism
for BPTF mutations in neurodevelopment.
As mentioned above, EED (MIM: 605984) is a major subunit of PRC2 complex as
it recognizes methylated histones (Margueron et al. 2009). EED is required for
maintaining neurogenesis and neurosphere formation through regulation of p21 (B. Sun
et al. 2018). Heterozygous mutations in EED results in the overgrowth disorder CohenGibson syndrome (COGIS) (MIM: 617561) (Cooney et al. 2017). COGIS affected
individuals have ID, dysmorphic facial features, advanced bone age and skeletal
abnormalities (A. S. A. Cohen et al. 2016; Cooney et al. 2017; A. S. Cohen and Gibson 2016;
Imagawa et al. 2017). Eed-deficient mice exhibited postnatal lethality and diminished
neuronal differentiation in the hippocampal dentate gyrus potentially explaining the
pathomechanism of COGIS (Liu et al. 2019). Additionally, EED establishes a chromatin
landscape that selectively represses inhibitory WNT and bone morphogenetic protein
(BMP) signaling which is required for oligodendrocyte differentiation and maturation
(Jiajia Wang et al. 2020). Taken together, EED plays a critical role in CNS development,
through regulation of neuronal and oligodendrocytic differentiation, however, the field
lacks biochemical characterization of COGIS mutations.
Suz12 (MIM: 606245) is a another component of the Polycomb group complexes
and aids in recruiting PRC2 to target genes (Højfeldt et al. 2018). Like the other core PRC2
subunits, EZH2 and EED, mice with mutations in Suz12 have decreased di- and trimethylation H3K27 and are embryonic lethal due to severe developmental and
proliferative defects(Pasini et al. 2004). Unfortunately, the SUZ12-related overgrowth
syndrome, Imagawa-Matsumoto syndrome (IMMAS) (MIM: 618786) is the least
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characterized of the PRC2-related syndromes (Imagawa et al. 2017; 2018). Individuals
with IMMASS exhibit pre- and postnatal overgrowth, dysmorphic features, ID,
macrocephaly and DD (Imagawa et al. 2017). SUZ12 is required for proper differentiation
as SUZ12-deficient stem cells are de-repressed, increasing levels of differentiation specific
genes (Pasini et al. 2004). Moreover, heterozygous Suz12 mice exhibit neural tube defects
and severely impaired differentiation (Miró et al. 2009).
1.3.7

Histone mutations
All the disorders previously described originate from germline mutations in

enzymes that either catalyze histone post-translational modifications or function in
chromatin remodeling. Recent studies have discovered germline mutations in histone
proteins, allowing us to define their roles not only in the context of gene regulation but
also in development. In 2017, Tatton-Brown et. al. conducted a study with 710 individuals
all suffering from overgrowth syndrome and ID to explore the underlying genetic
predispositions (Tatton-Brown et al. 2017). Utilizing WES, they reported de novo
heterozygous germline mutations in the HIST1H1E (MIM: 142220) gene (5/710) which
encodes linker histone, histone H1.4 (H1.4). Patients bearing H1.4 mutations suffer from
distinct facial features, ID, and macrocephaly (Tatton-Brown et al. 2017). This syndrome
was coined Rahman syndrome (MIM: 617537). Following the 2017 study, 42 patients were
discovered suffering from Rahman Syndrome, all exhibiting distinct facial gestalt, ID,
skeletal, and congenital cardiac abnormalities (Burkardt et al. 2019; Duffney et al. 2018;
n.d.). Reported frameshift mutations are centralized to the C-termini of the protein and
result in a truncated H1.4 with a charge reduced from +44 to +7. Linker histones play a
critical role in regulating higher-order chromatin structure through neutralization of
negatively charged linker DNA via its positively charged tails. Thus, as H1.4 is often
sequestered in heterochromatic regions, the truncation of H1.4 ultimately impairs the
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linker histone’s ability to generate higher-order structures (Tatton-Brown et al. 2017;
McGinty and Tan 2015; Ponte et al. 2017; Song et al. 2014).
Conducting a robust functional assessment of the HIST1H1E mutations
determined that these mutants had proper nuclear localization and increased stability
compared to wild-type (Flex et al. 2019). Typically, the C-terminal tail of H1 undergoes
reversible phosphorylation which mitigates chromatin compaction, chromosome
segregation, and chromatin decondensation; however, these residues are all lost in
HIST1H1E mutants (Flex et al. 2019; Chadee et al. 1997; Ajiro, Borun, and Cohen 1981).
Interestingly, patient-derived fibroblasts showed significantly more relaxed DNA as well
as a decrease in H3K4me2, H3K9me3, H3K27me3, and HP1β (Flex et al. 2019).
Ultimately, the frameshift mutations disrupt chromatin structure, alter nuclear lamina
organization, generate a hypomethylated DNA signature, and drive replicative senescence
(Flex et al. 2019). Another study determined that the aberrant DNA methylation profile
resulted in altered gene regulation, which was exacerbated in post-mitotic cells as genes
involved in neural signal transduction were significantly altered (Ciolfi et al. 2020).
Overall, there is sufficient evidence to start elaborating on the pathomechanism of H1.4
mutations and the role of this linker histone in neuronal development.
Histone H4 (H4), which is encoded by 15 distinct genes, is ubiquitously expressed
in all cells and is a critical nucleosomal protein. In 2017, monoallelic missense
heterozygous mutations of HIST1H4C (MIM: 602827) were discovered via trio sequencing
(Tessadori et al. 2017). These mutations result in substitutions that cause a charge switch
(K->E), or lose (K->Q) or retain charge (K->R) at residue 91 of H4 (Tessadori et al. 2017).
These patients exhibit short stature, microencephaly, ID, craniofacial abnormalities, and
foot ray anomalies. RNA sequencing utilizing patient-derived fibroblasts revealing 115
genes differentially expressed in K91 mutants. Intriguingly, 25 of these genes encoded for
48

histone proteins. Enriched gene ontology (GO) terms for differentially regulated genes
related to chromosome organization, DNA packaging, and cell cycle progress (Tessadori
et al. 2017).
To assess the functional consequence of these mutations, zebrafish were injected
with mRNA encoding K91R/Q mutations and the embryos exhibited severe DD (Tessadori
et al. 2017). These embryos had underdeveloped brains and eyes, defective body axis
growth, and dysmorphic tails which recapitulated the phenotype seen in patients
(Tessadori et al. 2017). Thus, this in vivo model provided sufficient evidence that
HIST1H4C mutations were causative in the observed syndrome. Zebrafish larvae
expressing H4-K91R/Q exhibited increased accumulation of DNA double-strand breaks
(DDBs) specifically in the head and tail region, which was determined utilizing a wellknown readout for DDBs, γ-H2AX signal (Tessadori et al. 2017). Additionally, these
embryos had increased apoptosis in the head and tail regions (Tessadori et al. 2017). K91
is a known PTM site for H4, as acetylation at this site has been linked to chromatin
assembly regulation and ubiquitination at this site has been related to DNA damage
response (Ye et al. 2005; Q. Yan et al. 2009; Yang et al. 2011). Co-expression of DTX3L,
the E3 ligase responsible for K91 ubiquitination, with K91 mutants alleviated the increase
in double-strand breaks and morphological anomalies observed (Tessadori et al. 2017).
This study determined that the loss of K91 ubiquitination in the mutants was sufficient to
alter cell cycle progression and apoptosis.
Recent work from the Gijs van Haaften lab reported a de novo germline missense
mutation in HIST1H4J, another gene encoding histone H4 (Tessadori et al. 2019). This
patient had a K91E mutation and exhibited ID, microcephaly, and had dysmorphic facial
features, symptoms remarkably similar to the previous report HIST1H4C mutations
(Tessadori et al. 2017; 2019). Here they hypothesized that the glutamic acid (E)
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substitution may contribute to genomic instability due to its inability to be modified as
well as the addition of a negative charge. This study was critical in showing the importance
of K91 residue in H4, as different substitutions at this position can result in distinct
phenotypic outcomes.
1.3.8

Histone H3.3 in disease
Recurrent mutations in H3.3 are shown to be the oncogenic drivers of several

cancers, including pediatric high-grade gliomas (pHGGs), giant cell tumors of bone
(GCTB), and chondroblastoma. Therefore, in the context of cancer, pathogenic variants of
H3.3 are coined as oncohistones. Importantly, oncohistone expression results in
transcriptional reprogramming and aberrant gene expression, eventually leading to
increased proliferation and oncogenesis (Wan, Liu, and Chan, 2018). The H3.3 mutations
identified in these cancers involve point mutations such as Lys27Met (K27M), which is
associated with gliomas, Lys36Met (K36M) that is predominantly found in
chondroblastoma, and Gly34Arg/Trp/Val/Leu (G34R/W/V/L), which occurs in both
gliomas and tumors (Kallappagoudar et al., 2015; El-Hashash, 2021). Both the mortality
and morbidity rates of these cancers are high, with little to no prognosis. The K27M
mutation was the first described in the context of diffuse intrinsic pontine glioma (DIPG),
an aggressive childhood glial-cell derived tumor (Project et al., 2012; St. Jude Children’s
Research Hospital–Washington University Pediatric Cancer Genome Project, 2012; Chan
et al., 2013).
H3.3K27M, which primarily occurs on H3F3A, has been identified in 60% of
DIPGs and exists along the brain midline (Fontebasso et al., 2014; Castel et al., 2015).
Additionally, H3.3K27M tumors have a characteristic oligodendroglial phenotype, with a
median survival of 10 months, and display more metastatic relapses and radiotherapy
resistance (Castel et al., 2015). The K27M mutation affects the histone PTM landscape
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through the inhibition of polycomb repressive complex 2 (PRC2), resulting in global
reduction of K27 trimethylation (K27me3) (Lewis et al., 2013). Interestingly, specific loci
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shown that mutations at either
residue on H3.3 (G34 or K36) result in atypical K36 methylation. The G34R residue was
described to preferentially bind and inhibit the lysine demethylases (KDM) 4 resulting in
prolonged H3K9 and H3K36 trimethylation (Voon et al., 2018). Additionally, the G34R
mutant promoted PRC2 activity through its K36me3 inhibition (Jain et al., 2020).
The most recent discovery of histone H3.3 mutations comes from germline
missense mutations on both H3F3 genes (Bryant et al. 2020). This group discovered 37
unique de novo germline mutations in 46 unrelated patients. These patients suffered from
a typical pattern of neurodevelopmental disorder encompassing microencephaly,
craniofacial abnormalities, and intellectual disabilities (Bryant et al., 2020). Interestingly,
only 6 of the 37 mutations were found in more than one patient, and surprisingly the
severity of the disorder correlated with the H3F3B gene, which is distinct from the cancer
patients. Furthermore, these mutations are dispersed across the entire protein, affecting
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post-translational modification residues, the H3.3 specific residues involved in chaperone
recognition, protein-protein interactions at the H3-H3’ interface, and between H3.3-H4,
and protein-DNA contact points (Figure 1.6). Bottom-up mass spectrometry of patient
lymphoblasts revealed histone PTM changes which were reproducibly altered in patients
compared to controls (Bryant et al. 2020).
Additionally, RNA sequencing utilizing patient-derived fibroblasts identified 323
differentially expressed genes associated with mitosis and cell cycle regulation which were
upregulated (Bryant et al. 2020). Due to the locations of these mutations along H3F3A
and H3F3B, it is predicted that different biological processes are altered but appear to
converge on similar phenotypes. This suggests that the phenotype is generally due to
dysregulation of H3.3 and is not limited to a single mechanism. I will discuss germline
mutations in chromatin-modifying enzymes specifically associated with histone posttranslational modifications in the following section.
1.4

Interplay

between

chromatin

modifiers

and

histone

PTMs

in

neurodevelopment
While decades of research have studied histone PTMs and cross talk, evidence of
these interactions in neurodevelopment, specifically with chromatin-modifying enzymes,
remain limited. Studies demonstrate a critical role of class I HDACs in the repressive
function of REST and CoREST on neuronal gene activity (Battaglioli et al., 2002). In
addition, other evidence of epigenetic crosstalk was shown in a 2007 study where the
introduction of an HDAC inhibitor to cultured neurons resulted in not only global
hyperacetylation but upregulation of H3K4 methylation at a subset of promoters (Huang
et al. 2007). Other studies focus on the interplay of DNA modifying or binding proteins
and PRC2 in long-term gene silencing of terminally differentiated neurons (Mohn et al.,
2008). Lastly, a 2017 study provided vital evidence of epigenetic cooperation to mediate
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NSC proliferation and differentiation (Xia and Jiao 2017). This study demonstrated that
histone H3.3, specifically tri-methylated on H3K36, directly interacts with KAT8 to
promote H4K16ac, resulting in upregulation of a transcriptional regulator GLI1, necessary
for neurogenesis.
Taken together, it is evident that chromatin biology is essential for brain
development and function, and therefore it is not surprising that disruption of chromatin
proteins results in abnormal cortical neurogenesis and defective synaptic plasticity. The
clinical overlap between these different mutations is potentially because the loss of one of
these proteins will modify the tightly regulated structure of chromatin. For example, the
loss of either a HAT or a KDM, which both promote the opening of chromatin, can result
in a more closed chromatin state (Bjornsson 2015). This balance in epigenetic machinery
is critical for neurodevelopment, and alterations to any components in this intricate
protein network could lead to different pathologies. In addition, the post-mitotic nature
of neurons raises the question of whether neurons exhibit increased sensitivity to point
mutations or deletions of the epigenetic machinery. Utilizing MS-based techniques that
can define epigenetic signatures, specifically histone PTMs, provides a new arena for
diagnosis and clinical assessment in affected individuals. In a 2020 study, this strategy
was employed in the context of DNA modifications, where they evaluated and identified
specific methylation signatures across 42 Mendelian NDDs (Aref-Eshghi et al. 2020). In
this study, they determined a specific methylation signature for RSTS by determining
specific differentially methylated probes. This offers an exciting new avenue for diagnosis
and can be expanded to multi-omic approaches as a means of diagnosis and potentially
prognosis and therapeutic intervention.
Epigenetic therapies, including both HAT and HDAC inhibitors, are currently
being studied for the treatment of neurological conditions such as spinal muscle atrophy,
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bipolar disorder, and Alzheimer’s disease (“Histone Acetyltransferase Inhibitors and
Preclinical Studies: Expert Opinion on Therapeutic Patents: Vol 19, No 6” n.d.). As of 2021,
four HDAC inhibitors are FDA-approved: Vorinostat, Panobinostat, Romidepsin, and
Belinostat. These may be fruitful therapeutics in NDD disorders, especially those with
decreased histone acetylation, highlighting the importance of classifying these disorders
based on chromatin state and target gene expression. Furthermore, studies of chromatin
regulator proteins will offer keen insight into manipulating the epigenome in the context
of neurodevelopment to develop broad and potentially personalized therapeutics.
Undoubtedly, chromatin biology research promises to enhance knowledge underlying
mechanisms of neurodevelopmental disorders. Lastly, multi-omic approaches involving
recent technological advances, including ChIP-sequencing, Cut and Run, Hi-C, and ChIPMS, now makes it possible to study histone modifications, chromatin-binding proteins,
and looping in the genome in a highly quantitative manner. Furthermore, these
approaches can be combined with different in vivo and in vitro models to shed light on
how the epigenetic landscape of the central nervous system is regulated in developmental
and altered in neurodevelopmental disorders.
In this dissertation, I focus on germline mutations in Histone H3.3 discovered in
a neurodevelopmental disorder characterized by craniofacial abnormalities and
intellectual disabilities. Chapter two of this dissertation focused on mutations that alter
histone post-translational modifications, proteome, and protein-protein contacts. Here I
will show a characteristic phenotype observed at histone PTMs and on the global proteome
level. In chapter three of this dissertation, I describe the model organism Xenopus laevis
to functionally screen H3.3 mutants. Studies of H3.3 in X. laevis have shown its role in
gastrulation and the requirement of its chaperones for development. However, this is the
first

study

to

assess

non-cancerous

germline
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mutations

in

the context

of

neurodevelopment in this model system. Here, I show that mutations at the chaperone
recognition site cause specific impairments in the first pharyngeal arch and lead to an
upregulation of ectomesoderm specific markers. This work dictates the critical and
multifaceted role of H3.3 in development.
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Chapter 2: In vitro characterization of germline mutation in histone H3.3 in
human embryonic kidney cells
2.1

Introduction
The recently discovered histone H3.3 (H3.3) germline missense mutations piqued

curiosity in the field of Neuroepigenetics as patients bearing these mutations (Figure 1-6)
exhibited defects in central nervous system function (CNS) (Bryant et al., 2020). These
patients presented craniofacial abnormalities, severe intellectual disability, cortical
atrophy, hypomyelination, behavioral defects, and growth abnormalities (Bryant et al.,
2020) (Figure 2-1). Individuals with germline H3.3 mutations also had congenital cardiac
issues, often common comorbidities of neurodevelopmental disorders (Marino et al.,
2012; Ji et al., 2020). Importantly, all reported mutations are heterozygous, suggesting
that this disorder potentially has a dominant-negative effect as three wildtype (WT) alleles
remain intact in the genome. However, the expression of WT H3.3 was insufficient to

Figure 2-1. Patient facial features
Although the patients are not strikingly dysmorphic, they share some features that
Figure 2-2. Patient facial features
include a broad forehead, high insertion of the columella, and deep-set almond shaped
eyes with short palpebral fissures. Figure taken from Bryant et al., 2020.
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Although the patients are not strikingly dysmorphic, they share some features that
include a broad forehead, high insertion of the columella, and deep-set almond shaped
eyes with short palpebral fissures. Figure taken from Bryant et al., 2020.

compensate for these missense mutations’ effects. Intriguingly, mutations on either
H3F3A or H3F3B results in the same phenotype. Despite the two genes encoding the same
proteins, they have distinct intron-exon structures. Moreover, recent analysis suggests
H3F3B resembles the ancestral H3.3 gene with a broad expression pattern, while H3F3A
appears to have developed later in evolution for specific gene expression (Muhire, Booker,
and Tolstorukov, 2019). The severity of the disorder is linked to particular amino acid
substitutions rather than which of the H3F3 genes was mutated, suggesting that
alterations to H3.3 protein structure or function are a driving force in this disorder. Thus,
it is crucial to characterize the role of H3.3 in the genome, specifically in the CNS and
during development.
H3.3 replication-independent (RI) genome incorporation (Ahmad and Henikoff,
2002) extensively alters the histone H3 landscape in nondividing cells, such as postmitotic and senescent cells. As mammals age, H3.3 accumulates in the brain, heart, and
kidney, replacing canonical H3.1 and H3.2 (Urban and Zweidler, 1983; Wu, Tsai, and
Bonner, 1983; Piña and Suau, 1987; Chow et al., 2005; Tvardovskiy et al., 2017). Many
studies have assessed H3.3 function in the genome through biochemical assessment of
either H3.3 protein itself or its specific chaperones HIRA-UBN1-CABIN complex or
ATRX/DAXX (Grover, Asa, and Campos, 2018). Maze et al. (2015) demonstrated the
mechanistic role of H3.3 and its chaperone HIRA (histone cell cycle regulator) in postmitotic cells. This study shows that despite the H3.3 accumulation with age, it remains
highly dynamic in a modification-independent manner to mediate neuronal and glial gene
expression (Maze et al., 2015). Their findings revealed a critical role of H3.3 turnover in
activity-dependent transcription, neuronal plasticity, and cognition (Maze et al., 2015),
indicating a novel role of H3.3 during development.

57

Previous work in the field has elucidated the role of H3.3 during early
development. A 2016 study demonstrates HIRA knockout significantly impairs H3.3
deposition dysregulating cardiomyocyte homeostasis by promoting cardiomyocyte
degeneration (Valenzuela et al., 2016). During oogenesis, H3.3 is critical as conditional
knockout of both H3f3a and H3f3b resulted in oocyte death by embryonic day (E) 6.5
(Tang et al., 2015). This study was the first to identify the specific early developmental
processes, such as gametogenesis and fertilization, susceptible to H3.3 deficiency (Tang et
al., 2015). Another study corroborates this as they described developmental retardation
and lethality due to complete loss of H3.3 through the dysfunction of heterochromatic
structures, suggesting an essential role in maintaining genome integrity during
development (Jang et al., 2015). H3.3 is deposited at telomeric regions by the two proteins
DAXX (death domain associated protein) and ATRX (Alpha Thalassemia/Mental
Retardation Syndrome X-Linked) (Lewis et al., 2010). Mouse embryonic stem cells
(mESCs) with an H3.3 deficiency had a global decrease in H3K9me3 and H3K20me3, two
known heterochromatic marks, and ATRX at telomeres (Udugama et al., 2015).
Several studied have also determined the role of H3.3 in neuronal maturation and
function, as normal H3.3 function is crucial during early development. During embryonic
neural stem cell (NSC) differentiation, knockdown of H3.3 promotes premature terminal
mitosis and neuronal differentiation (Xia and Jiao, 2017). H3.3 begins accumulating in
mESCs at day 3 in vitro with its highest level of incorporation in day 9 during neuronal
maturation (Maze et al., 2015). Moreover, H3.3-deficient neurons have defective synapses
and a significant reduction in the density of dendritic spines (Maze et al., 2015). Strikingly,
H3.3 was found to mediate H4K16 hyperacetylation and GLI2 expression, which is a
transcriptional repressor, through a direct interaction with the histone acetyltransferase,
MOF/KAT8 (Xia and Jiao, 2017). This H3.3/MOF interaction was mediated by
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H3.3k36me3, as K36R mutations did not increase H4k16ac. In mature neurons,
stimulation results in an increased mRNA expression of both H3f3a and H3f3b, and it is
dynamically incorporated in an activity-dependent fashion (Maze et al., 2015; McNally et
al., 2016). This activity-dependent turnover is mediated by both HIRA and DAXX through
distinct mechanisms (Michod et al., 2012; Maze et al., 2015). Furthermore, upon neuronal
depolarization, H3.3 is loaded into specific genomic regions encoding for immediate early
genes such as Bdnf and Fos, which then mediate neuronal activity. Collectively, these
previous reports suggest a critical role of H3.3 in neural stem cell differentiation, neuronal
development, and overall CNS function.
To assess the pathological mechanism of H3.3 germline mutations, we decided to
study a few H3.3 mutants using in vitro cell models. We determined critical residues on
H3.3 and chose five mutations from the patients with neurodevelopmental disorders
(Figure 2-2). On the N-termini tail, where H3.3 is heavily modified (Figure 2-2A),
mutations were found directly before known modification sites, indicating their role in
regulating neighboring PTMs. (Figure 2-2B). Arginine 8 (R8) is post-translationally
modified

with

asymmetric

dimethylation

(H3R8me2a)

by

protein

arginine

methyltransferase 2 (PRMT2) and symmetrically dimethylation (H3R8me2s) by protein
arginine methyltransferase 5 (PRMT5) (Blythe et al., 2010; Majumder et al., 2010).
H3R8me2a was shown to establish poised chromatin architecture marking promoters at
essential organizer genes, while H3R8me2s was shown to play a role in gene repression
(Blythe et al., 2010; Tae et al., 2011). More importantly, R8 is directly next to K9, which,
when trimethylated, marks heterochromatic regions, playing a huge role in silencing
lineage-specific genes (Nicetto and Zaret, 2019). This R8 to Serine (R8S) mutation poses
a potential loss of not only R8 modifications but also potentially occludes K9
modifications. On a similar note, the residue Gly13 (G13) resides in the binding site for
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Gcn5/KAT2A, which mediates H3K14 acetylation. Therefore, this modification can
potentially alter K14 acetylation (K14ac). Threonine 45 (T45) is phosphorylated during
apoptosis and is essential for chromatin assembly during DNA replication (Hurd et al.,
2009; Baker et al., 2010; Darieva et al., 2015). Substitution of this residue, as seen in
germline mutation Threonine 45 to Isoleucine (T45I), will remove this modification,
potentially altering chromatin assembly.
Our studies also include H3.3 mutations within the globular domain, as
these mutations can alter H3.3 incorporation and nucleosome stabilization. As previously
mentioned, H3.3 varies from canonical H3 at positions 31, 87, 88, 90 (and 96 on H3.1).
Glycine 90 to Arginine (G90R), a mutation also found in patients, affects the binding of
both H3.3 chaperones, which can alter incorporation into the genome (Drane et al., 2010;
Elsaesser and Allis, 2010; Ricketts et al., 2015). Studies have shown that Met90 mutations
in H3.3 completely ablated H3.3 interaction with both chaperone complexes (Drane et al.,
2010; Lewis et al., 2010; Ricketts et al., 2015). Proline 121 to Arginine (P121R) mutations
in H3.3 also disrupt protein structure. Proline induces structural changes in secondary
structure as it forms sharp bends or kinks, contributing to the final protein structure. P121
plays an important role in H3 protein structure, in coordination with Met120 and Lys122,
wherein a ‘van der Waals cup’ with a Cl- ion is formed at H3 α-helix 3, stabilizing the
histone fold (Davey et al., 2002). Lastly, P121 resides next to K122, acetylated by the
coactivator p300/CBP complex (Tropberger et al., 2013). This mark is enriched explicitly
at active promoters, enhancers, and H3.3 and H2a.Z-containing nucleosomes (Tropberger
et al., 2013).
Collectively, these mutations can affect H3.3 function in three distinct
ways. The first way involves regulating the deposition and functionality of neighboring
histone post-translational modifications. This ablation of Histone PTMs could be
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Figure 2-2. Histone H3.3 sequence and structure.
(A) H3.3 amino acid sequence. Residues mutated are red, those that are posttranslationally modified are highlighted in yellow and finally H3.3 specific residues
Figure 2-3 Immunoblot of fractionated nucleus.Figure 2-2. Histone H3.3
are encapsulated in teal. (B) H3.3 containing nucleosome PDB:5x7x with core H3.3
sequence and structure.
mutations encircled in red. H3.3 (purple), H4 (yellow), H2a (pink), H2B (green).
potentially observed in the H3.3-R8S and H3.3-G13R lines, as they both occur before
heavily modified lysine residues (K9 and K14). The second way involves altering either
Figure 2-2. Histone H3.3 sequence and structure.
histone-histone or histone-DNA contacts, which would ultimately affect nucleosome
(A) H3.3 amino acid sequence. Residues mutated are red, those that are poststability, and this might be the cause for H3.3-T45I, G90R, and P121R. Finally, the third
translationally modified are highlighted in yellow and finally H3.3 specific residues
way involves H3.3-G90R specifically as it ablates the chaperone recognition site,
are encapsulated in teal. (B) H3.3 containing nucleosome PDB:5x7x with core H3.3
potentially affecting H3.3 incorporation into the genome. Thus, this mutation poses
mutations encircled in red. H3.3 (purple), H4 (yellow), H2a (pink), H2B (green).
multiple questions: 1) could there be another H3 chaperone that can incorporate in a
replication independent manner. 2) Would this G90R substitution result in preferential
chaperone binding, and finally 3) what are the effects of this mutation on nucleosome
stability as substitutions at this site can project toward the DNA minor groove (Figure 2B). Overall, these mutations can alter histone H3.3’s function, and loss of this can have
dramatic consequences on gene and protein expression. Thus, understanding the
mechanism of H3.3 dysregulation due to these mutations is critical for determining the
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underlying cause of this syndrome. Furthermore, identifying essential proteins and
pathways affected by H3.3 mutants will be critical for potential therapeutic development.

2.2
2.2.1

Results
Histone H3.3 mutations in stable human embryonic kidney cell line
Somatic H3.3 mutations such as H3.3-K27M and K36M are oncogenic drivers, and

expression of either of these mutants can result in global alterations to the histone posttranslational modifications (PTM). Utilizing patient-derived fibroblast, Bryant et al.
(2020) pooled five different patients’ cells and assessed histone PTM changes compared
to age-match controls. They noted statistically significant but modest alterations to H3
and H4 PTMs, including H3K27ac, H3K36me3, and H4K20me (Bryant et al., 2020). To
explore the effects of these mutants in a controlled context, we utilized human embryonic
kidney cells 293T (HEK293T) expressing H3.3 mutants that contain a 3x-repeated FLAG
(DYKDDDDK) tag. The introduction of this tag was critical to distinguish endogenous
H3.3 from the ectopically expressed mutant, as it adds weight to the protein allowing two
bands to be formed when run on a protein gel. There are two controls for the following
experiments: empty vector control (Empty), which only expresses endogenous H3.3, or
the H3.3-wild type (WT), which serves as a control for H3.3 overexpression. We confirmed
expression through immunoblot on a fractionated nucleus, looking at proteins that are
chromatin-bound and proteins that are in the nucleoplasm. We blotted for the FLAG
epitope and found our constructs are primarily chromatin-bound (Figure 2-3). We also
validated construct expression by blotting for histone H3.3 with H4 as a loading control
(Figure 2-1). Notably, a band is missing for G90R-line (lane 10) for the H3.3 blot; since
the epitope site is lost, the antibody fails to recognize H3.3-G90R (Figure 2-3, lane 10).
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Based on this, we decided our cell lines were stably expressing the H3.3-3xFLAG
constructs.

Figure 2-3 Immunoblot of fractionated nucleus.
Left blot represents chromatin bound proteins and right blot are proteins in the
Figure 2-3 Immunoblot of fractionated nucleus.
soluble nuclear.

2.2.2

Mutations in the globular domain of H3.3 induced distinct alterations of histone

acetylation globally.
Left blot represents chromatin bound proteins and right blot are proteins in the
To assess the alterations to the post-translational landscape globally, we
soluble nuclear.
performed quantitative mass spectrometry (qMS) to study histone PTM changes (Sidoli
and Garcia, 2017). The cell lines generated were grown and lysed for standard bottom-up
histone preparation. These samples were run on nano-liquid chromatography coupled
Heatmaps showing global acetylation changes (left), with the focus on increased
online with tandem mass spectrometry (nanoLC-MS/MS) on a Q-Exactive HF (Thermo
acetylation (right)Left blot represents chromatin bound proteins and right blot are
Fisher Scientific). We noted that overexpression of H3.3 did not result in large PTM
proteins in the soluble nuclear.
changes (Supplemental Figure 1-A), as there were similar PTM levels in both Empty and
WT samples. Both tail mutants R8S and G13R had minimal PTM alterations. However,
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Left blot represents chromatin bound proteins and right blot are proteins in the
soluble nuclear.

G13R induced more PTM changes than R8S (Supplemental Figure 1-B:D). Within the R8S
line, we observe a modest decrease in H3K9me2 and an increase in H2AxK5ac and K9ac,
H4K20me1, and H3K9acS10phK14ac. Intriguingly, H3K9acS10phK14ac is also increased
in G13R along with H3K9acK14ac, H3S10ph, and H3K9me1S10phK14ac. Most of the
altered marks are within five amino acids from the mutated residue.
When looking at the mutants in the globular domain, we noticed similar PTMs
increased across the three mutants that reside in the globular domain: T45I, G90R, and
P121R (Figure 2-4A, C). Furthermore, most of these increased marks are acetylation on
either H3, H4, and H2A variants (H2A.Z, H2A.V) (Figure 2-4. A, C) (Figure 2-5). Another
similarity involves two commonly decreased marks, H4K20me2, and H4K20me3. Eight
PTMs are upregulated globally within the T45I, G90R, and P121R cell lines (Figure 2-4.
D), including H2AV.K4ac/K7ac, H2AX.K5ac, H2Az.K11ac/K15ac, H3K18acK23ac,
H4K8acK16ac, and H4K5acK8acK12acK16ac (Figure 2-4. D). These marks are interesting
as they are associated with gene induction or transcriptional activation (Altaf et al., 2010;
Draker et al., 2012). Most of the upregulated marks present a hyperacetylated genome,
which is more related to gene activation. Furthermore, it is interesting that these mutants
that reside in the globular domain of H3 result in such drastic alterations to histone
acetylation, potentially affecting neighboring nucleosomes or chromatin-modifying
enzymes.
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Figure 2-4. Histone H3.3 mutation results in global increase in histone
acetylation.

A. A Volcano plot of the histone PTMs changes induced by T45I. The log2 fold change
of T45I/WT
is plotted with
the -log2acetylation
t-test p-valuePTMs.
on the y-axis. The green points are
Figure
2-5. Heatmap
of histone
significantly
T45I cell
line, andresults
pink points
are significantly
in
Figure
2-4. increased
HistoneinH3.3
mutation
in global
increasedecreased
in histone
the T45I cell line. B. A Volcano plot of the histone PTMs changes induced by G90R,
acetylation.
organized as in panel A C. A Volcano plot of the histone PTMs changes induced by
P121R, organized as in panel A. D. Intersection of Histone PTM increased in T45I,
G90R and P121R as compared to WT.

Figure 2-4. Histone H3.3 mutation65
results in global increase in histone
acetylation.
A. A Volcano plot of the histone PTMs changes induced by T45I. The log2 fold change

Figure 2-5. Heatmap of histone acetylation PTMs.
The z-scores of the relative abundance of detected histone acetylation PTMs are plotted
with hierarchical clustering. The heatmap is organized by Empty (pink), WT (lilac),
Figure 2-5. Heatmap of histone acetylation PTMs.
R8S (grey), G13R (sky blue), T45I (blue), G90R (teal) and P121R (green) with three
biological replicates each with the control cell being on the left.
2.2.3

Histone H3.3 mutations on N-termini H3 tail induced distinct alterations on

mutant peptide
Figure 2-6 Loss of methylation on mutant specific peptides. The z-scores of the relative
We noted no dramatic alterations for R8S and G13R, with significantly fewer
abundance of detected histone acetylation PTMs are plotted with hierarchical
marks differentially identified in R8S. This data posed the interesting question: if these
clustering. The heatmap is organized by Empty (pink), WT (lilac), R8S (grey), G13R
mutations are specifically affecting the mutated H3 peptides. For bottom-up histone
(sky blue), T45I (blue), G90R (teal) and P121R (green) with three biological replicates
preparation, we utilize the enzyme trypsin, which specifically cleaves are Arg/R or Lys/K.
each with the control cell being on the left.
We add a propionyl group to all unmodified and monomethylated lysine’s which inhibits
trypsin cleavage. Both N-termini mutants are either removing a cleavage site as with R8S
or gaining a cleavage site as with G13R resulting in a significantly longer or shorter
peptide. The differences in peptide length result in a different mass to charge ratio (m/z),
which allowed for specific targeting utilizing parallel reaction monitoring (PRM) to
specifically target these peptides for detection in the mass analyzer (Bourmaud, Gallien
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and Domon, 2016). Although there were no global changes to H3K9 in the R8S cell line
(Supplemental Figure 2-1), when we look at the R8S mutant peptide, we noticed
alterations to K4, K9, and K14 modifications since the peptide encompass all of these
residues (Table 1, Figure 2-6. A, C).
Moreover, we noticed a loss of methylation marks and a gain of acetylation marks
on both K4 and K9 on the R8S peptide. Similar to the R8S, we observed a similar loss of
methylation trend on the G13R peptide; however, only the monomethylation of H3K9 was
lost (Figure 2-6, B, D). Within the G13R peptide, we observed a statistically significant
increase of H3K9me2 (Figure 2-6, B). Notably, since the peptide is fragmented, for G13R,
we only looked at the K9 fragment (KSTGR), which neglects any marks on K14, which after
trypsin digest would reside on a four amino acid long peptide (KAPR). Thus, this peptide
was challenging to detect potentially due to its low abundance and increased
hydrophilicity. However, when we look at global trends for G13R, we note the significant
increase of some marks, including H3K18acK23ac, which was observed in the other
mutants (Supplemental Figure 2-B,D).
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Figure 2-6 Loss of methylation on mutant specific peptides.
Figure 2-6 Loss of methylation on mutant specific peptides.
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A. The relative abundance of H3K4/K9 and K14 modifications in the WT cell line
(teal), all H3 peptides in R8S peptides (pink) and R8S specific peptide (hot pink). The
mean of biological triplicates is plotted with the standard error of the mean. A two-way
ANOVA with Tukey correction was used to calculate significance. P-value < 0.05, *; pvalue < 0.01. **; p-value < 0.001, ***. B. The relative abundance of H3K9
modifications in the WT cell line (teal), all H3 peptides in G13R peptides (pink) and
G13R specific peptide (hot pink). The mean of biological triplicates is plotted with the
standard error of the mean. A two-way ANOVA with Tukey correction was used to
calculate significance. P-value < 0.05, *; p-value < 0.01. **; p-value < 0.001, ***. C.
The z-scores of the relative abundance of detected histone PTMs are plotted with
hierarchical clustering. The heatmap is organized by WT (teal), R8S cell line (pink),
R8S peptide (hot pink) with three biological replicates each with the control cell being
on the left. D. The z-scores of the relative abundance of detected histone PTMs are
plotted with hierarchical clustering. The heatmap is organized by WT (teal), R8S cell
line (pink), R8S peptide (hot pink) with three biological replicates each with the
control cell being on the left.
2.2.4

Immunopurified mononucleosomes can be utilized to study specific modifications

on H3.3 mutants
A. The relative abundance of H3K4/K9 and K14 modifications in the WT cell line
The results of this experiment remain inconclusive as only a few post-translational
(teal), all H3 peptides in R8S peptides (pink) and R8S specific peptide (hot pink). The
modifications were identified due to the limited concentration of the immunopurified
mean of biological triplicates is plotted with the standard error of the mean. A two-way
sample. However, this experiment will be critical for defining specific modifications on
ANOVA with Tukey correction was used to calculate significance. P-value < 0.05, *; pmutant peptides and involved many attempts to find a method to purify these histones
value < 0.01. **; p-value < 0.001, ***. B. The relative abundance of H3K9
successfully. The experiment is meant to isolate mononucleosomes that contain postmodifications in the WT cell line (teal), all H3 peptides in G13R peptides (pink) and
translational modifications. The first part of this experiment involves isolating
G13R specific peptide (hot pink). The mean of biological triplicates is plotted with the
mononucleosomes after nuclease digestion, followed by utilizing agarose beads containing
standard error of the mean. A two-way ANOVA
with Tukey correction was used to
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calculate significance. P-value < 0.05, *; p-value < 0.01. **; p-value < 0.001, ***. C.
The z-scores of the relative abundance of detected histone PTMs are plotted with
hierarchical clustering. The heatmap is organized by WT (teal), R8S cell line (pink),

anti-FLAG antibodies conjugated to it (Figure 2-7. A). We confirmed mononucleosomes
after micrococcal nuclease (MNase) digestion as we primarily see a band between 100 to
200 base pairs (bp) on an agarose gel (Figure 2-7. B). The empty cell line serves as a
negative control as it does not have a FLAG-tagged protein, and we do not observe any
enrichment of either FLAG or histone H4 (Figure 2-7. C, above). We note that no H4 was
also pulled down for empty control. All FLAG-tagged lines have enrichment for FLAG,
which is found above 20 kDa molecular weight band (Figure 2-7. C, above). It is important
to note that there is a large band above the FLAG, which is the light chain of the antibody
which potentially leaches during elution (Figure 2-7. C, below).

Figure 2-7 Mononucleosome Immunoprecipitation.
Schematic of FLAG immunoprecipitation of FLAG-tagged histones B. 1% Agarose gel
with mononucleosomes seen between 100 -200 base pairs C. Western blot analysis of
Figure
2-7
Mononucleosome
Immunoprecipitation.
different
cell
lines blotting for FLAG
enrichment. Empty is the control and Histone
H4 is the loading control (top) Ponceau stained blot (bottom)
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Figure 2-7 Mononucleosome Immunoprecipitation.

2.2.5

Histone H3.3 mutations on globular domain induced distinct proteomic

alterations
Thus far, our studies revealed that the mutations impact different histone posttranslational changes, with a high degree of overlap with the core mutants: T45I, G90R,
and P121R. Given the alterations to the histone modifications, we aimed to survey the
effects of these mutants on the whole proteome. Going forward, we focused on four
mutants: R8S, G13R, G90R, and P121R. Our cells were lysed and prepared utilizing the
suspension trapping (S-trap) protocol (ProFiti) which enhances the recovery of
hydrophobic peptides, therefore, boosting protein identification and quantification
(HaileMariam et al., 2018). Additionally, to further increase accurate protein
quantification, we performed high pH fractionation, which reduces the complexity of the
samples.
Proteomic analysis revealed no dramatic protein changes in HEK293Ts when H3.3
is overexpressed. The R8S cell line did not show many significantly affected proteins
showing minimal to no alterations to the proteome. (Figure 2-8. A, E). When compared to
both controls, G13R showed a statistically significant reduction of a few similar proteins,
one of which is Argininosuccinate synthase 1 (ASS1), which plays a role in the arginine
biosynthetic pathway. However, no specific gene ontology pathways were found in this cell
line. Interestingly, when we look at the proteome of both G90R and P121R cell lines, we
find a high overlap between the two. Both had dramatic increases in Serine
hydroxymethyltransferase 1 (SHMT1), Dehydrogenase/Reductase 7B (DHRS7B), AlkB
Homolog 5, RNA demethylase (ALKBH5), Neurofilament Medium-chain (NEFM), Lethal
(2) giant larvae protein homolog 1 (LLGL1) and Mitogen-activated protein kinase kinase
(MAP23K). These proteins have been linked to either Smith-Magenis Syndrome or
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Charcot-Marie-Tooth 1A (Gillentine et al., 2018) which are known neurodevelopmental
disorders.
The related pathways for the top significantly altered proteins included Gene
Ontology (GO) annotations, including GO:0072521 purine-containing compound
metabolic process, GO:0006637 acyl-CoA metabolic process, and GO:0042393 histone
binding (Figure 2-9). Twenty-two proteins were upregulated in both mutants compared
to WT, and these were found to be associated with specific cellular compartments,
including microtubule cytoskeleton (GO:0015630), axon (GO: 0030424), and
neurofilament (GO:005883). Conversely, the nineteen proteins that were downregulated
in both mutants were associated with a few KEGG (Kyoto encyclopedia of genes and
genomes) pathways, including amino acid degradation ( cysteine and methionine
metabolism: map00270, valine, leucine and isoleucine degradation: map00280), fatty
acid metabolism (beta-Alanine metabolism: map00410, fatty acid biosynthesis:
map00061), and carbon metabolism ( one carbon pool by folate: map00670, carbon
metabolism: map:01200). Interestingly, these pathways are all linked to metabolic
dysfunction.
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Figure 2-8. Volcano plots showing differentially expressed proteins.
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Figure 2-8. Volcano plots showing differentially expressed proteins.

Volcano plot of proteomics data plotting the log2 fold change of mutant/control cells
(left) or mutant/WT (right) and the -log2 adj.p-value is plotted on the y axis. The
horizontal dashed line indicates a -log2 p-value of 4.32 (equivalent to a p-value of
0.05), so anything above that line is statistically significant. Points indicated in green
were significantly increased in the mutant cells, Points indicated in pink were
significantly decreased in the mutant (and thus increased in the control/WT). Proteins
labeled had a p-value <0.01. A. R8S-Empty B. G13R-Empty C. G90R-Empty D. P121REmpty E. WT-R8S F. WT-G13R G. WT- G90R H. WT-P121R

Figure 2-8. Volcano plots showing differentially expressed proteins.
Volcano plot of proteomics data plotting the log2 fold change of mutant/control cells
(left) or mutant/WT (right) and the -log2 adj.p-value is plotted on the y axis. The
horizontal dashed line indicates a -log2 p-value of 4.32 (equivalent to a p-value of
0.05), so anything above that line is statistically significant. Points indicated in green
were significantly increased in the mutant cells, Points indicated in pink were
significantly decreased in the mutant (and thus increased in the control/WT). Proteins
labeled had a p-value <0.01. A. R8S-Empty B. G13R-Empty C. G90R-Empty D. P121REmpty E. WT-R8S F. WT-G13R G. WT- G90R H. WT-P121R
Figure 2-9. Significantly alter GO Biological processes.
Top
three
geneVolcano
ontology plot
(GO)of
terms
are visualized
as a heatmap
of their z-scoresexpressed
with
Figure
2-10.
ChIP-MS
data showing
the differentially
hierarchal
proteins. clustering. A. Purine-containing compound metabolic process B. Acyl-coA
metabolic process C. Histone binding. The heatmap is organized by genotype so
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2.2.6

Chromatin immunoprecipitation coupled to mass spectrometry revealed similar

interactomes in both core mutants
Given that both G90R and P121R resulted in similar proteomic alterations, we
aimed to assess if this is potentially due to similar protein-protein interactions. To this
end, we performed chromatin immunoprecipitation coupled to mass spectrometry (ChIPMS), now utilizing the 3xFLAG construct that was added. We validated that these histones
can be immunopurified using anti-FLAG beads from histones extracted from MNase
generated mononucleosomes from the HEK293Ts as seen in the section above (Figure 27) (Supplemental Figure 2). In addition, we also confirmed that we were able to isolate the
histones after chromatin immunoprecipitation as we were able to isolate mono- and dinucleosomes (Supplemental Figure 2). The empty vector cell line was used as our untagged
control. Therefore, proteins identified in this control were used to filter out the data. As
these proteins probably stuck to the beads rather than being bound to our target.
We found that both mutants have differential interactors from wildtype H3.3, as
seen in the volcano plots (Figure 2-10. A, B). Surprisingly, G90R was found to bind LLGL1,
and P121R was found to bind DHRS7B, both found in the whole proteome experiment.
Additionally, both mutants were found to lose interactions with alpha-thalassemia/mental
retardation, X-linked (ATRX), and Isocitrate Dehydrogenase (NADP+) (IDH2), both
proteins have been linked to H3.3 in the context of cancer (Figure 2-10. A, B). Pathway
analysis on the proteins lost with G90R showed that these proteins were associated with
GO:003732 poly(A) RNA binding and GO:003682 chromatin binding. Interestingly, there
has been experimental evidence supporting the interactions of a few of the proteins with
the GO terms previously mentioned (Figure 2-10. D). Proteins lost in P121R are associated
with gene ontology involving the G2/M transition of the mitotic cell cycle (GO:0000086)
and methylated histone binding (GO:0035064).
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Some of the enriched proteins for G90R included members of the
minichromosome maintenance (MCM) 2-7 complex, which play a crucial role in DNA
replication. Not surprisingly, pathway analysis on these G90R enriched proteins shows
molecular functions involving DNA replication (MCM2-4, 6). However, another pathway
found was acetylation as MRG/MORF4L-binding protein (MRGBP), a member of the
NuA4 histone acetyltransferase, was enriched in G90R ChIP (Figure 2-10. A). Thus, there
was a co-enrichment of three proteins across the two mutants: MCM4, MRGBP, and
Activating transcription factor 3 (ATF3) (Figure 2-10. A-B). In addition to these three
proteins, P121R also interacted with Adenylate Kinase 2 (AK2) and Nuclear Autoantigenic
Sperm Protein (NASP).
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substitutions assess the impact on protein structure. First, we looked at the effects of these
mutations in a nucleosome and utilized a protein data bank (PDB) of a crystal structure of
nucleosome containing H3.3 at 2.18-angstrom resolution (PDB: 5X7X) (Taguchi et al.,
2017). Utilizing PyMOL site-directed mutagenesis, we observed that conversion of G90R
projected this essential side chain toward the DNA minor groove structure (Figure 2-8A).
For P121R, the arginine side chain projects toward the H4 helix 2; however, no steric
strains were detected (Figure 2-8D). We then assessed the effects of these mutations on
the interactions with H3.3-specific chaperones DAXX and UBN1. We utilized the crystal
structure of the heterodimer (H3.3-H4) bound to UBN1 peptide and Anti-Silencing
Function 1A Histone Chaperone (ASF1A) at 2.25-angstrom resolution (PDB: 4ZBJ)
(Ricketts et al., 2015).
The substitution to R90 resulted in a steric strain with UBN1 residues (T132,
M128), with a 79.14± 24.30 strain across 22 rotamers (Table 2). The strain measures the
local distortions due to amino acid substitutions (Yamato, 1996) (Figure 2-8B). When we
looked at the interaction with the other chaperone, DAXX using the crystal structure of
the H3.3-H4 (PDB: 4HGA) at 2.80 angstroms (Liu et al., 2012). We saw steric clashes with
DAXX residues (Q206, E225); however, the rotamer strain was much lower, 38.09 ± 11.56
across 21 rotamers (Table 2). These strains were surprising as we saw direct clashes with
the DAXX residues in this in silico experiment (Figure 2-8C). We performed these
experiments looking at the P121R mutation; we first looked at the interaction with ASF1A,
which is the direct point of contact. We observed steric clashes with both ASF1A (R49) and
H4 (L49, E53) (Figure 2-8E). R121 had an average strain of 50.23 ± 27.70 with the residue
substituted (Table 2). Lastly, the interaction with R121 and DAXX showed steric clashes
with two of the chaperone’s residues (Y379 and I376) (Figure 2-8F).
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A. A Volcano plot of the histone PTMs changes induced by WT. The log2 fold change of
EMPTY/WT is plotted with the -log2 t-test p-value on the y-axis. The green points are
significantly increased in WT cell line, and pink points are significantly decreased in the
WT cell line. B. A Volcano plot of the histone PTMs changes induced by R8S, organized
as in panel A C. A Volcano plot of the histone PTMs changes induced by G13R, organized
as in panel A. D. Intersection of Histone PTM increased in R8S, and G13R as compared
to WT.
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Discussion
In this study, we explored the biochemical effects of five germline histone H3.3

mutations. As previously mentioned, each of the chosen mutations is hypothesized to
impact H3.3's function distinctly. For example, the R8S mutation is hypothesized to alter
K9 modifications while losing the arginine (R8) methylation site. The G13R substitution
is predicted to impair H3K9 and K14 modifications. The T45 mutation (T45I) will directly
impair T45 phosphorylation, potentially affecting the projection of the histone tail and
nucleosome stability. An intriguing substitution occurs at position G90 (G90R), which
directly alters the chaperone recognition site. Lastly, the P121R substitution occurs
directly before K122, which is essential for H3 stability. Given these different mechanisms,
we postulated that the disorder is driven by the dysregulation of H3.3 function through
different mechanisms. We generated stable HEK293T cell lines for all five mutants and
performed quantitative mass spectrometry analysis assessing histone post-translation
modifications

(PTMs),

proteome

alterations,

and

protein-protein

interactions.

Additionally, we performed computational experiments studying the effects of amino acid
substitution on the protein's structure.
Our analysis on the effects of these mutations on histone PTM landscape
demonstrated a statistically significant increase in histone acetylation in T45I, G90R, and
P121R with no global alterations observed in the cell lines containing H3.3-R8S and G13R.
Nevertheless, we determined local alterations to the mutant histones in these cell lines by
utilizing the mutant peptides. Both R8S and G13R generates different peptides as
compared to wild type after cleavage by the trypsin enzyme. We observed increased
acetylation on R8S specific peptides, including K4ac, K14ac, and K9acK14ac. We did not
observe this increase in acetylation on G13R but a significant increase in K9me2. The G13R
alterations come with a caveat as we have no information on K14 residue. Due to the
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cleavage at G13R, the K14-containing peptide is isolated, and it is too tiny and hydrophilic
to observe by nLC-MS/MS. This data suggests a potential mutant-specific effect, but more
information is needed about combinatorial marks for both and other histones on the
mutant-containing nucleosomes. Utilizing the mononucleosomes-IP coupled to mass
spectrometry, we will be able to address these questions.
The dominant effect of T45I, G90R, and P121R on histone acetylation is fascinating
as these mutations are predicted to have different effects on nucleosome structure. The
common characteristic is that they are predicted to alter nucleosome stability. Both G90R
and P121R involve arginine substitutions and are both near DNA. Therefore, these
residues have points of contact with the DNA either through water molecules or ions such
as chloride. Studies have shown that nucleosomes containing H3.3 have higher instability
than their canonical counterparts, H3.1 and H3.2 (Jin and Felsenfeld, 2007). We did not
conduct experiments assessing the stability with these mutations, although it is critical to
determine if these mutations impart increased stability to H3.3. With this hypothesis, the
mutant H3.3 would have a reduced turnover in the genome, potentially accumulating
histone PTMs.
This proposed increased stability would pose a significant problem as replicationindependent histone turnover reinforces the robustness of chromatin states for cellular
identity and homeostasis (Maze et al., 2015; Deaton et al., 2016; Wenderski and Maze,
2016; Li et al., 2019). Another point supporting increased nucleosome stability stems from
the fact that DNA interactions with histone tail depend highly on the charge. However,
recent studies have shown counteracting effects of acetylation of H3 and H4 (Gansen et
al., 2015). This study showed that H4 acetylation stabilized the nucleosome structure,
which had increased instability with H3 acetylation (Gansen et al., 2015). Our results
showed

an

increase

of

H4K5ac,
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H4K8acK16ac,

H4K12acK16ac,

and

H4K5acK8acK12acK16ac and H2A variant acetylation: H2AVK4ac, H2AVK7ac,
H2aZK11acK15ac, and H2aXK5ac. The hyperacetylation found on H2A and H4 is a
product of the histone acetyltransferase complexes NuA4 and a smaller complex Piccolo
NuA4. Strikingly, MRG domain-binding protein (MRGBP) was found as an interactor of
the G90R mutant based on our ChIP-MS results.
Ultimately, the mechanism in which these mutants result in increased acetylation
could be in three ways. The first option involves increasing the "1/2 life" of the mutant
histone in the genome allowing for the accumulation of histone PTMs. Given that histone
H3.3 is known as the active variant and is at sites of active transcription, if it is not removed
or exchanged, it can accumulate acetylation, potentially driving aberrant transcription.
Another option could involve a specific nucleosome conformation imposed by the
mutants, which increases the accessibility of specific HATs. For example, H4 acetylated
tail promotes H3-DNA contact through the H3 N-termini tail, which puts it in a favorable
conformation for Gcn5 (Furukawa et al., 2020). Lastly, the possibility that these mutants
increase the instability of H3.3 is probable, and therefore this can potentially promote
aberrant transcription due to nucleosome instability (Hu et al., 2014). Further studies are
required to determine which of these three options is mediating this global increase in
acetylation.
Our quantitative proteomics, surprisingly, mimicked histone PTM data such that
we saw similar proteomic alterations for both G90R and P121R mutant. The upregulated
proteins we observed SHMT1, LLGL1, ALKBH5, and DRHS7B had been linked to SmithMagenis syndrome (SMS) (Elsea and Girirajan, 2008). SMS is a neurodevelopmental
disorder characterized by distinct facial features, intellectual disability with language and
psychomotor delay (Elsea and Girirajan, 2008). In approximately 90% of SMS patients,
the short arm of chromosome 17 (17q11.2) is missing within this region. The proteins found
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upregulated are all found in the Smith-Magenis syndrome region on chromosome 17. Our
pathway analysis of these significantly altered proteins found both G90R and P121R had
an increase in acyl-CoA metabolic processes, which is attractive as acetyl-CoA generating
enzymes such as Acetyl-CoA carboxylase alpha (ACACA), ATP Citrate Lyase (ACLY), and
Acyl-CoA Synthetase short-chain family member 2 (ACSS2).
Given the increase in histone acetylation, acetyl-CoA producing enzymes can
potentially affect prolonged histone acetylation. Metabolomic studies in the mutants will
help elucidate if they have increased acetyl-CoA production. Another pathway worth
mentioning is the one-carbon metabolism pathway, which increased in both core mutants.
This pathway results in the production of the methyltransferase co-factor S-adenosylMethionine (SAM). Interestingly, we did not observe an increase in histone methylation
in our histone PTM analysis. Additional work looking at global protein methylation and
DNA methylation will be of interest to determine if these proteins result in alterations to
methylation.
We aimed to determine if these mutants had different protein-protein interactions
than WT, so we performed Chromatin-Immunoprecipitation coupled to Mass
spectrometry. We found a few of the proteins from the global proteome to be enriched and
bound to the mutants. However, some identified proteins are primarily localized in the
cytosol; this could either be an artifact or the result of some nuclear translocation. An
immunofluorescence experiment in these mutant cells would be highly beneficial in
determining this. One of the proteins found in both proteomic and ChIP experiments is
MCM2. MCM2 is a component of the MCM complex, an essential replicative helicase
required for DNA replication initiation and elongation (Tsai et al., 2015, p. 2). Given the
replication-independent nature of H3.3 and the highly proliferative nature of HEK293Ts,
this could be a cell-specific interactor. Studies in another in vitro model are needed to
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determine this especially looking at a more relevant cell model. Notably, we found that
ATRX, the second half of the DAXX/ATRX chaperone complex, was lost in both mutants.
Mutations in ATRX have been found as the predominant cause of alphathalassemia x-linked intellectual disability (ATRX) syndrome (Gibbons et al., 2008).
ATRX syndrome is characterized by intellectual disability, hypotonia, short stature,
distinct facial features, and genital abnormalities (Gibbons et al., 2003). Surprising
mutations in DAXX have not been identified in patients with ATRX syndrome, and they
do not increase cancer incidence. The loss of ATRX in the context of germline H3.3
mutations can be linked to either loss of chaperone interaction or the DAXX-independent
role of ATRX. Given that DAXX was not identified in this approach, another in vitro model
of protein-protein interactions should be explored to determine if the mutants can
colocalize or be deposited by DAXX/ATRX chaperone complex. Our in-silico analysis
showed a more considerable steric strain with G90R/UBN1 interaction rather than
G90R/DAXX interaction. Surprisingly the inverse was observed in P121R potentially, but
it is important to note that P121R causes direct steric strains with H4 potentially affecting
the tetramer structure. In vitro binding assays are required to validate these
computational results.
This chapter showcased our work assessing the effects of H3.3 mutations on
histone post-translational modifications and proteome in HEK293T cells. We found that
the mutations on the tail, R8S, and G13R, do not cause global histone post-translational
alterations. However, we found alterations to modifications on the peptides containing the
substituted amino acid. These modifications suggest that these mutations cause
nucleosome-specific effects, which can be detrimental in specific genomic loci. We found
a global increase in acetylation of H2a variants (H2aV, H2AZ), H3, and H4 in the T45I,
G90R, and P121R mutants. The similarities found in histone PTMs translated to proteomic
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alterations as we found a group of proteins, which all are derived from the same
chromosomal region, to be upregulated in the G90R and P121R mutants.
Additionally, these upregulated proteins were found to be associated with
metabolic processes, including acyl-CoA metabolism. Lastly, we showed the effects of
these mutations on the H3.3 interactome, albeit it will vary from cell to cell. We found that
proteins loss was associated with chromatin binding, which remains to be explored. In our
work, we were able to show the differential effects of H3.3 mutations in the genome,
opening a new avenue to study histone H3.3 as the mechanisms of each of these mutations
are unique. It will be imperative in future works to look at specific genomic localization of
the mutants and their potential interactors.
2.4
2.4.1

Materials and methods
Generation of HEK 293T cell lines
To generated FLAG-tagged H3.3 for wildtype and mutants, we utilized the pCDH-

CMV lentiviral vector. (pCDH-CMV was a gift from Kazuhiro Oka (Addgene plasmid #
72265 ; http://n2t.net/addgene:72265 ; RRID:Addgene_72265)). We cloned the wildtype
H3.3 DNA fragment into the pCDH plasmid generating a C-terminus 3xFLAG tag. We
used primers to introduce point mutation for the five mutants. HEK 293T cells were
cultured in DMEM (Sigma-Aldrich) medium supplemented with 10% Fetal Plex (Gembio)
and 1% Penicillin-Streptomycin (Thermo Fisher) in 5% CO2 at 37°C. To generate the
FLAG-tagged lines, HEK293T were seeded at a density of 5 x 105 in a 6-well plate and
allowed to sit overnight. The three packaging vectors, pRSV-rev, pVSVG, and pMDL, along
with 0.5 μg of pCDH-H3.3 was added to a 125 μL of Opti-MEM reduced serum medium
(Invitrogen) containing P3000 (Invitrogen). Another 125 μL of Opti-MEM, this time
containing lipofectamine 3000 (Invitrogen), was added to the plasmids and incubated for
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20 minutes at room temperature. The plasmid mixture was added to the cells, and virus
particles were collected for three days. Before transduction, the virus was filtered using
0.45μm, and polybrene (Santa Cruz Biotechnology) was added to a final concentration of
8ug/ml. Cells were infected for 24 hours, followed by selection with 1μg/ml of puromycin
(Thermo) for five days. Transduction efficiency of WT, R8S, G13R, T45I, G90R, P121R was
validated by immunoblotting with FLAG antibody (Sigma).

2.4.2

Western Blotting

Lysates were run on 15% NuPage gel for 1 hour at 175 Volts. These were then transferred
to a nitrocellulose membrane and blocked for 1 hour at room temperature in 5% milk in
Tris-buffered saline (TBS) supplemented with 0.1% Tween 20 (TBST). Primary antibodies
(αH3.3 (Invitrogen RM190), αH4 (Abcam 10158), αFLAG (Sigma)) were diluted 1:1000 in
5% milk in TBST and incubated overnight at 4°C. The membrane was washed three times
with TBST followed by incubation with HRP-conjugated secondary antibody for 1 hour at
room temperature in 5% milk/TBST. Finally, the membrane was rewashed and imaged by
the Fujifilm LAS-4000 imager.

2.4.3

Histone extraction and derivatization
Nuclei were extracted from cell pellets using nuclei isolation buffer (NIB) as

previously described with minor adjustments (Sidoli et al., 2016). First, cell pellets lysed
using ten cell pellet volumes of NIB + 0.3% NP-40 Alternative. The cells were then washed
twice with NIB only to remove any detergent. Next, histones were acid extracted from
nuclei with 0.2M H2SO4, followed by precipitation with a final concentration of 33%
trichloroacetic acid (TCA) overnight at 4°C. Precipitated histones were then washed first
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with ice-cold acetone-HCl (1%) and then with ice-cold acetone. The histones were then
derivatized with propionic anhydride for two rounds, followed by trypsin digestion
overnight (1:20, enzyme: histone). The histone peptides were then dried before another
two rounds of propionylation. Finally, the samples were desalted using in-house prepared
C18 stage-tips before nanoLC-MS/MS analysis.

2.4.4

Histone mass spectrometry analysis
Histone samples were analyzed by nanoLC-MS/MS with a Dionex-nanoLC coupled

to a Q Exactive-HF mass spectrometer (Thermo Fisher Scientific). The column was packed
in-house using reverse-phase 75 µm ID × 17 cm Reprosil-Pur C18-AQ (3 µm; Dr. Maisch
GmbH). The HPLC gradient was as follows: 5% to 40% solvent B (A = 0.1% formic acid; B
= 80% acetonitrile, 0.1% formic acid) over 47 min, from 40% to 90% solvent B in 5 min,
90% B for 8 min. The flow rate was at 300 nL/min. Data were acquired using a dataindependent acquisition method, consisting of a full scan MS spectrum (m/z 300−1100)
performed in the Orbitrap at 60,000 resolution with an AGC target value of 2e5, followed
by 16 MS/MS windows of 50 m/z using HCD fragmentation and detection in the ion trap.
The HCD collision energy was set to 28, AGC target at 1e4, and maximum inject time at
50 ms. Histone samples were resuspended in buffer A, and 1 ug of total histones was
injected.

2.4.5

Targeted-SIM Mass spectrometry method
Histones were acquired as previously mentioned. Briefly, Histone samples were

analyzed by nanoLC-MS/MS with a Dionex-nanoLC coupled to a QE-HF mass
spectrometer (Thermo Fisher Scientific). The column was packed in-house using reverse87

phase 75 µm ID × 17 cm Reprosil-Pur C18-AQ (3 µm; Dr. Maisch GmbH). The HPLC
gradient was as follows: 5% to 40% solvent B (A = 0.1% formic acid; B = 80% acetonitrile,
0.1% formic acid) over 47 min, from 40% to 90% solvent B in 5 min, 90% B for 8 min. The
flow rate was at 300 nL/min. Data were acquired using a full scan MS spectrum (m/z 3001200) performed in the Orbitrap at a resolution of 35,000. This was followed by a targeted
SIM/ddMS2 experiment, where the SIM had a 70,000 resolution with an AGC target value
of 2e5, a loop count of 5, and isolation windows of 2 m/z. This was followed by dd-MS2 at
an Orbitrap resolution of 17,500 with an AGC target value of 2e5 and an HDC
fragmentation energy set at 27. The inclusion list was set to on.

2.4.6

Mononucleosome Immunoprecipitation
Cells were lysed in Buffer A (10mM HEPES pH 7.9, 10mM KCL, 1.5mM MgCl2,

0.34M Sucrose, 10% glycerol 1mM DTT, 0.1% Triton-X and protease inhibitors) on ice for
5min. After centrifugation, pellets were washed with Buffer A without Triton-X. Soluble
nuclear proteins were released for 15 on ice in no salt buffer (3mM EDTA, 0.2mM EGTA,
0.1mM DTT). Mononucleosomes were obtained by digesting the chromatin in 15 units of
Micrococcal nuclease (Mnase) (Roche) in digestion buffer (50mM HEPES, 2mM CaCL2
0.2% NP-40) for 10min at 37 °C. Chromatin was briefly sonicated at 10% amplitude. The
sample was further clarified by centrifugation, and DNA was examined by agarose gel. The
input was separated, and mononucleosomes were diluted using 2x volume Buffer D
(20mM HEPES pH 7.9, 20% glycerol, 0.2mM EDTA 0.2% Triton X protease inhibitors).
Roughly 200ug of mononucleosomes were incubated with FLAG-M2 beads (20μl) for two
hours at room temperature. After three washes with Buffer D (+100mM NACL), samples
were eluted with 3X FLAG peptide (0.33mg/ml) on an end-over-end rotator overnight at
4°C and analyzed by immunoblotting.
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2.4.7

Proteomic sample preparation
Proteomics samples were prepared following ProtiFi s-trap protocol (HaileMariam

et al. 2018). Cells were lysed in 1x SDS lysis buffer (5% SDS in 100 mM TEAB, pH 7.55),
and DNA was sheared by probe sonication. 1o0 ug of proteins were reduced with
dithiothreitol (DTT) at a final concentration of 20mM at 95°C for 10 minutes, and then
alkylated with iodoacetamide to a final concentration of 40 mM and incubated 30 minutes
in the dark. Aqueous phosphoric acid was then added to a final concentration of 1.2%, and
then six volumes of s-trap buffer (90% methanol,100 mM TEAB, pH 7.55). S-traps were
made in-house using a P200 pipette tip, packed with one 2mm plug of C18 disk, and two
3mm plugs of a quartz disk. Sample was loaded onto the s-trap and washed with s-trap
buffer 3 times. Protein digestion was performed on the s-trap column for 1 hour at 47°C in
digestion buffer (50mM TEAB) containing trypsin (Promega) at a 1:20 wt:wt
(enzyme:protein) ratio. Peptides were eluted using three buffers: first 50 mM TEAB, then
0.2% formic acid, and lastly 50% acetonitrile containing 0.2% formic acid. Following this
elution, the samples were high pH fractionated using Pierce™ High pH Reversed-Phase
Peptide Fractionation (Thermo Fisher). Samples were dried in a speed-vac and desalted
by stage-tipping (Sidoli et al. 2016).

2.4.8 Chromatin Immunoprecipitation coupled to MS
ChIP samples were prepared according to (Raab, Resnick, and Magnuson, 2015).
Briefly, 500-100 x 106 cells were fixed in 0.3% formaldehyde for 30 minutes at 4°C and
then quenched with 0.125M glycine for 5 minutes at room temperature. Pellets were
washed three times in cold PBS, frozen in liquid nitrogen, and stored at -80°C. Cells were
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thawed on ice and resuspended in 1mL swelling buffer (25mM Hepes, 1.5mM MgCl2,
10mM KCl, 0.1% NP-40) with 1mM PMSF incubated 10 minutes on ice. Pellets were
dounced 20 strokes with B pestle and spun at 2000RPM for 7 minutes at 4°C in a swinging
bucket centrifuge. Cell pellets then resuspended in 5mL sucrose buffer A (0.32M Sucrose,
15mM Hepes pH 7.9, 50mM KCl, 2mM EDTA, 0.5mM EGTA, 0.5mM PMSF) and layered
over 5mL sucrose buffer B (30% Sucrose, 15mM Hepes pH 7.9, 50mM KCl, 2mM EDTA,
0.5mM EGTA, 0.5mM PMSF) and centrifuged 10 minutes at 3000 RPM in a swinging
buffer centrifuge at 4°C. Nuclei were washed once in 10mL digestion buffer (15mM Hepes
ph7.9, 60mM KCl, 15mM NaCl, 0.32M Sucrose, 0.5mM PMSF) and pelleted for 10 minutes
at 2000 RPM. They were then resuspended in 1mL per 4 × 107 cells with 3.3uL CaCl2 per
mL with 1X protease inhibitor (Roche) and 1mM PMSF and incubated for 5 minutes at
37°C. 0.5uL MNAse (NEB, 2 × 106 units/mL) was added to tubes and incubated for 15
minutes at 37°C. MNase digestion was stopped by adding 0.1 volumes 0.5M EDTA, and
reactions were incubated for 5 minutes on ice.
Nuclei were then passed 5 times through a 20G needle, 1 volume of double
concentration LB3 (20mM Tris-HCl pH 8.0, 100mM NaCl, 1mM EDTA, 0.5mM EGTA,
0.1% Na-Deoxycholate, 0.5% N-lauroylsarcosine) was added and lysate was passed 5X
through 25G needle. Triton X-100 was added to a final concentration of 1%, and cells were
spun at 13000G in a micro-centrifuge at 4° for 15 minutes. The supernatant was saved as
it contained the protein samples, and the pellet was resuspended in 1X LB3 buffer with 1%
Triton X-100 and incubated 1–2 hours rotating at 4°. The supernatants were combined
after another 13000G spin, and 10% was reserved as input DNA. 1mL (equivalent to 20 ×
106cells) was added to the prepared beads and incubated overnight. Beads were washed 8
times in RIPA (50mM Hepes-KOH, pH 7.6, 500mM LiCl, 1mM EDTA, 1% NP-40, 0.7%
Na-deoxycholate) and 1 time in TE (10mM Tris-HCl pH 8.0, 1mM EDTA) supplemented
90

with 50mM NaCl before elution in 100uL 1%SDS, 100mM NaHCO3 for 17 minutes at 65
degrees with agitation. The supernatant was removed and supplemented with 5uL of 5M
NaCl and incubated overnight at 65°C. 3uL RNAseA (30mg/mL) was added to reactions
and incubated for 30 minutes at 37°C, followed by 5ul DNAse1 (1 U/uL) at 56° for 1 hour.

2.4.9

Proteomics mass spectrometry and data analysis
Peptides were resuspended in Buffer A (0.1% Formic acid), and 1 ug of each

fraction was injected and analyzed by nanoLC-MS/MS with a Dionex-nanoLC coupled to
a QE-HF (Thermo fisher scientific). The column was packed in-house, as previously
mentioned. The 90-minute HPLC gradient was as follows: 4% to 25% solvent B (A= 0.1%
formic acid; B= 80% acetonitrile, 0.1% formic acid) over 53 minutes, from 25% to 35%
solvent B over 17 minutes, from 35% to 90% solvent B over 1 minute, it was held at 90%
solvent B for 10 minutes and returned to 4% solvent B over 1 minute. The flow rate was at
400 nL/min. Data was acquired using a data-dependent acquisition method, consisting of
a full scan MS spectrum (m/z 350 to 1200) performed in the orbitrap at 60,000 resolution
with an AGC target value of 1e6. For each cycle of the data-dependent acquisition, the top
25 most intense ions were selected for fragmentation used stepped normalized collision
energy of 25, 27, and 30% (HCD). Fragment ion spectra were acquired in the Orbitrap at
30,000 resolution with an AGC of 1e5 and a maximum injection time of 50ms for the
Orbitrap MS2 detection. Data analysis was conducted using the Proteome Discoverer
software (v2.4, Thermo Fisher Scientific). The data were searched against the Human
Universal Protein Resource (UniProt). Further processing was conducted utilizing the
MSstats package on R (Choi et al., 2014). Statistical analysis was conducted on R, Fold
Change and p-values were calculated using a TukeyHSD corrected ANOVA
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2.4.10 Pymol mutagenesis
The files were retrieved from Protein Databank and imported into PyMOL
(Schrödinger, LLC, 2015). Here we highlighted the residues G90 and P121 using pymol
sequence > color function. Lastly, we employed PyMOL mutagenesis to create the amino
acid substitutions, which generate the rotamer number and strain value.

2.4.11 Bioinformatics and statistical analysis
Gene ontology enrichment analysis was performed with a database for annotation,
visualization, and integrated discovery (DAVID) bioinformatics resources (Jiao et al.,
2012).
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2.5

Supplemental Figures

Supplemental Figure 2-1. Histone H3.3 mutations does not cause global
change.
A. A Volcano plot of the histone PTMs changes induced by WT. The log2 fold change
of EMPTY/WT is plotted with the -log2 t-test p-value on the y-axis. The green points
A. A Volcano plot of the histone PTMs changes induced by WT. The log2 fold change of
are significantly increased in WT cell line, and pink points are significantly decreased
EMPTY/WT is plotted with the -log2 t-test p-value on the y-axis. The green points are
in the WT cell line. B. A Volcano plot of the histone PTMs changes induced by R8S,
significantly increased in WT cell line, and pink points are significantly decreased in the
organized as in panel A C. A Volcano plot of the histone PTMs changes induced by
WT cell line. B. A Volcano plot of the histone PTMs changes induced by R8S, organized
G13R, organized as in panel A. D. Intersection of Histone PTM increased in R8S, and
as in panel A C. A Volcano plot of the histone PTMs changes induced by G13R, organized
G13R as compared to WT.
as in panel A. D. Intersection of Histone PTM increased in R8S, and G13R as compared
to WT.
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Supplemental Figure 2-19. Histone H3.3 mutations does not cause global
(Left) Agarose blot with highest intense bands between 0.1-0.2bp. (Right) Silverchange.
stained gel showing histones enriched.

Supplemental Figure 2-2. Chromatin Immunoprecipitation (ChIP)
validation.
(Left) Agarose blot with highest intense bands between 0.1-0.2bp. (Right) Silverstained gel showing histones enriched.
Figure 2-19. Neural crest states over developmental time.
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Chapter 3: Comprehensive in vitro profiling of germline histone h3.3
mutations in Xenopus laevis development
3.1

Introduction
Germline mutations in chromatin-modifying enzymes have been shown to impair

neurodevelopmental processes responsible for the growth, differentiation, synaptic
pruning, and brain wiring, all of which are critical for cognition in humans. Individuals
with these mutations often present with severe developmental delay, with the underlying
etiology unknown (Bjornsson, 2015). Additionally, these individuals exhibit intellectual
disability with many comorbidities, including behavioral deficits such as autism spectrum
disorder, cardiac defects, and craniofacial abnormalities. Intriguingly, recent studies have
shown that individuals with congenital heart defects and craniofacial abnormalities such
as orofacial clefts have an increased risk of neurodevelopmental disorders (Nattel et al.,
2017; Tillman et al., 2018). The co-occurrence of these comorbidities is particularly
striking as the affected cell types in the brain, heart, and face are derived from neural crest
cells (Figure 3-1). Understanding the association between these will be critical in the
diagnosis and pharmacological management of the affected individuals.
Craniofacial abnormalities (CFA) are of particular interest, as Bryant et al. (2020)
reported distinctive craniofacial features due to germline mutations in histone H3.3 in
approximately 30% of patients (Bryant et al., 2020). CFA includes a diverse group of
deformities in either the growth of the head or facial bones, which often occur early in
development (Twigg and Wilkie, 2015). Some common types of craniofacial anomalies
include cleft lip/palate, craniosynostosis, and deformational plagiocephaly. High,
prominent forehead, hypertelorism, and craniosynostosis were observed to some extent
in patients bearing either H3.3p.G90R (G90R) or H3.3p.P121R (P121r) (Table 3-1) (Bryant
et al., 2020). The individual with the G90R mutation displayed broad and flaring nostrils,
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wide maxilla with widely spaced upper teeth, and prominent lips with cupid bow, as well
as other abnormalities including mild cortical atrophy, white matter lesions, and
generalized hypotonia (Table 3-1). Two patients of the same sex but ten years apart in age,
carrying the p.P121R mutation, showed distinct craniofacial abnormalities. Individual 1,
male 8, displayed tented facies and large ears, while individual 2, male 18, had more
prominent abnormalities, including a high forehead with frontal bossing, low nasal bridge,
and anteverted nostrils (Table 3-1). The cells that govern craniofacial structure arise early
in development and could potentially be affected by these mutations despite the
inconsistency of the phenotypes.
The face and neck structure development in humans and most chordates originate
from the extreme anterior domain (EAD) (Chen et al., 2017). The EAD lies adjacent to the
juxtaposition of the ectoderm and endoderm, and it gives rise to the mouth nostrils and
anterior pituitary gland (Dickinson and Sive, 2006, 2007). Furthermore, the EAD was
demonstrated as a ‘face organizer’ as it directs the migration of the cranial neural crest
(NC) cells through the expression of Wnt signaling regulators (Jacox et al., 2014). Cranial
NC cells generate the facial skeleton, contribute to the peripheral nervous system, and
support the brain and sensory organ development (Schilling and Kimmel, 1994; Santagati
and Rijli, 2003). Therefore, it is not surprising that defects in the EAD lead to mouth/jaw
defects and distorted facial regions due to altered migration of cranial NC that form the
first pharyngeal arch (Santagati and Rijli, 2003; Jacox et al., 2014; Chen et al., 2017).
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Figure 3-1. Neural crest states over developmental time.

The steps of neural crest development during neurulation and organogenesis
are schematized. A. Neural crest cells (NCC) are specified in an anterior-toposterior wave. B. From the end of neurulation to late organogenesis stages,
NCCs

undergo
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The steps of neural crest development during neurulation and organogenesis are
schematized. A. Neural crest cells (NCC) are specified in an anterior-to-posterior wave.
B. From the end of neurulation to late organogenesis stages, NCCs undergo epithelialto-mesenchyme transition, migrate, and differentiate. C. Lastly, cranial, cardiac,
posterior vagal, and trunk NCCs differentiate into specific and common derivatives.
Cranial and cardiac NCCs for ectomesenchyme which forms (1) bone (2) cartilage, (3)
smooth muscle and mesenchyme, (4) cardiac neural crest (5) chromaffin cells in the
adrenal medulla. At all levels of the anterior–posterior axis, (6) neural crest cells
generate pigment cells including melanocytes, xanthophores, and iridophores. (7)
various types of neurons of the sensory, autonomous, and enteric nervous systems, (8)
Schwann cells and enteric glia (8), and (9) Schwann cell progenitors.
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Table 3-75. Clinical phenotypes of individuals with the G90R and P121R
mutation.

Table 3-1. Clinical phenotypes of individuals with the G90R and P121R
mutation.
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Figure 3-2. Mutations in the core of histone H3.3.
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Figure 3-2. Mutations in the core of histone H3.3.A. Schematic representing the core

crest cells by disrupting the H3.3 function. This disruption can potentially be due to the
loss of incorporation of H3.3 or the loss of stability. To determine the effects of these
mutants on craniofacial formation, we aimed to assess the role of these germline
mutations in a known model of neurodevelopment, Xenopus laevis.
The African clawed frog, Xenopus laevis, has been used to study many molecular
pathways and mechanisms underlying developmental biology (Pratt and Khakhalin,
2013). The role of many proteins, including members of the Wnt and Bmp developmental
signaling pathways, including Wnt and Bmp, were discovered utilizing this model
organism. X. laevis females produce a large number of eggs which are approximately 1
millimeter big, and their ovulation can be induced with hormonal injections. Furthermore,
these eggs can be fertilized outside the female body using testis from an X. laevis male.
This, in part, creates an ideal system to alter gene expression through either microinjection
of mRNA or morpholino antisense oligonucleotides allowing for biochemical analysis
(Figure 3-2E). Xenbase (www.xenbase.org, RRID: SCR 003280) is an online resource
containing curated biological, expression, and genomic data collections. Xenopus has
proved to be a powerful alternative to mouse models as it is cost-effective, requires less
maintenance, and is more closely related to humans than zebrafish (Supplemental Figure
3-1). For example, the morphology of the skull differs across species; however, the
underlying mechanisms are reproducible across vertebrates (Slater et al., 2009).
Therefore, Xenopus tadpole is an excellent system for studying head tissues and
organs originating from the neural crest (head bones, jaws) and anterior neural plate
(brain). Moreover, craniofacial development in Xenopus has critical features of
mammalian development, such as neural crest-derived branchial arches, hyoid and
mandibular arches, Meckel’s Cartilage, and the palatoquadate (Slater et al., 2009). With
this homology and the genetic similarities, Xenopus is an attractive model for human
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craniofacial developmental defects. Given this, many human diseases and conditions were
studied utilizing X. laevis as the underlying principles that govern craniofacial
development, and the role of the neural crest in this process has been extensively studied.
This chapter focuses on exploring the effects of the germline H3.3 mutations on
neurodevelopment in X. laevis.

Figure 3-3. Xenopus: a model to study craniofacial development.
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3.2
3.2.1

Results
Microinjection of H3.3 at a concentration of 0.03 ug/uL resulted in comparable

H3.3 expression with minimal death
To assess the effects of these mutations, we chose to perform microinjections of
these mutant and wildtype mRNA that was generated utilizing in vitro transcription using
mMessage mMachine SP6 transcription kit. We produced capped mRNA for H3.3-WT,
H3.3-G90R, and H3.3-P121R and performed experiments according to the schematic in
Supplemental Figure 3-2. We utilized previously published studies to determine a range
of suitable H3.3 mRNA to introduce at the one-cell stage. For all Xenopus experiments,
we had an uninjected control and an H3.3-WT as a control as well. We performed the
initial experiments introducing the H3.3-WT mRNA in 10 nL injections at varying final
mRNA concentrations (0.01 ng, 0.03 ng, 1 ng, 3 ng). We saw an increased percentage of
dead tadpoles in the 0.3 ug/uL injection, while we saw comparable death between the 0.1
ug/uL and uninjected control (Figure 3-4. A). Based on this, we decided to assess the levels
of H3.3 that is overexpressed with these different concentrations, and we added a 0.03
ug/uL concentration which was 10-fold more than the 0.003 ug/uL. In the immunoblot,
we can see that the 0.3 nanograms (lane 4) of mRNA resulted in comparable levels of
FLAG-tagged H3.3 while the 1 ng of mRNA had a strong band when blotting for H3.3 and
FLAG (Figure 3-4. B). Given this, we decided to conduct our experiments at the 0.1 ug/uL
concentration to introduce 1 ng of H3.3 mRNA into the embryos.
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Figure 3-4. Concentration of H3.3 mRNA for microinjections.
A. Stacked bar graph showing the percent of tadpoles that were dead (orange)
compared to (alive) at the varying concentrations. B. Immunoblot showing the levels
of H3.3 (top) and FLAG-tagged H3.3 (bottom) at the varying concentrations.

3.2.2

Mutants induced defects in gastrulation/neurulation conversion
Our initial experiments focused on the H3.3 G90R mutant as we aimed to

determine this approach’s validity. We noticed a severe phenotype in the G90R tadpoles
at stage 38. A large percentage of them exhibited reduced pigmentation in their cement
glands, missing or missing eyes, and shortened bodies (Supplemental figure 2). We also
observed a high amount of embryo death after gastrulation, during neurulation, and in the
tailbud stage for both mutants, with an increased death seen in P121R embryos (data not
shown). We did note impairments in blastopore closure. The surviving embryos, still
within the tailbud stage, with severe defects, did not survive until the tadpole stage. We
aimed to look at phenotypes of these tailbud embryos to perform dorsoanterior index
scoring as developmental phenotypes can be extremely useful tools for investigating largescale changes to the embryonic pattern. Upon further inspection, we noted the phenotype
we were observing did not fall with an impaired dorsoanterior axis which is usually
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classified by loss of either head or tail structures. Instead, we observed kinked or shortened
tails in G90R and P121R embryos (Figure 6A).
Furthermore, we saw reduced pigmentation in both mutant embryos and, to a
small extent, in the WT embryos (Figure 6A). Additionally, we observed missing or
reduced pigmented eyes and cement glands and altered head shapes in both mutants,
which was first observed in the G90R embryos (Figure 6A). These defects we observed
continued into the tadpole stage, with reduced cement glands and bent axis observed
(Figure 6B). Collectively this data suggests potential dysregulation during neurulation as
the phenotypes observed can be linked to neural crest-derived cells.

Figure 3-5. Embryo and tadpole phenotype.
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A. Representative images of tadpoles at stage 38 with Control, WT and G90R (from
left to right). B. Defects in anterior and posterior observed at stage 36 in embryos
injected with G90R and P121R.

3.2.3

Alcian blue to stain and assess craniofacial cartilage
To determine the effects of the H3.3 mutants on craniofacial cartilage, we

employed Alcian blue staining to visualize the facial cartilage. Chondrocytes, derivatives
of mesenchymal cells, secrete proteoglycans, glycosaminoglycans, and collagen. These
sulfated glycosaminoglycans form a strong interaction with the cationic dye Alcian blue.
Cartilage contains higher concentrations of sulfated glycosaminoglycans; therefore, it has
been used to dye cartilaginous tissues (Trofimov and Vershinina, 2018). As previously
mentioned, the general head development is homologous across species, and structures
like branchial, hyoid, and mandibular arches and Meckel’s Cartilage are evolutionarily
conserved (Figure 3-7. A). Therefore, we first assessed which tadpole stage would provide
the best staining. We first looked at stage 41 and saw reduced head size with an altered
shape in the G90R mutant (Figure 3-7. B). During stage 43, tadpoles have reduced alcian
blue staining in the branchial arches and Meckel’s Cartilage of G90R and P121R (Figure
3-7. C). At stage 45, we had the best staining as most of the cartilages are fully developed,
and we were able to see reduced staining and reduced arch structure in the G90R mutants.
Therefore, for future experiments assessing craniofacial staining, we evaluated them at
stage 45.
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Figure 3-6. Cartilage staining using Alcian blue.
A. Diagram of Xenopus cranial cartilage B. Stage 41 stained tadpoles, taken at different
magnifications, 500-pixel scale at the bottom. C. Stage 43 stained tadpoles, control, WT,
G90R, P121R (left to right). D. Stage 45 stained tadpoles, control, WT, G90R, P121R (left
to right).
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Figure 3-7 Cartilage staining and motility assay.
A. Diagram of Xenopus cranial cartilage B. Images show a normal infrarostral (top)
and inverted (bottom). C. Stacked bar graph depicting the percentage of tadpoles with
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of the Meckel’s Cartilage, which remains unchanged across groups. We saw no significant
difference in the height of the head or size of the ceratohyal for any of the mutants
(Supplemental Figure 4A-B). However, we saw a substantial reduction in the arch height
in all three conditions (WT, G90R, P121R) (Figure 3-7, D). Notably, we observed a
significantly larger arch width in the G90R mutant (Figure 3-7, E). Given the hypotonia
seeing in the patients (Table 1) and the kinked tails observed in the tailbud and tadpole
stage, we aimed to assess the motility of these tadpoles. We tracked the movement of the
tadpoles and calculated speed, distance, and pausing after stimulation (Figure 8F,
Supplemental Figure 3C-D). We saw reduced distance traveled in both WT and P121R,
with no change in G90R and an increase in pausing in the P121R tadpoles (Supplemental
Figure 4C-D). Lastly, we observed a significant reduction in mutant (G90R and P121R)
tadpoles speed; however, this was not seen in the WT condition.
3.2.5

Both mutants induced upregulation of proteins involved in metabolic pathways
Previous sections discussed the phenotypes observed in tailbud and

tadpoles injected with either WT, G90R, or P121R. The phenotypes observed depicted a
potential defect in neural crest cells. Therefore, to assess this alteration, we performed
quantitative, bottom-up mass spectrometry on stage 17 embryos, a late neurula stage. One
limitation to Xenopus proteomics is the enormous quantities of yolk protein, as
approximately 90% of protein mass is the yolk. Gupta et al. (2018) detailed a method in
which you can spin out the yolk protein, separating them from your sample, which
increased the quantification and number of proteins identified (Supplemental Figure 5A).
We employed this method and achieved a sample devoid of yolk proteins (Supplemental
Figure 5B). We identified over 2000 proteins on Q-Exactive HF (Thermo Fisher).
We compared both mutants to the WT injection to determine the differential effect
of introduction mutated H3.3. Surprisingly, we found more proteins downregulated (38,
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G90R; 59 P121R) than upregulated (25, G90R; 26 P121R). Seventeen proteins were
downregulated in both mutants (Figure 3-8, A-B, F). One downregulated protein is
heterogeneous nuclear ribonucleoprotein A2/B1 (Hnrnpa2) (Figure 3-8, A-B).
Interestingly, mutations in Hnrnpa2 have been linked to a developmental disorder named
Inclusion Body Myopathy with Paget Disease of Bone and Frontotemporal Dementia.
Using KEGG, we looked at the pathways affected by G90R upregulated proteins and found
upregulation of pathways associated with oxidative phosphorylation and carbon
metabolisms such as pyruvate metabolism and amino acid degradation (Figure 3-8, C,
Supplemental Table 3-1). No specific pathways were found to be downregulated in P121R.
However, some of the proteins found had specific KEGG pathways associated with them
(Supplemental Table 3-2). Interestingly, like G90R, P121R had upregulation of carbon
metabolism pathways, including amino acid degradation and metabolism (Figure 3-8, E,
Supplemental Table 3-2).
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Figure 3-8 Proteomic analysis of stage 17 embryos.
Volcano plot depicting fold change on x-axis and -log2 p-value for A. G90R-WT and
B. P121R-WT comparisons. P-values calculated with Tukey corrected ANOVA on R.
Figure 3-9 : A. Volcano plot showing differentially expressed genes for G90RC. KEGG pathway analysis on G90R significant proteins. D. Venn Diagram showing
Control. Figure 3-8 Proteomic analysis of stage 17 embryos.
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3.2.6

Transcriptomic analysis showed upregulation of homeodomain transcription

factors and bone morphogenetic protein genes in G90R embryos
Following the proteomic experiments, we aimed to determine the changes induced
by these mutations at the transcriptome level. The annotation of the genome of Xenopus
laevis has had a major increase allowing for an increased number of studies with RNAsequencing in X. laevis. However, one major caveat of this model stems from the fact that
the genome of X. laevis is allotetraploid, meaning it has four sets of chromosomes. Thus,
the Xenopus genome often poses a problem for genetic studies (Kobel and Du Pasquier,
1986; Session et al., 2016). The release of the completed X. laevis genome (version 9.1) by
the Joint Genome Institute (JGI) is now available for genome-wide studies. Lastly, it is
essential to note that there are gene duplicates which are denoted by the postfixes “L” and
“S” that stand for “long” and “short” chromosomes in the homoeologous pairs (Matsuda
et al., 2015). We performed the transcriptomic analyses using the DeSEQ2 package on R
and the uninjected control as the standard. Additionally, we had approximately ten
embryos from n = 4 females, totaling 40 embryos per condition.
The comparison between G90R and Control provided the most noticeable results,
as we saw a significant upregulation of transcriptional regulating genes (Figure 10A).
These included homeodomain transcriptional repressors, (ventx1.1, ventx1.2, ventx2.1,
ventx2.2, pou5f3.2) both L/S versions of these genes as well as Paired box 3 (pax3.L)
(Figure 10A). Other transcription factor-related genes found upregulated in G90R
included helt.L, foxa4.S, and pou5f3.2 (Figure 10A). These genes had a p-value < 0.01 and
an FDR < 0.001 according to the DeSEQ Wald Test. There were some common
differentially expressed genes for WT and G90R. However, the P121R transcriptome was
enriched for poorly annotated genes proving difficult for downstream analysis (Figure
10B-C, Supplemental Figure 5C). Notably, some commonly upregulated genes include
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ventx1.1.S, ventx2.1.S, and ventx2.2.S (Figure 10C, Supplemental Figure 5). Gene ontology
analysis of the G90R-specific upregulated genes demonstrated that these genes play key
roles in the determination of ventral identity, BMP signaling, negative regulation of
transcription, mesoderm formation, and ossification (Supplemental Table 3). We plotted
the gene counts for some of these genes involved in BMP signaling and mesoderm
formation showing the statistically significant upregulation in G90R (Figure 10E-I).
Performing functional annotation analysis of G90R-specific downregulated genes using
DAVID, and we only found one GO-Biological process downregulated ‘transcription,
DNA-templated. These downregulated genes included gli2.L, pou3f1.S, egr2.L, esrra.L,
gtf2h1.L, hoxb7.L, med1 and polr1b.L.
Using the normalized counts generated from DESEQ, we performed gene set
enrichment analysis using the molecular signature database gene sets C2: curated gene
sets (KEGG subset of CP) and C5: ontology gene set (GO: gene ontology gene set) (Mootha
et al., 2003; Subramanian et al., 2005). We found one gene set, One Carbon Pool by Folate,
upregulated in the control compared to G90R with Nominal p-value and FDR < 5%
(Figure 10J). We performed this analysis with WT and P121R and found significance for
WT but not P121R (Supplemental Figure 5B, D). Next, we utilized the gene ontology
analyses to assess the biological processes altered between the G90R and WT. We found
2010/3537 gene sets upregulated in G90R, but none of them had a significant FDR < 25%.
Additionally, only 96 gene sets were significantly enriched at a nominal p-value < 5%.
Some of these enriched datasets with a nominal p-value < 1% included RNA decapping,
presynapse organization, and bone growth. We found 1527/3537 gene sets upregulated in
WT, with 1 of the gene sets both statistically significant with a nominal p-value < 1% and
FDR < 25%. This gene set was Folic acid-containing compound metabolic process (Figure
10K). Moreover, there were 69 gene sets significantly enriched at a nominal p-value < 5%.
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Some gene sets with < 1% nominal p-value included somitogenesis, segmentation, and
protein localization to the centromeric chromosomal region.

Figure 3-9. Transcriptomic Analysis of stage 17 embryos.
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Figure 3-9 : A. Volcano plot showing differentially expressed genes for
G90R-Control.

A. Volcano plot showing differentially expressed genes for G90R-Control. X-axis: log10 p value, Y-axis: log2 Fold change. Calculations were done using DeSEQ2 script on
R. Venn diagram comparing B. Downregulated and C. Upregulated genes in G90R and
WT. Bar graphs showing normalized gene counts for D. bmp2.L E. bmp4.S F. pax3.L
G. ventx1.2.S H. ventx1.2.L I. ventx2.2.L all normalized to the counts of control. Gene
set enrichment analysis for J. G90R compared to Control for KEGG pathway: One
Carbon pool by Folate. K. G90R compared to WT for GOBP: Folic acid containing
compound metabolic process.
3.3 Discussion
A. Volcano plot showing differentially expressed genes for G90R-Control. X-axis: Germline mutations in H3.3 were recently described to result in a
log10 p value, Y-axis: log2 Fold change. Calculations were done using DeSEQ2 script on
neurodevelopmental disorder characterized by intellectual disabilities, mild craniofacial
R. Venn diagram comparing B. Downregulated and C. Upregulated genes in G90R and
abnormalities, hypotonia, and ASD (Bryant et al., 2020). The initial findings reported 36
WT. Bar graphs showing normalized gene counts for D. bmp2.L E. bmp4.S F. pax3.L
missense mutations, and two of these point mutations were of interest based on our initial
G. ventx1.2.S H. ventx1.2.L I. ventx2.2.L all normalized to the counts of control. Gene
cellular assessment (Chapter 2), H3.3 G90R and P121R. In addition, Bryant et al., 2020
set enrichment analysis for J. G90R compared to Control for KEGG pathway: One
cited a 2012 study that looked at an H3.3 point mutation D123N's effect on the
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A. Volcano plot showing differentially expressed genes for G90R-Control. X-axis: log10 p value, Y-axis: log2 Fold change. Calculations were done using DeSEQ2 script on

H3.3 incorporation results in impairments in late gastrulation and impairs further
development in Xenopus laevis (Szenker, Ray-Gallet, and Almouzni, 2011). Utilizing this
model organism, we profiled the effects of H3.3 G90R and P121R mutants on Xenopus
development and found gastrulation defects, impairments to craniofacial cartilage
formation, and motility in these mutants.
Our introduction of H3.3 mutants using microinjections of H3.3, G90R, or P121R
mRNA resulted in embryo death after gastrulation. Although we were not able to quantify
this event, we did see an increased fatality in the G90R and P121R groups. During the
tailbud stage, a severe phenotype was observed in the G90R embryos. The phenotype
observed was characteristics of defects in neural crest cells. These included reduced
pigmentation in the eyes and cement glands, both of which result from ectomesenchymal
differentiation. Both retinal pigment epithelial layer of the eye and melanocytes are
generated from cranial NCCs (Pla and Monsoro-Burq, 2018). In later developmental
stages, ocular abnormalities and microencephaly-like phenotype were observed in G90R
mutants (Figure 6A). Studies have shown that these structures are linked to specific
transcription factors, including otx2, pax6, en2, and tbx3 (Yelin et al., 2007). Another
phenotype we observed in earlier stages was an abnormal tail bending, which could be
attributed to several genes or a decreased size of the anterior-posterior axis.
Interestingly, the structure and shape of the head are dictated by the pharyngeal
arches during vertebrate development (Graham and Richardson, 2012). The cartilage and
bone of the jaw, ear, and neck are mainly dictated by the pharyngeal arch, which is derived
from cranial NCCs and mesoderm-derived cells (Graham and Richardson, 2012). The
mesoderm forms the musculature of the head, and NCCs develop into craniofacial skeletal
elements (Kong et al., 2014). Our initial alcian blue staining showed a reduced branchial
arch, another name for the pharyngeal arch, in both G90R and P121R (Figure 7B). We
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quantified this arch reduction and found a significant reduction in height and width in the
G90R mutant suggesting improper pharyngeal arch development. The pharyngeal arch
formation is dictated by dorso-ventral patterning, Wnt, and Bmp signaling, and alteration
to either can lead to alterations in the pharyngeal arch structure (Alexander et al., 2014).
Our assessment of craniofacial structure at stage 45 showed the inversion of the
infrarostral cartilage, which articulates the lower jaw explicitly near the intramandibular
joint (Svensson and Haas, 2005). The inversion was observed in over 50% of G90R
tadpoles and could be linked to defects in the forkhead/winged-helix transcription factor,
FoxN3. Interestingly, our transcriptomic data identified another forkhead transcription
factor, foxa4 which will be discussed in the upcoming sections. Foxa4 and FoxN3 have a
high degree of overlap for binding motifs which could be an interesting avenue to pursue
in the context of cranial developmental. As FoxN3 has been shown to play a critical role in
the formation of jaw cartilage and eye formation, loss of FoxN3 results in false positioning
of structures of the first pharyngeal arch which includes the infrarostral structure (Schuff
et al., 2007, p. 3; Schmidt, Schuff and Olsson, 2011). These defects were linked to neural
crest cells' failure to differentiate due to a missing histone deacetylase complex (Schuff et
al., 2007, p. 3).
The phenotypes we described suggest a potential issue with neural crest cell
differentiation or migration; we assessed this using proteomic and transcriptomic
analyses at stage 17 in Xenopus. Our proteome data suggested an upregulation in proteins
related to carbon metabolism with pathways associated with amino acid and pyruvate
metabolism altered (Figure 9, Supplemental Table 1-2). Branched-chain amino acids (ValLeu-Iso) metabolism is causative in neurocognitive phenotypes such as an intellectual
disability in maple syrup urine disease, a rare metabolic disorder (Hoffmann et al., 2006;
Simon, Schwarz and Wendel, 2007). The metabolism of these amino acids results in
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increased alpha-ketoacids which leads to lipid peroxidation and oxidative stress (Funchal
et al., 2006). Additionally, enzymes related to other metabolic pathways, including purine
metabolism, cysteine, and methionine metabolism, and glycolysis was found in both
mutants. It remains unclear if the mutations directly cause these effects through
mislocalization of H3.3 or lack of H3.3 incorporation due to either of the mutations. It is
also important to note that the Warburg effect seen in cancerous cells is a hallmark of
neural crest cells, and it is required for the migration of these cells (Bhattacharya,
Azambuja, and Simoes-Costa, 2020). Additionally, enhanced glycolysis drives neural crest
epithelial to mesenchymal transition suggesting that alterations to cellular metabolic
pathways can impair neural crest cell migration or differentiation.
A closer look at some of the significantly altered proteins gives insight into other
developmental disorders caused by some of the proteins listed. For example, Ahcy is
downregulated

in

both

Adenosylhomocysteinase

mutants,
(Ahcy),

with

mediates

an

increased

the

significance

conversion

from

in

P121R.

S-Adenosyl-L-

homocysteine (SAH) to homocysteine. Mutations in AHCY result in hypermethioninemia
due to S-adenosylhomocysteine hydrolase deficiency, a muscle disease involving
psychomotor delay, behavioral disorders, microencephaly, severe myopathy, and delayed
myelination from birth (Furujo et al., 2012). Another example, Cdc42 was downregulated
in both groups. Heterozygous mutation in CDC42 causes Takenouchi-Kosaki syndrome
characterized by delayed psychomotor development, dysmorphic facial features,
intellectual disability, and hematologic or lymphatic defects (Martinelli et al., 2018). From
our proteomic experiments, we identified potential candidate proteins that are
dysregulated due to G90R or P121R.
Finally, to explore the implications of these mutants at the transcript level, we
performed RNA-sequencing on stage 17 embryos. Unfortunately, we could not assess gene
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expression changes in the P121R embryos potentially due to one of two reasons: 1.
Embryonic death could have occurred during harvesting. 2. a High number of
unannotated genes made it difficult to determine which pathways are affected in that
dataset. Therefore, the focus of this transcriptomic was on the G90R mutant. Surprisingly,
our data suggest that G90R mutant leads to the upregulation of a group of transcriptional
repressors ventx, pax3.L, helt.L, foxa4.S, and pou5f3.2. Interestingly, the genes encoding
the bone morphogenetic proteins bmp2.L and bmp4.S (Figure 9D-E). The following
section will discuss the roles of these transcription factors and genes mentioned in neural
crest specification.
Secretion of Wnt, fibroblast growth factor (FGF), retinoic acid (RA), and BMP from
the mesoderm regulates the expression of Pax3, Zic1, Msx1, and this define the border of
the neural crest (Milet and Monsoro-Burq, 2012). Pax3 promotes neural crest cell fates
and acts downstream of msx1 to induce neural crest formation. In our study, we
demonstrated upregulation of Pax3.L in G90R. Another group showed that persistent
Pax3 expression in cranial neural crest cells could result in cleft palate, ocular defects, and
other malformations (Wu et al., 2008). This study showed the importance of Pax3
downregulation during differentiation as Pax3 can maintain the undifferentiated state of
neural crest mesenchyme, potentially blocking BMP-induced osteogenesis (Wu et al.,
2008). Ventx1.2 is a known transcriptional repressor, and it cooperates with ventx2.2 in
the ventral signaling pathway downstream of bmp4 (Onichtchouk, Glinka and Niehrs,
1998).
Ventx1/2 antagonizes the Spemann organizer and dorsal mesoderm formation
leading to ventral mesoderm formation (Gawantka et al., 1995). Thus, Ventx1.2 and
ventx2.2 counteract lineage commitment to both dorsal and ventral fates. Additionally,
ventx1.2 acts downstream of Bmp4 to repress the transcription of Foxa4, a transcriptional
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repressor involved in embryonic nervous system development. Foxa4 plays a role in the
patterning of the anterior-posterior neural axis, specifically patterning for the forebrain
through repression of anf1 (Murgan et al., 2014). FoxA4 is known as an immediate-early
response gene, and both an activin-responsive element and Ventx quickly silence its
expression in response to BMP signaling, which is at the FoxA4 promoter (Kaufmann et
al., 1996; Howell, 1997; Friedle, 1998). Like our data, overexpression of Foxa4 resulted in
head truncation, with the embryos lacking eyes and cement glands, which was due to
changes in expression of otx2 and Xanf1 (Murgan et al., 2014). Collectively our
transcriptomic data showed an increased expression of bmp2, bmp4, ventx1.2, ventx2.2,
and foxa4. The increase in TGF-beta signaling genes is interesting as the data suggest that
upon bmp4 stimulation, ventx1/2 represses the expression of foxa4. However, in our data
set, foxa4 expression is also significantly upregulated in addition to its inhibitors
suggesting another potential BMP antagonist.
GLI family Zinc Finger 2, GLI2, was found downregulated in the G90R dataset.
GLI2 is a transcriptional activator, and it plays a role in craniofacial and central nervous
system development (Lo et al., 2009; Palencia-Campos et al., 2017). Interestingly, it has
two paralog GLI1/3 and similar genomic targets, including BCL2, MYCN, and CCND1
promoters (Tolosa et al., 2020). These Gli proteins are critical for neurogenesis, and
despite the redundancy in targets, all three of them are required for neural plate induction
and in the regulation of the Notch neurogenic cascade (Nguyen et al., 2005). The GLI2
gene is expressed up until migration in neural crest cells and reduces apoptosis in NCCs.
Additionally, GLI2 is required for autonomous NC migration and the formation of
differentiated NCCs such as craniofacial cartilages, melanocytes, and the cranial ganglia.
A point of interest is the interplay shown with H3.3 in regulating GLI1 transcription in
neural stem cells (Xia and Jiao, 2017). H3.3K36me3 directly interacts with the histone
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acetyltransferase MOF promoting the hyperacetylation of H4K16. This upregulation of
H4K16ac coincided with increased expression of GLI1, promoting neural stem cell
proliferation and differentiation (Xia and Jiao, 2017).
Finally, our data also resulted in enrichment in both H3.3 WT and Control
compared to G90R for Folate acid, one-carbon metabolism. Folate deficiency has been
long known to be linked to neural tube and neural crest defects. Folate metabolism likely
potentiates gene expression in neural crest cells through epigenetic modifications such as
methylation (Li et al., 2011). Disturbances to folate metabolism can result in altered NCC
migration and have been shown to cause craniofacial abnormalities (Finnell et al., 1998;
Etchevers, Amiel and Lyonnet, 2006; Goldmuntz et al., 2008). Significant accumulation
of homocysteine can result in impaired neural crest migration, and this can be rescued by
the addition of methyltetrahydrofolate (Shi et al., 2014). Other studies have shown that
deficiency in either folate or its metabolites can result in neural defects, including orofacial
and cardiac developmental impairments (Boot et al., 2003). There is reduced expression
of folate pathway genes, and we also observed this at the protein level with the reduction
in Ahcy.
Our work found that the introduction of germline H3.3 mutant G90R and P121R
in Xenopus embryos resulted in phenotypic, proteomic, and transcriptomic alterations.
Furthermore, we found that Xenopus was a great model to profile the effects of these
mutations on craniofacial development, motility, and alterations to protein pathways.
Specifically, we observed upregulation in carbon metabolism pathways in the proteomics
data and the transcriptomic data set with the GSEA. These pathways can potentially be
regulated through the BMP proteins, which were found upregulated in our mutant and its
early immediate effector genes, ventx. The G90R mutant will likely have impaired genome
incorporation, suggesting a distinct but critical role for H3.3 in neural crest cell
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proliferation, differentiation, and migration. Our work highlights the importance of
Xenopus as a model for assessing human disorders involving developmental defects.
Future work should explore the potential targets found in the transcriptomics and
determine the genomic loci in which the mutant H3.3 is incorporated into the genome.

3.4
3.4.1

Materials and methods
Xenopus husbandry, fertilizations, and microinjections.
All experiments performed, including in vitro fertilization, microinjection, and

culture of Xenopus laevis embryos, were done as previously described (Sive, Grainger, and
Harland, 2010). Xenopus embryos were obtained by in vitro fertilization, and they were
cultured at room temperature in 0.1X MMR buffer (22 mM NaCl, 0.5 mM KCl, 0.5 mM
CaCl2, 0.25 mM MgCl2, 1.25 mM HEPES). The embryo staging was based on (Faber and
Nieuwkoop, 1967). Xenbase (http://www.xenbase.org/, RRID: SCR_003280) served as a
reference for gene expression patterns and developmental stages. Xenopus experiments
were approved by the Institutional Animal Care and Use Committee at the University of
Pennsylvania.
3.4.2

Western Blotting
Lysates were run on 15% NuPage gel for 1 hour at 175 Volts. These were then

transferred to a nitrocellulose membrane and blocked for 1 hour at room temperature in
5% milk in Tris-buffered saline (TBS) supplemented with 0.1% Tween 20 (TBST). Primary
antibodies (αH3.3 (Invitrogen RM190), αFLAG (Sigma)) were diluted 1:1000 in 5% milk
in TBST and incubated overnight at 4°C. The membrane was washed three times with
TBST followed by incubation with HRP-conjugated secondary antibody for 1 hour at room
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temperature in 5% milk/TBST. Finally, the membrane was rewashed and imaged with a
Fujifilm LAS-4000 imager.
3.4.3

Motility Assay
Stage 47 tadpoles were individually placed into wells of a standard 24-well culture

dish with 0.1X MMR under lighting as previously described (Marquez, Criscione, and
Charney, 2020). Thirty-second videos of the tadpoles were filmed with a Dinoscope (DinoLite Pro AM4113T). Before filming, tadpoles were released into the well to cause
stimulation. Videos were analyzed using the tracking feature on Kinovea version 0.8.15
(https://www.kinovea.org/). The analysis consisted of using the data collected from the
program provided XY coordinates for the tadpoles every 0.08 seconds that were used to
calculate the distance and speed of the tadpoles.
3.4.4

Whole mount Alcian blue cartilage staining
Stage 45 tadpoles were prepared as previously described (Hilton and Springer

Science+Business Media, 2014). Briefly, tadpoles were fixed in 100% ethanol for 48 hours
at room temperature with gentle shaking. They were then washed with acid alcohol (1.2%
HCl in 70% EtOH). This solution was replaced with a 0.25% Alcian blue solution in acid
alcohol, and this was gentle nutating for 48 hours. The specimens were then washed fivesix times in acid alcohol. Slow rehydration of H2O using an ethanol gradient (Fron 70%
ethanol to 0% Ethanol). Following this, allow the specimen to sit in water for at least 2
hours before bleaching overnight with 1.2% hydrogen peroxide under bright (2500 lux)
light. Finally, a 0.02 % KOH was used to briefly wash tadpoles and then processed through
a glycerol gradient up to 80% glycerol.
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3.4.5

Proteomics sample preparation
Stage 17 embryos were prepared as described previously with minor adjustments

(Gupta et al., 2018). Briefly, twenty stage 17 embryos were pooled for each genotype and
lysed in freshly prepared buffer containing 250mM sucrose, 1% nonident P-40 substitute,
10mM EDTA (Ethylenediaminetetraacetic acid), 25mM HEPES (4-(2-hydroxyethyl)-1piperazineethanesulfonic acid) pH= 7.2, 10 mM cytochalasin D and, cOmplete, mini
protease inhibitor cocktail. First, the yolks were spun down at 2500 rcf for 5 minutes at 4
°C, then the concentration of HEPES was raised to 100mM (pH 7.2), and the lysate was
sheared by probe sonication. Next, the proteins were denatured by adding an equal volume
of SDS buffer (10% SDS in 100 mM TEAB (Triethylammonium bicarbonate), pH 7.55).
Following this, the samples were prepared according to the ProtiFi S-TrapTM protocol
(HaileMariam et al., 2018; Elinger, Gabashvili, and Levin, 2019).
First, denatured proteins were reduced with DTT (dithiothreitol) at a final
concentration of 20 mM at 95 °C for 10 minutes and then alkylated with a 30-minute
incubation in 40 mM IAA (iodoacetamide) in the dark. Aqueous phosphoric acid was then
added to a final concentration of 1.2%. The volume was then raised using six volumes of
S-trap buffer (90% methanol, 100mM TEAB, pH 7.55). Samples were loaded onto an inhouse S-trap made using a P200 pipette tip, packed with one 2mm plug of C18 disk and
two 3mm plugs of quartz fiber (MK360, Munktell or QM-A, Whatman) filters. The samples
were washed five times using S-trap buffer and digested for 1 hour at 47 °C in digestion
buffer (50 mM TEAB) containing trypsin (Promega) at a 1:20 (enzyme: protein) ratio.
Finally, peptides were eluted first with 50 mM TEAB, then 0.2% formic acid, and finally
with 40% acetonitrile containing 0.2% formic acid. Samples were dried in a speed vac and
desalted by stage-tipping (Sidoli et al., 2016).
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3.4.6

Proteomics mass spectrometry and data analysis
Peptides were resuspended in Buffer A (0.1% Formic acid), and 1 ug of each

fraction was injected and analyzed by nanoLC-MS/MS with a Dionex-nanoLC coupled to
a QE-HF (Thermo fisher scientific). The column was packed in-house, as previously
mentioned. The 90-minute HPLC gradient was as follows: 4% to 25% solvent B (A= 0.1%
formic acid; B= 80% acetonitrile, 0.1% formic acid) over 53 minutes, from 25% to 35%
solvent B over 17 minutes, from 35% to 90% solvent B over 1 minute, it was held at 90%
solvent B for 10 minutes and returned to 4% solvent B over 1 minute. The flow rate was at
400 nL/min. Data was acquired using a data-dependent acquisition method, consisting of
a full scan MS spectrum (m/z 350 to 1200) performed in the orbitrap at 60,000 resolution
with an AGC target value of 1e6. For each cycle of the data-dependent acquisition, the top
25 most intense ions were selected for fragmentation used stepped normalized collision
energy of 25, 27, and 30% (HCD). Fragment ion spectra were acquired in the Orbitrap at
30,000 resolution with an AGC of 1e5 and a maximum injection time of 50ms for the
Orbitrap MS2 detection. Data analysis was conducted using the Proteome Discoverer
software (v2.4, Thermo Fisher Scientific). The data were searched against the Human
Universal Protein Resource (UniProt). Further processing was conducted utilizing the
MSstats package on R (Choi et al., 2014). Unless otherwise indicated, a Tukey HSD
corrected ANOVA was used to determine statistical significance for proteomics mass
spectrometry datasets between conditions. Data visualization was performed using R
packages such as ggplot2 (Wickham 2016). The colors and fonts of plots were altered using
Adobe Illustrator.
3.4.7

Bioinformatics and statistical analysis
Gene ontology enrichment analysis was performed with a database for annotation,

visualization, and integrated discovery (DAVID) bioinformatics resources (Jiao et al.,
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2012). Transcription factor signatures were assessed using Gene Set Enrichment Analysis
(GSEA) (Subramanian et al., 2005; Mootha et al., 2003).
3.4.8

RNA-seq sample preparation
RNA was extracted using an RNAeasy kit (Qiagen 74014) following the

manufacturer’s guidelines. Treatment with DNAse for 15 minutes was included in order to
degrade genomic DNA. Libraries were prepared using NEBNext Poly(A) mRNA magnetic
isolation module and NEB Ultra Directional RNA Library kit for Illumina (New England
Biolabs). Library quality and quantification were assessed and were sequenced.
3.4.9

RNA-seq data analysis
FASTQ files were mapped to the Xenopus genome version XL-9.1_v1.8.3.2

(Xenbase) using HISAT2 (Kim, Langmead and Salzberg, 2015). The total mapped reads
were larger than 80%. The sequences were counted using the HTSeq package (Anders, Pyl,
and Huber, 2015). The differentially expressed genes (DEGs) were detected using DESeq
(Anders and Huber, 2010). The P-value estimation was based on the negative binomial
distribution, using the Benjamini-Hochberg estimation model with an adjusted P-value of
<0.05. The heatmap and volcano plots were generated using the publicly available ggplot
on R. Unranked gene counts were used for analysis by GSEA (Subramanian et al., 2005).
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3.5

Supplemental Figures
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Tree depicting the main animal models commonly used in biomedical research and
their evolutionary relationships. The divergence time, in millions of years (Mya), is
based on multiple gene and protein divergences studies. Figure taken from Wheeler
and Brändli, 2009

Tree depicting the main animal models commonly used in biomedical research and
their evolutionary relationships. The divergence time, in millions of years (Mya), is
Supplemental Figure 3-2. Schematic of Xenopus experiments
based on multiple gene and protein divergences studies. Figure taken from Wheeler
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and Brändli, 2009

Supplemental Figure 3-3. Representative images of stage 38 tadpoles.
Supplemental Figure 3-6. Representative images of stage 38 tadpoles.
Supplemental Figure 3-7. Representative images of stage 38 tadpoles.
Supplemental Figure 3-8. Representative images of stage 38 tadpoles.
Supplemental Figure 3-5. Yolk Spin out.Supplemental Figure 3-9.
Representative images of stage 38 tadpoles.
Supplemental Figure 3-10. Representative images of stage 38
tadpoles.
Supplemental Figure 3-11. Representative images of stage 38 tadpoles.
Supplemental Figure 3-12. Representative images of stage 38
tadpoles.
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Supplemental Figure 3-4. Additional measurements taken from stage 45
were calculated using a One-Way ANOVA.
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Supplemental Table 3-1. G90R significantly altered proteins with KEGG
pathways. Proteins downregulate are in pink, while upregulated is in green.

Supplemental Figure 3-6. Transcriptomic and GSEA analysis for WT and
P121R.Supplemental Table 3-1. G90R significantly altered proteins with
KEGG pathways. Proteins downregulate are in pink, while upregulated is in
green.
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Supplemental Table 3-2. P121R significantly altered proteins with KEGG
pathways. Proteins downregulate are in pink, while upregulated is in green.
A. Volcano plot showing differentially expressed genes for WT-Control. -log10
pvalue on x-axis, log2 Fold change on y-axis, calculations were done using
DeSEQ2 script on R. B. Gene set enrichment analysis for One Carbon Pool by
Folate for WT compared to control. C. Volcano plot showing differentially
expressed genes for P121R-Control. -log10 p value on x-axis, log2 Fold change
on y-axis, calculations were done using DeSEQ2 script on R. B. Gene set
enrichment analysis for One Carbon Pool by Folate for P121R compared to
control.Supplemental Table 3-2. P121R significantly altered proteins with
KEGG pathways. Proteins downregulate are in pink, while upregulated is in
green.
A. Volcano plot showing differentially expressed genes for WT-Control. -log10 pvalue on
x-axis, log2 Fold change on y-axis, calculations were done using DeSEQ2 script on R. B.
Gene set enrichment analysis for One Carbon Pool by Folate for WT compared to control.
C. Volcano plot showing differentially expressed genes for P121R-Control. -log10 p value
on x-axis, log2 Fold change on y-axis, calculations were done using DeSEQ2 script on R.
B. Gene set enrichment analysis for One Carbon Pool by Folate for P121R compared to
control.

Supplemental Table 3-3. Output of DAVID analysis of G90R specific genA.
Volcano plot showing differentially expressed genes for WT-Control. -log10
pvalue on x-axis, log2 Fold change on y-axis, calculations were done using
DeSEQ2 script on R. B. Gene set enrichment analysis for One Carbon Pool by
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Folate for WT compared to control. C. Volcano plot showing differentially
expressed genes for P121R-Control. -log10 p value on x-axis, log2 Fold change
on y-axis, calculations were done using DeSEQ2 script on R. B. Gene set

Supplemental Figure 3-6. Transcriptomic and GSEA analysis for WT and
P121R.
A. Volcano plot showing differentially expressed genes for WT-Control. -log10 pvalue on
x-axis, log2 Fold change on y-axis, calculations were done using DeSEQ2 script on R. B.
Gene set enrichment analysis for One Carbon Pool by Folate for WT compared to control.
Supplemental Table 3-2. P121R significantly altered proteins with KEGG
C. Volcano plot showing differentially expressed genes for P121R-Control. -log10 p value
pathways. Proteins downregulate are in pink, while upregulated is in
on x-axis, log2 Fold change on y-axis, calculations were done using DeSEQ2 script on R.
green.Supplemental Figure 3-6. Transcriptomic and GSEA analysis for WT
B. Gene set enrichment analysis for One Carbon Pool by Folate for P121R compared to
and P121R.
control.
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Supplemental Table 3-3. Output of DAVID analysis of G90R specific genA. Volcano plot

Supplemental Table 3-3. Output of DAVID analysis of G90R specific genes
Figure 3-78. Complex landscape of epigenetic mechanisms.Supplemental
Table 3-3. Output of DAVID analysis of G90R specific genes
Figure 3-79. Complex landscape of epigenetic mechanisms.
Figure 3-80. Complex landscape of epigenetic mechanisms.Supplemental
Table 3-3. Output of DAVID analysis of G90R specific genes
Figure 3-81. Complex landscape of epigenetic mechanisms.Supplemental
Table 3-3. Output of DAVID analysis of G90R specific genes
Figure 3-82. Complex landscape of epigenetic mechanisms.
Supplemental Table 3-3. Output of DAVID analysis of G90R specific genes
Figure 3-83. Complex landscape of epigenetic mechanisms.Supplemental
Table 3-3. Output of DAVID analysis of G90R specific genes
Figure 3-84. Complex landscape of epigenetic mechanisms.
Figure 3-85. Complex landscape of epigenetic mechanisms.Supplemental
Table 3-3. Output of DAVID analysis of G90R specific genes
Figure 3-86. Complex landscape of epigenetic mechanisms.Supplemental
Table 3-3. Output of DAVID analysis of G90R specific genes
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Chapter 4: Conclusions and Future Directions
4.1

Summary of Main Findings
This dissertation highlights the work assessing the effects of germline H3.3

mutations in an in vitro and in vivo context. These mutations were causative for a
neurodevelopmental syndrome characterized by intellectual disability, developmental
delay, mild craniofacial anomalies, and hypotonia. To this end, the effects of these
mutations on global histone post-translational modifications and protein expression were
investigated (Chapter 2). Additionally, the consequences of these H3.3 mutations in
Xenopus laevis, a model for developmental disorders, were also studied (Chapter 3). H3.3
is critical for early development as loss of this variant, or its chaperones result in severe
gastrulation impairments (Szenker, Lacoste, and Almouzni, 2012).
Moreover, studies have shown the critical role of H3.3 in the transition from
cranial neural crest cells to ectomesenchyme which is a critical biological process for
craniofacial, cardiac, and CNS development (Cox et al., 2012). This work determined that
two of these mutants, G90R and P121R, induce similar proteomic changes in both the
cellular and animal models. Throughout this dissertation, a collection of techniques were
applied to explore these mutations. These included quantitative mass spectrometry,
genomes, and this model organism to elucidate the pathomechanism of these germline
H3.3 mutations.
The second chapter of this dissertation focuses on in vitro work. This involved
HEK 293T cells stably expressing either FLAG-tagged H3.3 wildtype or a germline mutant
to interrogate alterations to global histone modifications, changes in proteome
composition, and altered protein-protein interactors.
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1. R8S and G13R mutation showed no significant global changes to histone
post-translational modifications or the proteome. We observed minor alterations
to global PTMs but surprisingly found alterations on the mutant peptides
themselves, suggesting that the changes can be happening locally. In this cellular
context, it is essential to note that H3.3 makes up less than 10% of the cell’s H3
content. Moreover, these effects may be more pronounced in a different cell line or
through enrichment of the mutant, which is achievable, as seen in chapter 2.
2. Global increase in histone H2A.V, H2A.Z, H3, and H4 acetylation
induced by the core mutations: T45I, G90R, and P121R. H3.3 is known as the active
variant as it accumulates activating marks and can be found at transcriptionally
active regions (Chow et al., 2005; Ng and Gurdon, 2008; Chen et al., 2013).
Furthermore, this “active” nature of H3.3 is highlighted by its increased instability
within nucleosomes and has been shown to have an increased turnover during
cellular activity (Jin et al., 2009; Maze et al., 2015). Thus, the phenotypes we
observed are consistent with an open chromatin state. However, it remains unclear
if the increase in acetylation is due to A) Nucleosome-free regions due to mutant
H3.3 instability and eviction B) Increased contact with DNA resulting in slower
turnover allowing the marks to accumulate.
3. Proteomic analysis on these mutants revealed a specific group of proteins
upregulated by G90R and P121R. A unique find in this chapter was the
upregulation of proteins linked to Smith-Magenis Syndrome (SMS). The genes of
these proteins all reside on chromosome 17, in the arm that’s deleted in SMS (Elsea
and Girirajan, 2008). Thus, there is some clinical overlap between SMS and the
germline patients; however, it remains unclear if these proteins were upregulated
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in response to mutant H3.3 being in their direct genomic loci or due to a
downstream effect of mutant H3.3 incorporation into the genome.
4. Branched Chain Amino Acids and One-Carbon metabolic pathways were
found in both G90R and P121R in both chapter 2 and chapter 3. The consistent
observation of these metabolic pathways was fascinating. Both have been linked to
neurological disorders, BCAAs specifically dysregulated in maple syrup urine
disease (Simon, Schwarz and Wendel, 2007), and the one-carbon metabolism. The
folate pathway has long been critical for neurodevelopment. Folic acid deficiency
results in a host of developmental problems, one of which is Spina bifida. It will be
interesting to determine whether there is a metabolic link between H3.3 and the
folate cycle metabolites.
The third chapter of this dissertation surveyed the effects of these germline H3.3
mutations, G90R and P121R, in the model organism Xenopus laevis. We aimed to
interrogate phenotypic changes induced by these mutations and proteomic and
transcriptomic changes at the neural crest stage.
1. Both mutants induced gastrulation defects leading to a high number of
cell death, the embryos that survived exhibited reduced pigmentation in eyes,
cement glands and showed signs of microencephaly. Cranial neural crest cells
generate melanocytes, cartilage, and bones of the face and periocular mesenchyme
(Santagati and Rijli, 2003; Akula, Park and West-Mays, 2019; Méndez-Maldonado
et al., 2020). Furthermore, all the structures mentioned are derived from
ectomesenchymal (EMT) cells, which depend highly on the H3.3 function. Thus,
the mutant H3.3 potentially dysregulates H3.3 function affecting the EMT
transition. However, we would need to study this in an in vitro model for EMT
conversion.
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2. G90R had reduced craniofacial cartilage, specifically the branchial
arches, and had an increased number of inverted infrarostral structures. Our alcian
blue stained tadpoles revealed a specific phenotype for G90R involving the
inversion of the infrarostral structure which points back to the defects in cranial
neural crest cells. As the structures altered, all derive from the first pharyngeal
arch.
3. Both mutants had motility defects: G90R had decreased movement
speed while P121R had increased pausing. Although these two effects are described
differently, both circulate the idea of impaired motility. However, the cause of this
is unclear as not many have studied kinked structures in tadpole tails, especially as
the tail is gone by adulthood.
4. Both mutants induced proteomic alterations affecting metabolic
pathways. As previously mentioned, BCAA and Carbon metabolism have been
found in both cell line proteomes and the Xenopus proteome. A potential question
is also posed due to the RNA seq data if these mutations alter the one-carbon
metabolic pool. They are potentially reducing the levels of S-Adenosyl-Methionine,
which will have global consequences on protein and DNA methylation.
5. BMP proteins and their target transcriptional repressors: VENTX is
upregulated during the neural stage in the G90R mutant. We observed
upregulation of a neural-specification pathway involved bmp2/4 and one of its
downstream effectors ventx. Significantly, these genes are tightly regulated during
gastrulation – early neurulation. Hence, seeing them be upregulated at stage 17
suggests aberrant transcriptional activity in the G90R embryo.
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In conclusion, these findings highlight the significance of studying the effects of
germline histone H3.3 mutations in multiple models. We provide the first profiling of
these pathogenic variants during development and in proliferating cells. Furthermore, we
determined multiple pathways that are affected by these mutations, most of which involve
metabolism. Based on our evidence, we believe there is a crucial role for H3.3 in neural
crest cell specification, and in these mutant embryos, this is dysregulated. This work was
the beginning of the Garcia lab’s goal of characterizing the germline histone H3.3 variants.

4.2

Future Directions
The work presented here set an excellent foundation for the characterization of

these mutations. However, many other experiments could be performed stemming from
this data. An initial follow-up involves determining the validity of the effects seen in the
HEK 293Ts using additional assays. For example, Reverse transcription-polymerase chain
reaction (RT-PCR), immunoblotting, and immunofluorescence for live-cell imaging
experiments must be conducted to corroborate the proteomic and transcriptomic data.
The data in this manuscript provided a few putative gene and protein targets that could be
pharmacologically altered. These include some transcription factors and some metabolic
enzymes. These findings must be followed up on as there is a high degree of overlap
between candidate proteins and other neurodevelopmental disorders.
These mutations must be introduced to primary cell lines, including human
embryonic stem cells (hESCs), murine neurons, and glial cells. We would fully explore the
effects of these germline mutations on differentiation into different lineages within this
cell line. Specifically, the ectomesenchymal transition should be explored in the context of
these germline mutations, given the role H3.3 has in mediating that transition. Neural
crest stem cells are also a favorable cellular environment to study these mutations since
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the observations in the Xenopus pointed to dysfunction in the genome of these cells. As
the derivatives of these cells, including osteoblasts and melanocytes.
Based on the histone post-translational modifications, the effects of these
mutations

should

be

assessed

genome-wide

scale.

For

example,

chromatin

immunoprecipitation coupled to sequencing (ChiP-seq) and DNA methylation assays such
as sodium bisulfite conversion and sequencing is critical experiments needed to be done.
Moreover, the alterations to the one-carbon metabolic pool but no histone methylation
changes could suggest other types of methylation. Therefore, it would be essential to
determine if these mutations can affect DNA methylation or other forms of protein
methylation.
Given the extensive evidence of H3.3 dysregulation seen in the G90R mutant. It is
essential to determine how it is incorporated into the genome as the primary contact point
for H3.3 chaperones in ablated. In our ChIP-MS experiment, we were unable to identify
peptides of HIRA or DAXX. However, we did find a loss of interaction with ATRX, which
would be worth exploring. However, ChIP-MS is just one measure of protein-protein
interaction. We should employ immunocytochemistry in cells to look at the colocalization
of the G90R mutant and its chaperones. On the biochemistry side, we should also look at
isothermal calorimetry (ITC) and other in vitro binding assays with this mutant and its
chaperones.
Based on our data, we can infer that these mutations potentially affect nucleosome
stability. However, this was not directly tested. Therefore, we must perform Hydrogen
deuterium exchange coupled mass spectrometry to look at the solvent accessibility of the
nucleosomes containing these mutations. Determining if the DNA binds looser or stronger
to the mutant containing octamer will infer a lot on nucleosome stability. Another
essential experiment is Assay for Transposase-Accessible Chromatin using sequencing
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(ATAC-seq) in cells stably expressing these mutants. This will aid in our understanding of
how the mutants affect nucleosome arrays and chromatin compaction. Lastly, using Stable
Isotope Labeling by/with Amino acids in Cell culture (SILAC), we could assess the
turnover of these mutant histones in the genome. Ultimately these experiments will be
beneficial for determining the effects of these mutations and the mechanisms involved in
the pathological germline mutants.
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